2023


  1. Hiller GGR, Höhn AK, Mayr D, Brambs CE, Horn LC (2023). Molecular classification of endometrial carcinoma - a short summary for clinical use Pathologie, 44, 392-400.
     
  2. Brambs CE, Horn LC, Hiller R, Krücken I, Braun C, Christmann C, Monecke A, Höhn AK (2023). Mesonephric-like adenocarcinoma of the female genital tract: possible role of KRAS-targeted treatment-detailed molecular analysis of a case series and review of the literature for targetable somatic KRAS-mutations. J Cancer Res Clin Oncol, 149(17), 15727-15736.
     
  3. Hiller GGR, Höhn AK, Krücken I, Hagert-Winkler A, Martin M, Pilny A, Plett H, Brambs CE, Horn LC (2023). Mesonephric-Like Adenocarcinoma of the Endometrium Mimicking Advanced Tubo-Ovarian Cancer - A Literature Review Based on a Special Case Cancer Research Journal, 11, 127-135.
     
  4. Boeschen M, Kuhn CK, Wirtz H, Seyfarth HJ, Frille A, Lordick F, Hacker UT, Obeck U, Stiller M, Bläker H, von Laffert M (2023). Comparative bioinformatic analysis of KRAS, STK11 and KEAP1 (co-)mutations in non-small cell lung cancer with a special focus on KRAS G12C. Lung Cancer, 184(), 107361.
     
  5. Bläker H (2023). Hereditary colorectal carcinogenesis. Pathologie (Heidelb), 44(5), 311-317.
     
  6. Bläker H (2023). Colorectal cancer-The role of pathology. Pathologie (Heidelb), 44(5), 277-278.
     
  7. Ahadova A, Stenzinger A, Seppälä T, Hüneburg R, Kloor M, Bläker H (2023). A "Two-in-One Hit" Model of Shortcut Carcinogenesis in MLH1 Lynch Syndrome Carriers. Gastroenterology, 165(1), 267-270.e4.
     
  8. Ahadova A, Stenzinger A, Seppälä T, Hüneburg R, Kloor M, Bläker H (2023). [The two-in-one hit model of the short-cut carcinogenesis of colorectal carcinomas in MLH1-associated Lynch syndrome]. Pathologie (Heidelb), 44(Suppl 3), 188-192.
     
  9. Boeschen M, Le Duc D, Stiller M, von Laffert M, Schöneberg T, Horn S (2023). Interactive webtool for analyzing drug sensitivity and resistance associated with genetic signatures of cancer cell lines. J Cancer Res Clin Oncol, 149(9), 5539-5545.
     
  10. Horn LC, Krücken I, Hiller GGR, Niedermair M, Perac K, Pietsch C, Höhn AK (2023). Placental pathology in sudden intrauterine death (SIUD) in SARS-CoV-2-positive oligosymptomatic women. Arch Gynecol Obstet, 307(6), 1811-1822.
     
  11. Tempfer C, Horn LC, Ackermann S, Dittrich R, Einenkel J, Günthert A, Haase H, Kratzsch J, Kreißl M, Polterauer S, Ebert A, Steiner E, Thiel F, Eichbaum M, Fehm T, Koch MC, Gass P (2023). Gestational and Non-gestational Trophoblastic Neoplasia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No.?032/049, April 2022). Geburtshilfe Frauenheilkd, 83(3), 267-288.
     
  12. Emons G, Steiner E, Vordermark D, Uleer C, Paradies K, Tempfer C, Aretz S, Cremer W, Hanf V, Mallmann P, Ortmann O, Römer T, Schmutzler RK, Horn LC, Kommoss S, Lax S, Schmoeckel E, Mokry T, Grab D, Reinhardt M, Steinke-Lange V, Brucker SY, Kiesel L, Witteler R, Fleisch MC, Friedrich M, Höcht S, Lichtenegger W, Mueller M, Runnebaum I, Feyer P, Hagen V, Juhasz-Böss I, Letsch A, Niehoff P, Zeimet AG, Battista MJ, Petru E, Widhalm S, van Oorschot B, Panke JE, Weis J, Dauelsberg T, Haase H, Beckmann (2023). Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures. Geburtshilfe Frauenheilkd, 83(8), 919-962.
     
  13. König T, Dogan S, Höhn AK, Weydandt L, Aktas B, Nel I (2023). Multi-Parameter Analysis of Disseminated Tumor Cells (DTCs) in Early Breast Cancer Patients with Hormone-Receptor-Positive Tumors. Cancers (Basel), 15(3), 568.
     
  14. Horn LC, Krücken I, Hiller GGR, Niedermair M, Perac K, Pietsch C, Höhn AK (2023). Placental pathology in sudden intrauterine death (SIUD) in SARS-CoV-2-positive oligosymptomatic women. Arch Gynecol Obstet, 307(6), 1811-1822.
     
  15. Wolf B, Weydandt L, Dornhöfer N, Hiller GGR, Höhn AK, Nel I, Jain RK, Horn LC, Aktas B (2023). Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype. Sci Rep, 13(1), 18946.
     
  16. Schwarzkopf L, Büttner P, Scholtyssek K, Schröter T, Hiller R, Hindricks G, Bollmann A, Laufs U, Ueberham L (2023). C-kit(pos) cells in the human left atrial appendage. Heliyon, 9(11), 21268.
     
  17. Gorczy?ski A, Miszewski K, Gager Y, Koch S, Pötschke J, Ugrinovski D, Gabert J, Pospieszy?ska A, Wydra D, Duchnowska R, Szymanowski B, Cierniak S, Kruecken I, Neumann K, Mirkov K, Biernat W, Czapiewski P (2023). Prognostic value of ALK overexpression and molecular abnormalities in high-grade serous ovarian carcinoma. Cancer Biomark, 38(1), 17-26.
     
  18. Röhl L, Wellhausen J, Berszin M, Krücken I, Zebralla V, Pirlich M, Wiegand S, Dietz A, Wald T, Wichmann G (2023). Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome. Front Immunol, 14(), 1237623.
     
  19. Lückemeier P, Radujkovic A, Holtick U, Kurch L, Monecke A, Platzbecker U, Herling M, Kayser S (2023). Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study. Front Oncol, 13(), 1208028.
     
  20. Lückemeier P, Radujkovic A, Holtick U, Kurch L, Monecke A, Platzbecker U, Herling M, Kayser S (2023). Radical surgery and venetoclax plus azacitidine in an octogenarian with acute myeloid leukemia. Front Oncol, 13(), 1208028.
     
  21. Kuhn CK, Meister J, Kreft S, Stiller M, Puppel SH, Zaremba A, Scheffler B, Ullrich V, Schöneberg T, Schadendorf D, Horn S (2023). TERT expression is associated with metastasis from thin primaries, exhausted CD4+ T cells in melanoma and with DNA repair across cancer entities. PLoS One, 18(7), 281487.
     
  22. Rüschoff J, Schildhaus HU, Rüschoff JH, Jöhrens K, Bocker-Edmonston T, Dietmaier W, Bläker H, Baretton G, Horst D, Dietel M, Hartmann A, Klauschen F, Merkelbach-Bruse S, Stenzinger A, Schöniger S, Tiemann M, Weichert W, Büttner R (2023). Erratum zu: Testung auf Mismatch-Reparatur-Defizienz und Mikrosatelliteninstabilität. Pathologie (Heidelb), 44, 71-72.
     
  23. Rüschoff J, Schildhaus HU, Rüschoff JH, Jöhrens K, Bocker Edmonston T, Dietmaier W, Bläker H, Baretton G, Horst D, Dietel M, Hartmann A, Klauschen F, Merkelbach-Bruse S, Stenzinger A, Schöniger S, Tiemann M, Weichert W, Büttner R (2023). Testing for deficient mismatch repair and microsatellite instability : A focused update. Pathologie (Heidelb), 44, 61-70.
     
  24. Madisch A, Koop H, Miehlke S, Leers J, Lorenz P, Lynen Jansen P, Pech O, Schilling D, Labenz J, Allescher HD, Bläker H, Caca K, Frieling T, Granderath F, Hörning A, Hosie S, Langer R, Messmann H, Möller G, Pehl C, Schlag C, Schmidt-Choudhury A, von Arnim U, Wenzl T (2023). S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) ? März 2023 ? AWMF-Registernummer: 021?013. Z Gastroenterol, 61(7), 862-933.
     
  25. Rüschoff J, Schildhaus HU, Rüschoff JH, Jöhrens K, Bocker-Edmonston T, Dietmaier W, Bläker H, Baretton G, Horst D, Dietel M, Hartmann A, Klauschen F, Merkelbach-Bruse S, Stenzinger A, Schöniger S, Tiemann M, Weichert W, Büttner R (2023). [Testing deficient mismatch repair and microsatellite instability : A focused update. German version]. Pathologie (Heidelb), 44(5), 301-310.
     
  26. Kolbe K, Haffner I, Schierle K, Maier D, Geier B, Luber B, Bläker H, Wittekind C, Lordick F (2023). Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study. J Cancer Res Clin Oncol, 149(3), 1319-1329.
     
  27. Krause A, Stocker G, Gockel I, Seehofer D, Hoffmeister A, Bläker H, Denecke T, Kluge R, Lordick F, Knödler M (2023). Guideline adherence and implementation of tumor board therapy recommendations for patients with gastrointestinal cancer. J Cancer Res Clin Oncol, 149(3), 1231-1240.
     
  28. Lieb S, Heni M, Rauschenberg S, Lange K, Feisthammel J, Bläker H, Wiegand J (2023). Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis. Z Gastroenterol, 61(11), 1500-1503.
     
  29. Dietz A, Wiegand S, Bläker H, Budach W (2023). [Therapy of tumor recurrences or secondary carcinomas in pretreated area is not compatible with the primary therapy in non-previously treated tissue - an overview]. Laryngorhinootologie, 102(12), 908-915.
     
  30. Jansen-Winkeln B, Eberth J, Moulla Y, Mehdorn M, Niebisch S, Schierle K, Bläker H, Lordick F, Gockel I, Thieme R (2023). Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study. J Cancer Res Clin Oncol, 149(3), 1331-1341.
     
  31. Stolze T, Franke S, Haybaeck J, Moehler M, Grimminger PP, Lang H, Roth W, Gockel I, Kreuser N, Bläker H, Wittekind C, Lordick F, Vieth M, Veits L, Waidmann O, Lingohr P, Peitz U, Schildberg C, Kruschewski M, Vassos N, Goni E, Bruns CJ, Ridwelski K, Wolff S, Lippert H, Schumacher J, Malfertheiner P, Venerito M (2023). Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis. J Cancer Res Clin Oncol, 149(3), 1007-1017.
     
  32. Philip M, Puppel SH, Stiller M, Paschen A, Roesch A, Zaremba A, Schadendorf D, Horn S (2023). Database for queries of melanoma cohorts with molecular and clinical data. Pigment Cell Melanoma Res, 36(2), 252-258.
     
  33. Kuhn H, Frille A, Petersen MA, Oberhuber-Kurth J, Hofmann L, Gläser A, Taubenheim S, Klagges S, Kraemer S, Broschewitz J, von Laffert M, Wirtz H (2023). IGFBP3 inhibits tumor growth and invasion of lung cancer cells and is associated with improved survival in lung cancer patients. Transl Oncol, 27(), 101566.
     
  34. Krämer S, Bläker H, Denecke T, Nicolay N, von Laffert M, Lordick F (2023). Lungenmetastasen ? Onkologische Bedeutung und Therapie. best practice onkologie, 18, 242-250.
     


    35. 2022


  35. Horn LC, Höhn AK, Burghaus S, Schäfer SD, Ulrich UA, Schmidt D (2022). [S2k guidelines for the diagnosis and treatment of endometriosis-Recommendations for pathology]. Pathologe, 43(2), 117-125.
     
  36. Thompson EF, Hoang L, Hohn AK, Palicelli A, Talia KL, Tchrakian N, Senz J, Rusike R, Jordan S, Jamieson A, Huvila J, McAlpine JN, Gilks CB, Hockel M, Singh N, Horn LC (2022). Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 32, 977-985.
     
  37. Dannenmann A, Hiller GGR, Hohn AK, Gorling S, Einenkel J, Horn LC (2022). Tumorlike Endmetriosis Mimicking Uterine Sarcoma GEBURTSHILFE UND FRAUENHEILKUNDE, 82, 11-12.
     
  38. Horn LC, Eckey C, Hiller RGG, Hockel M, Krucken I, Obeck U, Stiller M, Hohn KA (2022). Epithelial-mesenchymal transition (EMT) in vulvar cancer GEBURTSHILFE UND FRAUENHEILKUNDE, 82, 30-30.
     
  39. Horn LC, Aktas B, Dannemann A, Einenkel J, Hockel M, Krucken I, Teichmann G, Obeck U, Stiller M, Hohn KA (2022). Differentiated High-Grade Squamous Intraepithelial Lesion of the Uterine Cervix (d-HSLI, d-CIN 3) as a Distinct Precursor Lesion in Keratinising HPV-negative Squamous Cell Carcinoma of the Uterine Cervix GEBURTSHILFE UND FRAUENHEILKUNDE, 82, 29-30.
     
  40. Horn LC, Hiller GGR, Mayr D, Schmoeckel E, Hohn AK (2022). Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification PATHOLOGE, 43, 196-201.
     
  41. Horn LC, Hiller GGR, Mayr D, Schmoeckel E, Höhn AK (2022). Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification PATHOLOGE, 43, 196-201.
     
  42. Horn LC, Beckmann MW, Follmann M, Koch MC, Nothacker M, Pöschel B, Stübs F, Schmidt D, Höhn AK (2022). Revised German guidelines on the diagnosis and treatment of carcinoma of the uterine cervix-what's new for pathologists in 2021 Pathologie (Heidelb), 43(4), 292-302.
     
  43. Brambs CE, Horn LC, Mende M, Höckel M, Eckey C, Hiller GGR, Höhn AK (2022). Epithelial-mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement J Cancer Res Clin Oncol, 148(5), 1183-1193.
     
  44. Thompson EF, Hoang L, Höhn AK, Palicelli A, Talia KL, Tchrakian N, Senz J, Rusike R, Jordan S, Jamieson A, Huvila J, McAlpine JN, Gilks CB, Höckel M, Singh N, Horn LC (2022). Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique. Int J Gynecol Cancer, 32(8), 977-985.
     
  45. Brambs CE, Höhn AK, Klagges S, Gläser A, Taubenheim S, Dornhöfer N, Einenkel J, Hiller GGR, Horn LC (2022). Clinico-pathologic characteristics and prognostic factors of ovarian carcinoma with different histologic subtypes - A benchmark analysis of 482 cases. Pathol Res Pract, 233, 153859.
     
  46. Blaker, H, Langer, R (2022). Report of the working group for gastroenteropathology : 105th annual meeting of the German Society of Pathology PATHOLOGIE, 43, 150-151.
     
  47. Jöhrens K, Fischer J, Möbs M, Junker K, Kirfel J, Perner S, Laßmann S, Werner M, Borgmann V, Bläker H, Hummel M (2022). [Detection of BRAF V600E mutation in metastatic colorectal carcinoma : A QuIP round robin test]. Pathologe, 43(2), 126-134.
     
  48. Bohaumilitzky L, Kluck K, Hüneburg R, Gallon R, Nattermann J, Kirchner M, Kristiansen G, Hommerding O, Pfuderer PL, Wagner L, Echterdiek F, Kösegi S, Müller N, Fischer K, Nelius N, Hartog B, Borthwick G, Busch E, Haag GM, Bläker H, Möslein G, von Knebel Doeberitz M, Seppälä TT, Ahtiainen M, Mecklin JP, Bishop DT, Burn J, Stenzinger A, Budczies J, Kloor M, Ahadova A (2022). The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients. Gastroenterology, 162(3), 907-919.
     
  49. Wrede N, Hoffmann I, Vollbrecht C, Koch I, Wolkenstein P, Klauschen F, Capper D, von Laffert M, Jurmeister P (2022). Comparative investigation of cell cycle and immunomodulatory genes in mucosal and cutaneous melanomas: Preliminary data suggest a potential promising clinical role for p16 and the PD-1/PD-L1 axis. Pathol Res Pract, 229(), 153689.
     
  50. Machens A, Kaatzsch P, Lorenz K, Horn LC, Wickenhauser C, Schmid KW, Dralle H, Siebolts U (2022). Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer. Surgery, 171(2), 360-367.
     
  51. Meyer HJ, Höhn AK, Prasse G, Hoffmann KT, Surov A (2022). Associations between tumor and edema volumes with tumor infiltrating lymphocytes in brain metastasis - A preliminary study. Clin Neurol Neurosurg, 212(), 107088.
     
  52. Szymski D, Opitz S, Pfeifer C, Rupp M, Angele P, Alt V, Krutsch W, Krutsch V (2022). High injury rates and weak injury prevention strategies in football referees at all levels of play. Scand J Med Sci Sports, 32(2), 391-401.
     
  53. Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Fehr M, Follmann M, Haase H, Harter P, Hettmer S, Horn LC, Juhasz-Boess I, Kast K, Köhler G, Kröncke T, Lindel K, Mallmann P, Meyer-Steinacker R, Mustea A, Petru E, Reichardt P, Schmidt D, Strauss HG, Thiel F, Ulrich UA, Vogl T, Vordermark D, Wallwiener M, Gass P, Beckmann MW (2022). Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No.?015/074, April 2021). Geburtshilfe Frauenheilkd, 82(12), 1337-1367.
     
  54. Weydandt L, Kreklau A, Nel I, Horn LC, Aktas B (2022). Heterogeneity between core needle biopsy and primary tumor tissue in early breast cancer patients: Comparison of intrinsic subtypes after different treatment regimes ONCOLOGY RESEARCH AND TREATMENT, 45, 23-23.
     
  55. Weydandt L, Nel I, Kreklau A, Horn LC, Aktas B (2022). Heterogeneity between Core Needle Biopsy and Synchronous Axillary Lymph Node Metastases in Early Breast Cancer Patients-A Comparison of HER2, Estrogen and Progesterone Receptor Expression Profiles during Primary Treatment Regime. Cancers (Basel), 14(8), 0.
     
  56. Fehm T, Stübs FA, Koch MC, Mallmann P, Dannecker C, Dietl A, Sevnina A, Mergel F, Lotz L, Ehret A, Gantert D, Martignoni F, Cieslik JP, Menke J, Ortmann O, Stromberger C, Oechsle K, Hornemann B, Mumm F, Grimm C, Sturdza A, Wight E, Loessl K, Golatta M, Hagen V, Dauelsberg T, Diel I, Münstedt K, Merz E, Vordermark D, Lindel K, Wittekind C, Küppers V, Lellé R, Neis K, Griesser H, Pöschel B, Steiner M, Freitag U, Gilster T, Schmittel A, Friedrich M, Haase H, Gebhardt M, Kiesel L, Reinhardt M, Kreiß (2022). Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No.?032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities. Geburtshilfe Frauenheilkd, 82(2), 181-205.
     
  57. Beckmann MW, Stübs FA, Koch MC, Mallmann P, Dannecker C, Dietl A, Sevnina A, Mergel F, Lotz L, Hack CC, Ehret A, Gantert D, Martignoni F, Cieslik JP, Menke J, Ortmann O, Stromberger C, Oechsle K, Hornemann B, Mumm F, Grimm C, Sturdza A, Wight E, Loessl K, Golatta M, Hagen V, Dauelsberg T, Diel I, Münstedt K, Merz E, Vordermark D, Lindel K, Wittekind C, Küppers V, Lellé R, Neis K, Griesser H, Pöschel B, Steiner M, Freitag U, Gilster T, Schmittel A, Friedrich M, Haase H, Gebhardt M, Kiesel L, Rein (2022). Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No.?032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy. Geburtshilfe Frauenheilkd, 82(2), 139-180.
     
  58. Fehm T, Stübs FA, Koch MC, Mallmann P, Dannecker C, Dietl A, Sevnina A, Mergel F, Lotz L, Ehret A, Gantert D, Martignoni F, Cieslik JP, Menke J, Ortmann O, Stromberger C, Oechsle K, Hornemann B, Mumm F, Grimm C, Sturdza A, Wight E, Loessl K, Golatta M, Hagen V, Dauelsberg T, Diel I, Münstedt K, Merz E, Vordermark D, Lindel K, Wittekind C, Küppers V, Lellé R, Neis K, Griesser H, Pöschel B, Steiner M, Freitag U, Gilster T, Schmittel A, Friedrich M, Haase H, Gebhardt M, Kiesel L, Reinhardt M, Kreiß (2022). Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No.?032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities. Geburtshilfe Frauenheilkd, 82(2), 181-205.
     
  59. Lia M, Horn LC, Sodeikat P, Höckel M, Aktas B, Wolf B (2022). The diagnostic value of core needle biopsy in cervical cancer: A retrospective analysis. PLoS One, 17(1), 0.
     
  60. Machens A, Kaatzsch P, Lorenz K, Horn LC, Wickenhauser C, Schmid KW, Dralle H, Siebolts U (2022). Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer. Surgery, 171(2), 360-367.
     
  61. Reif S, Horn LC, Pietsch C, von Braun A, Wolf B, Aktas B, Dornhofer N (2022). Endomyometritis caused by HSV-2 in an immunocompromised woman GEBURTSHILFE UND FRAUENHEILKUNDE, 82, 147-148.
     
  62. Weydandt L, Wolf B, Horn LC, Aktas B (2022). A new aspect of tumor aggressiveness: the role of desmoplasia in endometrial carcinoma GEBURTSHILFE UND FRAUENHEILKUNDE, 82, 181-182.
     
  63. Fuhs T, Wetzel F, Fritsch AW, Li XZ, Stange R, Pawlizak S, Kiessling TR, Morawetz E, Grosser S, Sauer F, Lippoldt J, Renner F, Friebe S, Zink M, Bendrat K, Braun J, Oktay MH, Condeelis J, Briest S, Wolf B, Horn LC, Hockel M, Aktas B, Marchetti MC, Manning ML, Niendorf A, Bi DP, Kas JA (2022). Rigid tumours contain soft cancer cells NATURE PHYSICS, 0, 0.
     
  64. Steiner E, Horn LC, Mokry T, Lax SF, Mayr D, Cremer W, Prompeler HJ, Grab D, Reinhardt M (2022). Screening, diagnosis, imaging, and pathology GYNÄKOLOGIE, 55, 481-492.
     
  65. Hagedorn C, Berbee C, Dornhofer N, Horn LC, Muller W, Aktas B (2022). Cerebral metastatic mesonephric-like Adenocarcinoma of the Corpus uteri - a rare Case GEBURTSHILFE UND FRAUENHEILKUNDE, 82, 29-29.
     
  66. Wolf B, Horn LC, Hockel M, Aktas B (2022). Tumor-stroma interaction in cervical cancer: The prognostic importance of desmoplasia JOURNAL OF CLINICAL ONCOLOGY, 40, 17519.
     
  67. Mayr D, Horn LC, Hiller GGR, Hohn AK, Schmoeckel E (2022). Endometrial and other rare uterine sarcomas Diagnostic aspects in the context of the 2020 WHO classification PATHOLOGE, 43, 183-195.
     
  68. Aubert O, Wachowiak R, Roth C, Höhn AK, Lacher M, Mayer S (2022). Resection of an Extraovarian Noniuteinized Thecoma in a 14-Year-Old Girl. European J Pediatr Surg Rep, 10(1), 37-40.
     
  69. Mayr D, Horn LC, Hiller GGR, Höhn AK, Schmoeckel E (2022). Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification Pathologe, 43(3), 183-195.
     
  70. Meyer HJ, Höhn AK, Prasse G, Hoffmann KT, Surov A (2022). Associations between tumor and edema volumes with tumor infiltrating lymphocytes in brain metastasis - A preliminary study. Clin Neurol Neurosurg, 212, 107088.
     
  71. Meyer HJ, Höhn AK, Surov A (2022). Associations Between ADC and Tumor Infiltrating Lymphocytes, Tumor-Stroma Ratio and Vimentin Expression in Head and Neck Squamous Cell Cancer. Acad Radiol, 29, 107-113.
     
  72. Münch J, Engesser M, Schönauer R, Hamm JA, Hartig C, Hantmann E, Akay G, Pehlivan D, Mitani T, Coban Akdemir Z, Tüysüz B, Shirakawa T, Dateki S, Claus LR, van Eerde AM, Smol T, Devisme L, Franquet H, Attié-Bitach T, Wagner T, Bergmann C, Höhn AK, Shril S, Pollack A, Wenger T, Scott AA, Paolucci S, Buchan J, Gabriel GC, Posey JE, Lupski JR, Petit F, McCarthy AA, Pazour GJ, Lo CW, Popp B, Halbritter J (2022). Biallelic pathogenic variants in roundabout guidance receptor 1 associate with syndromic congenital anomalies of the kidney and urinary tract. Kidney Int, 101(5), 1039-1053.
     
  73. Wrede N, Hoffmann I, Vollbrecht C, Koch I, Wolkenstein P, Klauschen F, Capper D, von Laffert M, Jurmeister P (2022). Comparative investigation of cell cycle and immunomodulatory genes in mucosal and cutaneous melanomas: Preliminary data suggest a potential promising clinical role for p16 and the PD-1/PD-L1 axis. Pathol Res Pract, 229, 153689.
     
  74. Jurmeister P, Wrede N, Hoffmann I, Vollbrecht C, Heim D, Hummel M, Wolkenstein P, Koch I, Heynol V, Schmitt WD, Thieme A, Teichmann D, Sers C, von Deimling A, Thierauf JC, von Laffert M, Klauschen F, Capper D (2022). Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations. J Pathol, 256(1), 61-70.
     
  75. Hertel M, Heiland M, Nahles S, von Laffert M, Mura C, Bourne PE, Preissner R, Preissner S (2022). Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virus. J Eur Acad Dermatol Venereol, 36(8), 1342-1348.
     
  76. Eisenhardt AE, Schmid A, Esser J, Brugger Z, Lausch U, Kiefer J, Braig M, Runkel A, Wehrle J, Claus R, Bronsert P, Leithner A, Liegl-Atzwanger B, Zeller J, Papini R, von Laffert M, Pfitzner BM, Koulaxouzidis G, Giunta RE, Eisenhardt SU, Braig D (2022). Targeted next-generation sequencing of circulating free DNA enables non-invasive tumor detection in myxoid liposarcomas. Mol Cancer, 21(1), 50.
     
  77. Jurmeister P, Glöß S, Roller R, Leitheiser M, Schmid S, Mochmann LH, Payá Capilla E, Fritz R, Dittmayer C, Friedrich C, Thieme A, Keyl P, Jarosch A, Schallenberg S, Bläker H, Hoffmann I, Vollbrecht C, Lehmann A, Hummel M, Heim D, Haji M, Harter P, Englert B, Frank S, Hench J, Paulus W, Hasselblatt M, Hartmann W, Dohmen H, Keber U, Jank P, Denkert C, Stadelmann C, Bremmer F, Richter A, Wefers A, Ribbat-Idel J, Perner S, Idel C, Chiariotti L, Della Monica R, Marinelli A, Schüller U, Bockmayr M, Li (2022). DNA methylation-based classification of sinonasal tumors. Nat Commun, 13(1), 7148.
     
  78. Lordick F, Hacker U, Hoffmeister A, Blaker H, Gockel I (2022). What is confirmed in the treatment of colon cancer? INNERE MEDIZIN, 63, 1250-1256.
     
  79. Kolbe K, Haffner I, Schierle K, Maier D, Geier B, Luber B, Blaker H, Wittekind C, Lordick F (2022). Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 0, 0.
     
  80. Haffner I, Kolbe K, Schierle K, Maier D, Geier B, Luber B, Wittekind C, Blaker H, Lordick F (2022). Why isn't all Patients confirmed for initial HER2 Status? (Results of the VARIANZ Study) ONCOLOGY RESEARCH AND TREATMENT, 42, 165-165.
     
  81. Felber J, Blaker H, Fischbach W, Koletzko S, Laass M, Lachmann N, Lorenz P, Lynen P, Reese I, Scherf K, Schuppan D, Schumann M (2022). Updated S2k guidelines for celiac disease from the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) December 2021-AWMF registration number: 021-021 ZEITSCHRIFT FUR GASTROENTEROLOGIE, 60, 790-856.
     
  82. Krause A, Stocker G, Gockel I, Seehofer D, Hoffmeister A, Blaker H, Denecke T, Kluge R, Lordick F, Knodler M (2022). Guideline adherence and implementation of tumor board therapy recommendations for patients with gastrointestinal cancer JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 0, 0.
     
  83. Stocker G, Blaker H, Denecke T, Gockel I, Hoffmeister A, Kuhnt T, Hambsch P, Lordick F (2022). Diagnosis and treatment of gastric cancer and adenocarcinoma of the esophago-gastric junction GASTROENTEROLOGE, 17, 120-131.
     
  84. Stolze T, Franke S, Haybaeck J, Moehler M, Grimminger PP, Lang H, Roth W, Gockel I, Kreuser N, Blaker H, Wittekind C, Lordick F, Vieth M, Veits L, Waidmann O, Lingohr P, Peitz U, Schildberg C, Kruschewski M, Vassos N, Goni E, Bruns CJ, Ridwelski K, Wolff S, Lippert H, Schumacher J, Malfertheiner P, Venerito M (2022). Mismatch repair deficiency chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 0, 0.
     
  85. Bohaumilitzky L, Kluck K, Huneburg R, Gallon R, Nattermann J, Kirchner M, Kristiansen G, Hommerding O, Pfuderer PL, Wagner L, Echterdiek F, Kosegi S, Muller N, Fischer K, Nelius N, Hartog B, Borthwick G, Busch E, Haag GM, Blaker H, Moslein G, Doeberitz MV, Seppala TT, Ahtiainen M, Mecklin JP, Bishop DT, Burn J, Stenzinger A, Budczies J, Kloor M, Ahadova A (2022). The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients GASTROENTEROLOGY, 0, 0.
     
  86. Götze KJ, Mrestani A, Beckmann P, Krohn K, Le Duc D, Velluva A, Böhme MA, Heckmann M, Abou Jamra R, Lemke JR, Bläker H, Scholz N, Ljaschenko D, Langenhan T (2022). Improving one-step scarless genome editing in Drosophila melanogaster by combining ovo(D) co-CRISPR selection with sgRNA target site masking. Biol Methods Protoc, 7(1), 0.
     
  87. Auer TA, Fehrenbach U, Grieser C, Penzkofer T, Geisel D, Schmelzle M, Müller T, Bläker H, Seehofer D, Denecke T (2022). Correction to: Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Eur Radiol, 32(5), 3609.
     
  88. Jöhrens K, Fischer J, Möbs M, Junker K, Kirfel J, Perner S, Laßmann S, Werner M, Borgmann V, Bläker H, Hummel M (2022). [Detection of BRAF V600E mutation in metastatic colorectal carcinoma : A QuIP round robin test]. Pathologe, 43(2), 126-134.
     
  89. Agaimy A, Arbogast H, Barth T, Blaker H, Bode PK, Boor P, Braunschweig T, Bubendorf L, Buhl R, Dalquen P, Danebrock R, Dertinger S, Dietmaier W, Dirnhofer S, Drebber U, Eckert C, Erbersdobler A, Evert M, Fangerau H, Feist H, Feuerhake F, Flechtenmacher C, Franke N, Fritz F, Gaida M, Gaisa N, Gaiser T, Grabsch H, Gross D, Hackert T, Haller F, Hammerle M, Hansch G, Hartleben B, Hartmann A, Hayback J, Hewer E, Hopfer H, Horst D, Hummel M, Jesinghaus M, Johrens K, Klauschen F, Knuchel-Clarke R, Komm (2022). Dank an die Gutachter*innen von Der Pathologe. Pathologe, 43(1), 3-4.
     
  90. Kowalleck U, Ahmed MAA, Koedel J, Schierle K, Salameh A, Rassler B (2022). Relaxin does not prevent development of hypoxia-induced pulmonary edema in rats. Pflugers Arch, 474(10), 1053-1067.
     
  91. Ramdohr F, Hennings R, Monecke A, Kayser S (2022). Radical surgery and venetoclax + azacitidine in an octogenarian with acute myeloid leukemia. Haematologica, 0, 0.
     
  92. Ramdohr F, Fabarius A, Maier B, Bretschneider D, Jauch A, Monecke A, Metzeler KH, Janssen JWG, Schlenk RF, Kayser S (2022). Atypical presentation of patients with chronic myeloid leukemia in chronic phase-Case report. Front Oncol, 12, 960914.
     
  93. Mertens M, Schumann I, Stiller M, Lemke JR, Strehlow V, Hentschel J (2022). Genetische Tumorprädispositionssyndrome Onkologie, 28, 534-545.
     
  94. Philip M, Puppel SH, Stiller M, Paschen A, Roesch A, Zaremba A, Schadendorf D, Horn S (2022). Database for queries of melanoma cohorts with molecular and clinical data. Pigment Cell Melanoma Res, 0, 0.
     


    95. 2021


  95. Bläker H (2021). [Meeting of the Gastroenteropathology Working Group on 10 June 2021 : 105th annual conference of the German Society of Pathology, online conference]. Pathologe, 42(Suppl 2), 178-179.
     
  96. Höhn AK, Brambs CE, Erber R, Hiller GGR, Mayr D, Schmidt D, Schmoeckel E, Horn LC (2021). [Reporting and handling of lymphonodectomy specimens in gynecologic malignancies and sentinel lymph nodes]. Pathologe, 42(3), 319-327.
     
  97. Horn LC, Höhn AK, Hampl M, Mehlhorn G, Follmann M, Schnürch HG (2021). [Interdisciplinary S2k guidelines on the diagnosis and treatment of vaginal carcinoma and its precursors-recommendations on surgical pathology for histopathological workup, diagnostics, and reporting]. Pathologe, 42(1), 116-124.
     
  98. Höhn AK, Klagges S, Gläser A, Taubenheim S, Dornhöfer N, Einenkel J, Hiller GGR, Brambs CE, Horn LC (2021). Increase of fallopian tube and decrease of ovarian carcinoma: fact or fake? J Cancer Res Clin Oncol, 147(3), 911-925.
     
  99. Mayr D, Schmoeckel E, Höhn AK, Hiller GGR, Horn LC (2021). [Current WHO classification of the female genitals : Many new things, but also some old]. Pathologe, 42(3), 259-269.
     
  100. Höhn AK, Brambs CE, Hiller GGR, May D, Schmoeckel E, Horn LC (2021). 2020 WHO Classification of Female Genital Tumors. Geburtshilfe Frauenheilkd, 81(10), 1145-1153.
     
  101. Brambs CE, Horn LC, Mende M, Höckel M, Eckey C, Hiller GGR, Höhn AK (2021). Epithelial-mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement. J Cancer Res Clin Oncol, (), 907-919.
     
  102. Meyer HJ, Höhn AK, Surov A (2021). Associations between dynamic-contrast enhanced MRI and tumor infiltrating lymphocytes and tumor-stroma ratio in head and neck squamous cell cancer. Cancer Imaging, 21(1), 60.
     
  103. Braunschweig T, Schierle K (2021). [Report of the History and Ethics of Pathology Working Group : Virtual working group meeting during the Virtual Pathology Days of the German Society of Pathology (ViPa2021), 9 June 2021]. Pathologe, 42(Suppl 2), 180-181.
     
  104. Ahadova A, Seppälä TT, Engel C, Gallon R, Burn J, Holinski-Feder E, Steinke-Lange V, Möslein G, Nielsen M, Ten Broeke SW, Laghi L, Dominguez-Valentin M, Capella G, Macrae F, Scott R, Hüneburg R, Nattermann J, Hoffmeister M, Brenner H, Bläker H, von Knebel Doeberitz M, Sampson JR, Vasen H, Mecklin JP, Møller P, Kloor M (2021). The "unnatural" history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance. Int J Cancer, 148(4), 800-811.
     
  105. Rüschoff J, Baretton G, Bläker H, Dietmaier W, Dietel M, Hartmann A, Horn LC, Jöhrens K, Kirchner T, Knüchel R, Mayr D, Merkelbach-Bruse S, Schildhaus HU, Schirmacher P, Tiemann M, Tiemann K, Weichert W, Büttner R (2021). MSI testing : What's new? What should be considered? Pathologe, 42, 110-118.
     
  106. Alwers E, Jansen L, Kather J, Amitay E, Bläker H, Kloor M, Tagscherer KE, Roth W, Herpel E, Chang-Claude J, Brenner H, Hoffmeister M (2021). Response to neoadjuvant treatment among rectal cancer patients in a population-based cohort. Int J Colorectal Dis, 36, 177-185.
     
  107. Le Duc D, Hentschel J, Neuser S, Stiller M, Meier C, Jäger E, Abou Jamra R, Platzer K, Monecke A, Ziemer M, Markovic A, Bläker H, Lemke JR (2021). In cis TP53 and RAD51C pathogenic variants may predispose to sebaceous gland carcinomas. Eur J Hum Genet, 29(3), 489-494.
     
  108. Dobrindt EM, Saeger W, Bläker H, Mogl MT, Bahra M, Pratschke J, Rayes N (2021). The challenge to differentiate between sarcoma or adrenal carcinoma-an observational study. Rare Tumors, 13(), 20363613211057746.
     
  109. Adam P, Kircher S, Sbiera I, Koehler VF, Berg E, Knösel T, Sandner B, Fenske WK, Bläker H, Smaxwil C, Zielke A, Sipos B, Allelein S, Schott M, Dierks C, Spitzweg C, Fassnacht M, Kroiss M (2021). FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale. Front Endocrinol (Lausanne), 12(), 712107.
     
  110. Zimmermann A, Hänsel R, Gemünden K, Kegel-Hübner V, Babel J, Bläker H, Matz-Soja M, Seehofer D, Damm G (2021). In Vivo and In Vitro Characterization of Primary Human Liver Macrophages and Their Inflammatory State. Biomedicines, 9(4), 406-406.
     
  111. Haupt S, Zeilmann A, Ahadova A, Bläker H, von Knebel Doeberitz M, Kloor M, Heuveline V (2021). Mathematical modeling of multiple pathways in colorectal carcinogenesis using dynamical systems with Kronecker structure. PLoS Comput Biol, 17(5), 406-406.
     
  112. Glöss S, Jurmeister P, Thieme A, Schmid S, Cai WY, Serrette RN, Perner S, Ribbat-Idel J, Pagenstecher A, Bläker H, Keber U, Stadelmann C, Zechel S, Johann PD, Hasselblatt M, Paulus W, Thomas C, Dohmen H, Baumhoer D, Frank S, Agaimy A, Schüller U, Vasudevaraja V, Snuderl M, Liu CZ, Pfister DG, Jungbluth AA, Ghossein RA, Xu B, Capper D, Dogan S (2021). IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable Outcome. Am J Surg Pathol, 45(9), 1190-1204.
     
  113. Ahadova A, Pfuderer PL, Ahtiainen M, Ballhausen A, Bohaumilitzky L, Kösegi S, Müller N, Tang YL, Kosmalla K, Witt J, Endris V, Stenzinger A, von Knebel Doeberitz M, Bläker H, Renkonen-Sinisalo L, Lepistö A, Böhm J, Mecklin JP, Seppälä TT, Kloor M (2021). Distinct Mutational Profile of Lynch Syndrome Colorectal Cancers Diagnosed under Regular Colonoscopy Surveillance. J Clin Med, 10(11), 907-919.
     
  114. Busch E, Ahadova A, Kosmalla K, Bohaumilitzky L, Pfuderer PL, Ballhausen A, Witt J, Wittemann JN, Bläker H, Holinski-Feder E, Jäger D, von Knebel Doeberitz M, Haag GM, Kloor M (2021). Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers. Front Oncol, 11(), 669774.
     
  115. Striefler JK, Riess H, Lohneis P, Bischoff S, Kurreck A, Modest DP, Bahra M, Oettle H, Sinn M, Bläker H, Denkert C, Stintzing S, Sinn BV, Pelzer U (2021). Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study. Front Oncol, 11(), 670-396.
     
  116. Auer TA, Fehrenbach U, Grieser C, Penzkofer T, Geisel D, Schmelzle M, Müller T, Bläker H, Seehofer D, Denecke T (2021). Correction to: Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Eur Radiol, (), 907-919.
     
  117. Frost N, Kollmeier J, Misch D, Vollbrecht C, Grah C, Matthes B, Pultermann D, Olive E, Raspe M, Ochsenreither S, von Laffert M, Suttorp N, Witzenrath M, Grohé C (2021). Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (? 50%) NSCLC: Real-world Results with Special Focus on PS ? 2, Brain Metastases, and Steroids. Clin Lung Cancer, 22(5), 411-422.
     
  118. Burghaus S, Schäfer SD, Beckmann MW, Brandes I, Brünahl C, Chvatal R, Draho?ovský J, Dudek W, Ebert AD, Fahlbusch C, Fehm T, Fehr PM, Hack CC, Häuser W, Hancke K, Heinecke V, Horn LC, Houbois C, Klapp C, Kramer H, Krentel H, Langrehr J, Matuschewski H, Mayer I, Mechsner S, Müller A, Müller A, Müller M, Oppelt P, Papathemelis T, Renner SP, Schmidt D, Schüring A, Schweppe KW, Seeber B, Siedentopf F, Sirbu H, Soeffge D, Weidner K, Zraik I, Ulrich UA (2021). Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020). Geburtshilfe Frauenheilkd, 81(4), 422-446.
     
  119. Schaudinn A, Michaelis J, Franz T, Ho-Thi P, Horn LC, Blana A, Hadaschik B, Stumpp P, Stolzenburg JU, Schlemmer HP, Denecke T, Busse H, Ganzer R, Linder N (2021). High-intensity focused ultrasound (HIFU) hemiablation of the prostate: Late follow-up MRI findings in non-recurrent patients. Eur J Radiol, 144(), 109957.
     
  120. Beckmann MW, Stuebs FA, Vordermark D, Koch MC, Horn LC, Fehm T (2021). The Diagnosis, Treatment, and Aftercare of Cervical Carcinoma. Dtsch Arztebl Int, 118(47), 806-812.
     
  121. Sodeikat P, Lia M, Martin M, Horn LC, Höckel M, Aktas B, Wolf B (2021). The Importance of Clinical Examination under General Anesthesia: Improving Parametrial Assessment in Cervical Cancer Patients. Cancers (Basel), 13(12), 907-919.
     
  122. Meyer HJ, Leonhardi J, Höhn AK, Pappisch J, Wirtz H, Denecke T, Frille A (2021). CT Texture Analysis of Pulmonary Neuroendocrine Tumors-Associations with Tumor Grading and Proliferation. J Clin Med, 10(23), 670-396.
     
  123. Meyer HJ, Hohn AK, Prasse G, Hoffmann KT, Surov A (2021). Associations Between ADC Texture Analysis and Tumor Infiltrating Lymphocytes in Brain Metastasis - A Preliminary Study. Anticancer Res, 41(9), 4549-4554.
     
  124. Meyer HJ, Höhn AK, Surov A (2021). Histogram parameters derived from T1 and T2 weighted images correlate with tumor infiltrating lymphocytes and tumor-stroma ratio in head and neck squamous cell cancer. Magn Reson Imaging, 80(), 127-131.
     
  125. Meyer HJ, Höhn AK, Surov A (2021). Relationships between apparent diffusion coefficient (ADC) histogram analysis parameters and PD-L 1-expression in head and neck squamous cell carcinomas: a preliminary study. Radiol Oncol, 55(2), 150-157.
     
  126. Brückner L, Reinshagen A, Hoang NA, Höhn AK, Lordick F, Bechmann I, Aktas B, Nel I, Kallendrusch S (2021). FOXM1 Inhibition in Ovarian Cancer Tissue Cultures Affects Individual Treatment Susceptibility Ex Vivo. Cancers (Basel), 13(5), 512-513.
     
  127. Meyer HJ, Hamerla G, Höhn AK, Hoffmann KT, Surov A (2021). Perifocal edema volume is not associated with immunohistochemical features reflecting proliferation potential, microvessel density, neoangiogenesis and invasiveness in brain metastasis. Clin Neurol Neurosurg, 202(), 106537.
     
  128. Meyer HJ, Höhn AK, Woidacki K, Andric M, Powerski M, Pech M, Surov A (2021). Associations between IVIM histogram parameters and histopathology in rectal cancer. Magn Reson Imaging, 77(), 21-27.
     
  129. Remtisch L, Wiltberger G, Schierle K, Yousef M, Thieme R, Jansen Winkeln B, Wittekind C, Gockel I, Lyros O (2021). The WNT5A/ROR2 signaling pathway in pancreatic ductal adenocarcinoma (PDAC). J BUON, 26(4), 1595-1606.
     
  130. Maktabi M, Tkachenko M, Kohler H, Schierle K, Gockel I, Jansen-Winkeln B, Chalopin C (2021). Using physiological parameters measured by hyperspectral imaging to detect colorectal cancer. Annu Int Conf IEEE Eng Med Biol Soc, 2021(), 3865-3868.
     
  131. Rhode P, Mehdorn M, Lyros O, Kahlert C, Kurth T, Venus T, Schierle K, Estrela-Lopis I, Jansen-Winkeln B, Lordick F, Gockel I, Thieme R (2021). Characterization of Total RNA, CD44, FASN, and PTEN mRNAs from Extracellular Vesicles as Biomarkers in Gastric Cancer Patients. Cancers (Basel), 13(23), 907-919.
     
  132. Haffner I, Schierle K, Raimúndez E, Geier B, Maier D, Hasenauer J, Luber B, Walch A, Kolbe K, Riera Knorrenschild J, Kretzschmar A, Rau B, Fischer von Weikersthal L, Ahlborn M, Siegler G, Fuxius S, Decker T, Wittekind C, Lordick F (2021). HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study. J Clin Oncol, 39(13), 1468-1478.
     
  133. Appelt P, Gabriel P, Bölter C, Fiedler N, Schierle K, Salameh A, Rassler B (2021). Left ventricular depression and pulmonary edema in rats after short-term normobaric hypoxia: effects of adrenergic blockade and reduced fluid load. Pflugers Arch, 473(11), 1723-1735.
     
  134. Jansen-Winkeln B, Barberio M, Chalopin C, Schierle K, Diana M, Köhler H, Gockel I, Maktabi M (2021). Feedforward Artificial Neural Network-Based Colorectal Cancer Detection Using Hyperspectral Imaging: A Step towards Automatic Optical Biopsy. Cancers (Basel), 13(5), 406-406.
     
  135. Rudolph J, Zebralla V, Gradistanac T, Dietz A (2021). [Interdisciplinary Management of a subglottical stenosis during pregnancy]. Laryngorhinootologie, 100(1), 54-56.
     
  136. Wichmann G, Pavlychenko M, Willner M, Halama D, Kuhnt T, Kluge R, Gradistanac T, Fest S, Wald T, Lethaus B, Dietz A, Wiegand S, Zebralla V (2021). Standardized Diagnostic Workup and Patient-Centered Decision Making for Surgery and Neck Dissection Followed by Risk-Factor Adapted Adjuvant Therapy Improve Loco-Regional Control in Local Advanced Oral Squamous Cell Carcinoma. Front Oncol, 11(), 737080.
     
  137. Spindler N, Moter A, Wiessner A, Gradistanac T, Borger M, Rodloff AC, Langer S, Kikhney J (2021). Fluorescence in situ Hybridization (FISH) in the Microbiological Diagnostic of Deep Sternal Wound Infection (DSWI). Infect Drug Resist, 14(), 2309-2319.
     
  138. Wichmann G, Willner M, Kuhnt T, Kluge R, Gradistanac T, Wald T, Fest S, Lordick F, Dietz A, Wiegand S, Zebralla V (2021). Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients. Front Oncol, 11(), 682088.
     
  139. Höra A, Wilhelm T, Rudhart SA, Hoch S, Gradistanac T, Stankovic P (2021). [Osteolytic tumor of the forehead causing impression to the frontal lobe]. Laryngorhinootologie, (), 406-406.
     
  140. Roschke E, von der Höh NH, Dietz A, Stingu CS, Gradistanac T, Henkelmann J, Heyde CE (2021). A Rare Case of Wear Induced Complications after Cervical Disc Replacement. Z Orthop Unfall, (), 670-396.
     
  141. Meyer HJ, Monecke A, Hagert-Winkler A (2021). Pannikulitis der Mamma ? eine seltene Differenzialdiagnose der Mamma. Rofo, 193(11), 1327-1330.
     
  142. Ramdohr F, Monecke A, Jentzsch M, Zehrfeld T, Borte G, Schwind S, Franke GN, Metzeler KH, Platzbecker U, Vucinic V (2021). Extramedullary Clonal Hematopoiesis with Indeterminate Potential. Clin Lymphoma Myeloma Leuk, 21(9), 696-698.
     
  143. Meyer HJ, Pönisch W, Monecke A, Gundermann P, Surov A (2021). Bone mineral density in patients with systemic mastocytosis: correlations with clinical and histopathological features. Clin Exp Rheumatol, 39(1), 52-57.
     
  144. Junk D, Krämer S, Broschewitz J, Laura H, Massa C, Moulla Y, Hoang NA, Monecke A, Eichfeld U, Bechmann I, Lordick F, Seliger B, Kallendrusch S (2021). Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibition. Cell Death Discov, 7(1), 264.
     
  145. Hußtegge M, Hoang NA, Rebstock J, Monecke A, Gockel I, Weimann A, Schumacher G, Bechmann I, Lordick F, Kallendrusch S, Körfer J (2021). PD-1 inhibition in patient derived tissue cultures of human gastric and gastroesophageal adenocarcinoma. Oncoimmunology, 10(1), 1960729.
     
  146. Franke GN, Dumann K, Jentzsch M, Monecke A, Doehring C, Nehring-Vucinic C, Schwind S, Niederwieser D, Platzbecker U, Ziemer M, Vucinic V (2021). Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome. Front Oncol, 11(), 749691.
     
  147. Gerhardt K, Jentzsch M, Georgi T, Sretenovi? A, Cross M, Bach E, Monecke A, Leiblein S, Hoffmann S, Todorovi? M, Bila J, Sabri O, Schwind S, Franke GN, Platzbecker U, Vu?ini? V (2021). Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two Cases. Front Oncol, 11(), 737645.
     
  148. Bartsch F, Eberhard J, Rückert F, Schmelzle M, Lehwald-Tywuschik N, Fichtner-Feigl S, Gaedcke J, Oldhafer KJ, Oldhafer F, Diener M, Mehrabi A, Settmacher U, Becker T, Keck T, Friess H, Strücker B, Opitz S, Lemke J, Schnitzbauer A, Lang H (2021). Repeated resection for recurrent intrahepatic cholangiocarcinoma: A retrospective German multicentre study. Liver Int, 41(1), 180-191.
     
  149. Liebmann N, Sterker I, Sorge I, Opitz S, Merkenschlager A, Gburek-Augustat J (2021). [Unusual Localisation of a Borrelia Lymphocytoma]. Klin Monbl Augenheilkd, (), 512-513.
     
  150. Bielow T, Blank V, Opitz S, Gößmann H, Hecker M, Seehofer D, Lübbert C, Karlas T (2021). Klebsiella Pneumoniae Liver Abscess Syndrome - A Challenge for Contrast-Enhanced Ultrasound. Ultrasound Int Open, 7(1), 2-5.
     
  151. Panitz N, Gerhardt K, Becker C, Schleife H, Bach E, Opitz S, Schaudinn A, Platzbecker U, Kayser S (2021). Two rare cases of bronchus-associated lymphoid tissue lymphoma successfully treated with rituximab-bendamustine. Clin Case Rep, 9(8), 04557.
     
  152. Scheiter A, Keil F, Lüke F, Grosse J, Verloh N, Opitz S, Schlosser S, Kandulski A, Pukrop T, Dietmaier W, Evert M, Calvisi DF, Utpatel K (2021). Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy. Curr Oncol, 28(2), 1161-1169.
     
  153. Wang SY, Thomassen K, Kurch L, Opitz S, Franke GN, Bach E, Platzbecker U, Kayser S (2021). Combination of Tagraxofusp and Azacitidine Is an Effective Option for Relapsed Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem-Cell Transplantation. Clin Lymphoma Myeloma Leuk, 21(7), 579-582.
     
  154. Bähr I, Pörtner OJ, Glass M, Doberstein H, Goritz V, Hiller GGR, Spielmann J, Kielstein H (2021). Characterization of natural killer cells in colorectal tumor tissue of rats fed a control diet or a high-fat diet. Ann Anat, 233(), 151586.
     
  155. Seliger G, Bergner M, Haase R, Stepan H, Schleußner E, Zöllkau J, Seeger S, Kraus FB, Hiller GGR, Wienke A, Tchirikov M (2021). Daily monitoring of vaginal interleukin 6 as a predictor of intraamniotic inflammation after preterm premature rupture of membranes - a new method of sampling studied in a prospective multicenter trial. J Perinat Med, 49(5), 572-582.
     
  156. Vershinina AO, Heintzman PD, Froese DG, Zazula G, Cassatt-Johnstone M, Dalén L, Der Sarkissian C, Dunn SG, Ermini L, Gamba C, Groves P, Kapp JD, Mann DH, Seguin-Orlando A, Southon J, Stiller M, Wooller MJ, Baryshnikov G, Gimranov D, Scott E, Hall E, Hewitson S, Kirillova I, Kosintsev P, Shidlovsky F, Tong HW, Tiunov MP, Vartanyan S, Orlando L, Corbett-Detig R, MacPhee RD, Shapiro B (2021). Ancient horse genomes reveal the timing and extent of dispersals across the Bering Land Bridge. Mol Ecol, 30(23), 6144-6161.
     
  157. Zacher P, Mayer T, Brandhoff F, Bartolomaeus T, Le Duc D, Finzel M, Heinze A, Horn S, Klöckner C, Körber G, Hentschel J, Kalita M, Krey I, Nastainczyk-Wulf M, Platzer K, Rebstock J, Popp B, Stiller M, Teichmann AC, Jamra RA, Lemke JR (2021). The genetic landscape of intellectual disability and epilepsy in adults and the elderly: a systematic genetic work-up of 150 individuals. Genet Med, 23(8), 1492-1497.
     
  158. Stocker G, Blaker H, Denecke T, Gockel I, Hoffmeister A, Kuhnt T, Hambsch P, Lordick F (2021). Diagnosis and treatment of gastric cancer and adenocarcinoma of the esophago-gastric junction. Onkologe, 10, 1033-1044.
     
  159. Wolf B, Horn LC, Aktas B, Dornhofer N (2021). R1 Conization in Cervical Cancer: Impact on Prognosis and Tumor Biology Geburtshilfe Frauenheilkd, 06, 36-37.
     
  160. Wolf B, Horn LC, Aktas B, Dornhofer N (2021). Prognostic Significance of histological Subtype in Cervical Carcinoma - new Answers to an old Question Geburtshilfe Frauenheilkd, 06, 42-43.
     
  161. Lia M, Horn LC, Sodeikat P, Hockel M, Aktas B, Wolf B (2021). The diagnostic value of core needle biopsy in cervical cancer: A retrospective analysis. J Clin Oncol, 15, 0.
     
  162. Weydandt L, Nel I, Kreklau A, Horn LC, Aktas B (2021). Heterogeneity between core needle biopsy and synchronous axillary lymph node metastases in early breast cancer patients: Comparison of HER2, estrogen and progesterone receptor expression profiles during primary treatment regime. J Clin Oncol, 15, 0.
     
  163. Wolf B, Sodeikat P, Lia M, Martin M, Horn LC, Hockel M, Aktas B (2021). Parametrial evaluation in cervical cancer by magnetic resonance imaging and clinical examination: Analysis of data from the prospective Leipzig School MMR study. J Clin Oncol, 15, 0.
     
  164. Grosser S, Lippoldt J, Oswald L, Merkel M, Sussman DM, Renner F, Gottheil P, Morawetz EW, Fuhs T, Xie XF, Pawlizak S, Fritsc AW, Wolf B, Horn LC, Briest S, Aktas B, Manning ML, Kas JA (2021). Cell and Nucleus Shape as an Indicator of Tissue Fluidity in Carcinoma. Phys Rev X, 1, 11033.
     
  165. Kurch L, Georgi TW, Monecke A, Seehofer D, Borte G, Sabri O, Kluge R, Heyn S, Pierer M, Platzbecker U, Kayser S (2021). Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report. Front Oncol, 11, 798757.
     
  166. Pflug N, Littauer A, Beverungen D, Sretenovic A, Wahnschaffe L, Braun T, Dechow A, Jungherz D, Otte M, Monecke A, Bach E, Franke GN, Schwind S, Jentzsch M, Platzbecker U, Herling M, Vucinic V (2021). Case Report: Large Granular Lymphocyte Leukemia (LGLL)-A Case Series of Challenging Presentations. Front Oncol, 11, 775313.
     
  167. Gebauer B, Denecke T, Savic LJ, Hering AH, Schierle K, Jentzsch M, Hacker U (2021). Remissionsparameter In: Schmoll HJ, Kompendium Internistische Onkologie (S. 0), Berlin, Heidelberg: Springer Verlag.
     


    168. 2020


  168. Arnold A, Tronser M, Sers C, Ahadova A, Endris V, Mamlouk S, Horst D, Möbs M, Bischoff P, Kloor M, Bläker H (2020). The majority of ?-catenin mutations in colorectal cancer is homozygous. BMC Cancer, 20(1), 1038.
     
  169. Mamlouk S, Simon T, Tomás L, Wedge DC, Arnold A, Menne A, Horst D, Capper D, Morkel M, Posada D, Sers C, Bläker H (2020). Malignant transformation and genetic alterations are uncoupled in early colorectal cancer progression. BMC Biol, 18(1), 116.
     
  170. Horn LC, Höhn AK, Denschlag D, Follmann M, Schmidt D (2020). [Interdisciplinary S2k guidelines on the diagnosis and treatment of uterine sarcomas-recommendations for surgical pathology]. Pathologe, 41(6), 621-633.
     
  171. Turashvili G, Samore WR, Oliva E, Ioffe O, Riddell R, Park KJ, Horn LC (2020). Secondary Involvement of the Uterine Cervix by Nongynecologic Neoplasms: A Detailed Clinicopathologic Analysis. Am J Surg Pathol, 44(12), 1699-1711.
     
  172. Bläker H, Haupt S, Morak M, Holinski-Feder E, Arnold A, Horst D, Sieber-Frank J, Seidler F, von Winterfeld M, Alwers E, Chang-Claude J, Brenner H, Roth W, Engel C, Löffler M, Möslein G, Schackert HK, Weitz J, Perne C, Aretz S, Hüneburg R, Schmiegel W, Vangala D, Rahner N, Steinke-Lange V, Heuveline V, von Knebel Doeberitz M, Ahadova A, Hoffmeister M, Kloor M (2020). Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnostics. Int J Cancer, 147(10), 2801-2810.
     
  173. Horn LC, Höhn AK, Krücken I, Stiller M, Obeck U, Brambs CE (2020). Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma. J Cancer Res Clin Oncol, 146(4), 971-983.
     
  174. Gockel I, Lordick F, Lyros O, Kreuser N, Hölscher AH, Wittekind C (2020). [Pretherapeutic misclassification of esophageal cancer and adenocarcinoma of the esophagogastric junction : Possibilities and clinical consequences]. Chirurg, 91(1), 41-50.
     
  175. Wittekind C, Hofstädter F, Hartmann A (2020). [Paul Hermanek : 08.03.1924-17.09.2020]. Pathologe, 41(Suppl 2), 202-203.
     
  176. Carr PR, Amitay EL, Jansen L, Alwers E, Roth W, Herpel E, Kloor M, Schneider M, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M (2020). Association of BMI and major molecular pathological markers of colorectal cancer in men and women. Am J Clin Nutr, 111(3), 562-569.
     
  177. Auer TA, Fehrenbach U, Grieser C, Penzkofer T, Geisel D, Schmelzle M, Müller T, Bläker H, Seehofer D, Denecke T (2020). Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Eur Radiol, 30(6), 3497-3506.
     
  178. Ballhausen A, Przybilla MJ, Jendrusch M, Haupt S, Pfaffendorf E, Seidler F, Witt J, Hernandez Sanchez A, Urban K, Draxlbauer M, Krausert S, Ahadova A, Kalteis MS, Pfuderer PL, Heid D, Stichel D, Gebert J, Bonsack M, Schott S, Bläker H, Seppälä T, Mecklin JP, Ten Broeke S, Nielsen M, Heuveline V, Krzykalla J, Benner A, Riemer AB, von Knebel Doeberitz M, Kloor M (2020). The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution. Nat Commun, 11(1), 4740.
     
  179. Hoffmeister M, Bläker H, Jansen L, Alwers E, Amitay EL, Carr PR, Kloor M, Herpel E, Roth W, Chang-Claude J, Brenner H (2020). Colonoscopy and Reduction of Colorectal Cancer Risk by Molecular Tumor Subtypes: A Population-Based Case-Control Study. Am J Gastroenterol, 115(12), 2007-2016.
     
  180. Gockel I, Jansen-Winkeln B, Haase L, Niebisch S, Moulla Y, Lyros O, Lordick F, Schierle K, Wittekind C, Thieme R (2020). Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in patients with peritoneal metastasized colorectal, appendiceal and small bowel cancer. Tumori, 106(1), 70-78.
     
  181. Atanasov G, Dino K, Schierle K, Dietel C, Aust G, Pratschke J, Seehofer D, Schmelzle M, Hau HM (2020). Recipient Hepatic Tumor-Associated Immunologic Infiltrates Predict Outcomes After Liver Transplantation for Hepatocellular Carcinoma. Ann Transplant, 25, 919414.
     
  182. Metelmann IB, Seyfarth HJ, Schierle K, Kraemer S (2020). Utility of immunohistochemical staining for the diagnosis of Extra-adrenal mediastinal paraganglioma. Respir Med Case Rep, 31, 101278.
     
  183. Mentzel J, Ziemer M, Gradistanac T, Simon JC, Grunewald S (2020). Schub einer Polychondritis recidivans et atrophicans nach Exzision eines Plattenepithelkarzinoms an der Ohrmuschel. J Dtsch Dermatol Ges, 18(5), 485-488.
     
  184. Surov A, Meyer HJ, Höhn AK, Wienke A, Sabri O, Purz S (2020). Combined parameter SUVmax/ADCmean predicts microvessel density in head and neck squamous cell carcinoma. Preliminary results. Oral Oncol, 101, 104355.
     
  185. Meyer HJ, Höhn AK, Surov A (2020). Associations between histogram analysis parameters derived from dynamic-contrast enhanced MRI and PD L1-expression in head and neck squamous cell carcinomas. A preliminary study. Magn Reson Imaging, 72, 117-121.
     
  186. Stolnicu S, Segura S, Parra-Herran C, Horn LC, Hoang L, Terinte C, Pesci A, Aviel-Ronen S, Kyokawa T, Alvarado-Cabrero I, Oliva E, Soslow RA, Park KJ (2020). Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Cervix: A Study on Morphologic Diversity. Am J Surg Pathol, 44(7), 873-880.
     
  187. Kortekaas KE, Van de Vijver KK, van Poelgeest MIE, Gilks CB, Smit VTHBM, Arif S, Arora D, Faruqi A, Ganesan R, Griffin NR, Hale R, Hock YE, Horn LC, McCluggage WG, Mukonoweshuro P, Park KJ, Rous B, Tanchel B, Van Rompuy AS, van Schalkwyk G, Vella J, Vergine M, Singh N, Bosse T (2020). Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer. Int J Gynecol Pathol, 39(5), 420-427.
     
  188. Stolnicu S, Boros M, Segura S, Horn LC, Parra-Herran C, Oliva E, Abu-Rustum N, Soslow RA, Park KJ (2020). Invasive Stratified Mucinous Carcinoma (iSMC) of the Cervix Often Presents With High-risk Features That Are Determinants of Poor Outcome: An International Multicenter Study. Am J Surg Pathol, 44(10), 1374-1380.
     
  189. Engel C, Ahadova A, Seppälä TT, Aretz S, Bigirwamungu-Bargeman M, Bläker H, Bucksch K, Büttner R, de Vos Tot Nederveen Cappel WT, Endris V, Holinski-Feder E, Holzapfel S, Hüneburg R, Jacobs MAJM, Koornstra JJ, Langers AM, Lepistö A, Morak M, Möslein G, Peltomäki P, Pylvänäinen K, Rahner N, Renkonen-Sinisalo L, Schulmann K, Steinke-Lange V, Stenzinger A, Strassburg CP, van de Meeberg PC, van Kouwen M, van Leerdam M, Vangala DB, Vecht J, Verhulst ML, von Knebel Doeberitz M, Weitz J, Zachariae S, L (2020). Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome. Gastroenterology, 158(5), 1326-1333.
     
  190. Gockel I, Jansen-Winkeln B, Sucher R, Rayes N, Thieme R, Moulla Y, Niebisch S, Rademacher S, Seehofer D, Schierle K, Bläker H, Neumuth T, Melzer A, Maktabi M, Köhler H, Chalopin C (2020). Hyperspektral-Imaging (HSI) ? eine verlässliche Gewebedifferenzierung? Zentralbl Chir, 145(2), 125-129.
     
  191. Auer TA, Fehrenbach U, Grieser C, Penzkofer T, Geisel D, Schmelzle M, Müller T, Bläker H, Seehofer D, Denecke T (2020). Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Eur Radiol, 30(6), 3497-3506.
     
  192. Neumeyer S, Hua X, Seibold P, Jansen L, Benner A, Burwinkel B, Halama N, Berndt SI, Phipps AI, Sakoda LC, Schoen RE, Slattery ML, Chan AT, Gala M, Joshi AD, Ogino S, Song M, Herpel E, Bläker H, Kloor M, Scherer D, Ulrich A, Ulrich CM, Win AK, Figueiredo JC, Hopper JL, Macrae F, Milne RL, Giles GG, Buchanan DD, Peters U, Hoffmeister M, Brenner H, Newcomb PA, Chang-Claude J (2020). Genetic Variants in the Regulatory T cell-Related Pathway and Colorectal Cancer Prognosis. Cancer Epidemiol Biomarkers Prev, 29(12), 2719-2728.
     
  193. Amitay EL, Carr PR, Jansen L, Alwers E, Roth W, Herpel E, Kloor M, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M (2020). Postmenopausal hormone replacement therapy and colorectal cancer risk by molecular subtypes and pathways. Int J Cancer, 147(4), 1018-1026.
     
  194. Amitay EL, Carr PR, Jansen L, Roth W, Alwers E, Herpel E, Kloor M, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M (2020). Smoking, alcohol consumption and colorectal cancer risk by molecular pathological subtypes and pathways. Br J Cancer, 122(11), 1604-1610.
     
  195. Alwers E, Jansen L, Bläker H, Kloor M, Tagscherer KE, Roth W, Boakye D, Herpel E, Grüllich C, Chang-Claude J, Brenner H, Hoffmeister M (2020). Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study. Mol Oncol, 14(2), 363-372.
     
  196. Sinn M, Sinn BV, Treue D, Keilholz U, Damm F, Schmuck R, Lohneis P, Klauschen F, Striefler JK, Bahra M, Bläker H, Bischoff S, Pelzer U, Oettle H, Riess H, Budczies J, Denkert C (2020). TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial. Clin Cancer Res, 26(14), 3732-3739.
     
  197. Meyer HJ, Höhn AK, Surov A (2020). Associations between histogram analysis parameters derived from dynamic-contrast enhanced MRI and PD L1-expression in head and neck squamous cell carcinomas. A preliminary study. Magn Reson Imaging, 72, 117-121.
     
  198. Kalra S, Bajaj S, Sharma SK, Priya G, Baruah MP, Sanyal D, Das S, Chaudhury T, Gangopadhyay KK, Das AK, Sethi B, Ayyar V, Shaikh S, Shah P, Jindal S, Deshmukh V, Dave J, Amod A, Joshi A, Pokharel S, Pathan F, Afsana F, Prasad I, Murad M, Soelistijo SA, Purwoto J, Hussein Z, Horn LC, Sahay R, Somasundaram N, Antonypillai C, Sumanathilaka M, Bulugahapitiya U (2020). A Practitioner's Toolkit for Insulin Motivation in Adults with Type 1 and Type 2 Diabetes Mellitus: Evidence-Based Recommendations from an International Expert Panel. Diabetes Ther, 11(3), 585-606.
     
  199. Wolf B, Espig O, Stolzenburg JU, Horn LC, Aktas B, Höckel M (2020). Preservation of the mesureter to reduce urinary complications: analysis of data from the observational Leipzig School MMR study. BJOG, 127(7), 859-865.
     
  200. Wenzel T, Büch T, Urban N, Weirauch U, Schierle K, Aigner A, Schaefer M, Kalwa H (2020). Restoration of MARCKS enhances chemosensitivity in cancer. J Cancer Res Clin Oncol, 146(4), 843-858.
     
  201. Metelmann IB, Seyfarth HJ, Schierle K, Kraemer S (2020). Utility of immunohistochemical staining for the diagnosis of Extra-adrenal mediastinal paraganglioma. Respir Med Case Rep, 31, 101278.
     
  202. Mentzel J, Ziemer M, Gradistanac T, Simon JC, Grunewald S (2020). Acute flare of relapsing polychondritis following surgical treatment of auricular squamous cell carcinoma. J Dtsch Dermatol Ges, 18(5), 483-486.
     
  203. Harapan BN, Frydrychowicz C, Classen J, Wittekind C, Gradistanac T, Rumpf JJ, Mueller W (2020). No enhanced (p-) ?-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients. Parkinsonism Relat Disord, 80(), 82-88.
     
  204. Freitag J, Wald T, Kuhnt T, Gradistanac T, Kolb M, Dietz A, Wiegand S, Wichmann G (2020). Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma. Cancer, 126(9), 1856-1872.
     
  205. Pouyiourou M, Meyer A, Stroux A, Viardot A, La Rosée P, Maschmeyer G, Kämpfe D, Kahl C, Vucinic V, Monecke A, Hirt C, Weber T, Meissner J, Witzens-Harig M, Böttcher S, Schmalenberg H, Marks R, Prange-Krex G, Kroschinsky F, Hauf E, Keller U, Koch K, Klapper W, Herold M, Scholz CW (2020). First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysis. Ann Hematol, 99(12), 2821-2829.
     
  206. Meyer HJ, Pönisch W, Monecke A, Gundermann P, Surov A (2020). Can Diagnostic Low-dose Whole-body CT Reflect Bone Marrow Findings in Systemic Mastocytosis? Anticancer Res, 40(2), 1015-1022.
     
  207. Wolf B, Horn LC, Aktas B, Dornhöfer N (2020). Angiokeratom der Vulva Frauenarzt, 11, 766.
     
  208. Rami-Porta R, Wittekind C, Goldstraw P (2020). Complete Resection in Lung Cancer Surgery: From Definition to Validation and Beyond. J Thorac Oncol, 15(12), 1815-1818.
     
  209. Abshagen K, Berger C, Dietrich A, Schütz T, Wittekind C, Stumvoll M, Blüher M, Klöting N (2020). A Human REPIN1 Gene Variant: Genetic Risk Factor for the Development of Nonalcoholic Fatty Liver Disease. Clin Transl Gastroenterol, 11(1), 00114.
     
  210. Gerhardt F, Petroff D, Blank V, Böhlig A, van Bömmel F, Wittekind C, Berg T, Karlas T, Wiegand J (2020). Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD). Scand J Gastroenterol, 55(6), 706-711.
     
  211. Tischoff I, Tannapfel A, Wittekind C (2020). Stoffwechselstörungen, Kreislaufstörungen, Störungen der Motorik, traumatische Veränderungen und Fremdkörper In: Tannapfel A, Klöppel G, Pathologie ? Leber, Gallenwege und Pankreas (S. 519-531), Berlin: Springer Verlag.
     
  212. Tischoff I, Tannapfel A, Wittekind C (2020). Entzündungen und Cholelithiasis In: Tannapfel A, Klöppel G, Pathologie ? Leber, Gallenwege und Pankreas (S. 531-565), Berlin: Springer Verlag.
     
  213. Tischoff I, Tannapfel A, Wittekind C (2020). 7 Tumoren der Gallenblase und der extrahepatischen Gallengänge In: Tannapfel A, Klöppel G, Pathologie ? Leber, Gallenwege und Pankreas (S. 565-609), Berlin: Springer Verlag.
     
  214. Tischoff I, Wittekind C, Tannapfel A (2020). 8 Ampulla Vateri In: Tannapfel A, Klöppel G, Pathologie ? Leber, Gallenwege und Pankreas (S. 609-631), Berlin: Springer Verlag.
     


    215. 2019


  215. Horn LC, Brambs CE, Opitz S, Ulrich UA, Hohn AK (2019). [The 2019 FIGO classification for cervical carcinoma-what's new?] Pathologe, 40(6), 629-635.
     
  216. Hohn AK, Brambs CE, Opitz S, Erber R, Hartmann A, Horn LC (2019). [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis]. Pathologe, 40(6), 609-618.
     
  217. Horn LC, Handzel R, Borte G, Siebolts U, Haak A, Brambs CE (2019). Invasive stratified mucin-producing carcinoma (i-SMILE) of the uterine cervix: report of a case series and review of the literature indicating poor prognostic subtype of cervical adenocarcinoma. J Cancer Res Clin Oncol, 145(10), 2573-2582.
     
  218. Rudolph J, Just M, Trawinski H, Monecke A (2019). [A rare differential diagnosis of tonsillopharyngitis]. Laryngorhinootologie, 98(2), 105-107.
     
  219. Schmid KW, Synoracki S, Dralle H, Wittekind C (2019). Proposal for an extended pTNM classification of thyroid carcinoma : Commentary on deficits of the 8th edition of the TNM classification. Pathologe, 40(1), 18-24.
     
  220. Wittekind C (2019). Balthasar Wohlgemuth PATHOLOGE , 0, 0.
     
  221. Hockel M, Wolf B, Schmidt K, Mende M, Aktas B, Kimmig R, Dornhofer N, Horn LC (2019). Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study. Lancet Oncol, 20(9), 1316-1326.
     
  222. Horn LC, Hohn AK, Stark S, Einenkel J, Borte G, Haak A, Siebolts U, Brambs CE (2019). Endocervical adenocarcinoma in situ (AIS) with ovarian and pulmonary involvement: report of a case and review of the literature suggesting a "seed and soil hypothesis". J Cancer Res Clin Oncol, 145(8), 2061-2069.
     
  223. Brambs CE, Hohn AK, Hentschel B, Fischer U, Bilek K, Horn LC (2019). The Prognostic Impact of Grading in FIGO IB and IIB Squamous Cell Cervical Carcinomas. Geburtshilfe Frauenheilkd, 79(2), 198-204.
     
  224. Horn LC, Emons G, Aretz S, Bock N, Follmann M, Lax S, Nothacker M, Steiner E, Mayr D (2019). [S3 guidelines on the diagnosis and treatment of carcinoma of the endometrium : Requirements for pathology]. Pathologe, 40(1), 21-35.
     
  225. Horn LC, Brambs CE, Opitz S, Einenkel J, Mayr D (2019). [TNM classification of gynecologic malignancies : What remains to be done beyond 2017?] Pathologe, 40(1), 73-79.
     
  226. Horn LC, Hohn AK, Hentschel B, Fischer U, Bilek K, Brambs CE (2019). Prognostic relevance of low-grade versus high-grade FIGO IB1 squamous cell uterine cervical carcinomas. J Cancer Res Clin Oncol, 145(2), 457-462.
     
  227. Blaker H, Alwers E, Arnold A, Herpel E, Tagscherer KE, Roth W, Jansen L, Walter V, Kloor M, Chang-Claude J, Brenner H, Hoffmeister M (2019). The Association Between Mutations in BRAF and Colorectal Cancer-Specific Survival Depends on Microsatellite Status and Tumor Stage. Clin Gastroenterol Hepatol, 17(3), 455-462.
     
  228. Blaker H, Langer R (2019). [Meeting of the Gastroenteropathology Working Group of the German Society for Pathology : 103rd Annual Meeting of the German Society for Pathology, 13 June 2019, Frankfurt am Main]. Pathologe, 40, 376-377.
     
  229. Henker R, Oltmanns A, Wald A, Tuennemann J, Opitz S, Hoffmeister A, Wirtz H, Mossner J, Jansen-Winkeln B, Karlas T (2019). Severe ileocecal inflammatory syndrome in adult patients with cystic fibrosis. Z Gastroenterol, 57(3), 312-316.
     
  230. Schnurch HG, Ackermann S, Alt-Radtke CD, Angleitner L, Barinoff J, Beckmann MW, Boing C, Dannecker C, Fehm T, Gaase R, Gass P, Gebhardt M, Gieseking F, Gunthert A, Hack CC, Hantschmann P, Horn LC, Koch MC, Letsch A, Mallmann P, Mangold B, Marnitz S, Mehlhorn G, Paradies K, Reinhardt MJ, Tholen R, Torsten U, Weikel W, Wolber L, Hampl M (2019). Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No.?032/042, October 2018). Geburtshilfe Frauenheilkd, 79(10), 1060-1078.
     
  231. Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Follmann M, Haas H, Harter P, Hettmer S, Horn LC, Juhasz-Boess I, Kast K, Kohler G, Kroncke T, Lindel K, Mallmann P, Meyer-Steinacker R, Mustea A, Petru E, Reichardt P, Schmidt D, Strauss HG, Tempfer C, Thiel F, Ulrich U, Vogl T, Vordermark D, Gass P, Beckmann MW (2019). Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019). Geburtshilfe Frauenheilkd, 79(10), 1043-1060.
     
  232. Kubitschke H, Wolf B, Morawetz E, Horn LC, Aktas B, Behn U, Hockel M, Kas J (2019). Roadmap to Local Tumour Growth: Insights from Cervical Cancer. Sci Rep, 9(1), 12768-.
     
  233. Atanasov G, Dino K, Schierle K, Dietel C, Aust G, Pratschke J, Seehofer D, Schmelzle M, Hau HM (2019). Angiogenic inflammation and formation of necrosis in the tumor microenvironment influence patient survival after radical surgery for de novo hepatocellular carcinoma in non-cirrhosis. World J Surg Oncol, 17(1), 217-217.
     
  234. Bolter C, Gabriel P, Appelt P, Salameh A, Schierle K, Rassler B (2019). Effects of Adrenergic Agonists and Antagonists on Cardiopulmonary Function During Normobaric Hypoxia in Rat. Front Physiol, 10, 860-860.
     
  235. Atanasov G, Dino K, Schierle K, Dietel C, Aust G, Pratschke J, Seehofer D, Schmelzle M, Hau HM (2019). Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomes. World J Surg Oncol, 17(1), 97-97.
     
  236. Niebisch S, Staab H, Ullrich S, Hoffmann KT, Sabri O, Thieme R, Schierle K, Wittekind C, Gockel I (2019). Retroperitoneal space-occupying lesion with displacement of the inferior vena cava. Int J Surg Case Rep, 57, 170-174.
     
  237. Lyros O, Moulla Y, Mehdorn M, Schierle K, Sucher R, Dietrich A (2019). Coincidental Detection of Gastrointestinal Stromal Tumors During Laparoscopic Bariatric Procedures-Data and Treatment Strategy of a German Reference Center. Obes Surg, 29(6), 1858-1866.
     
  238. Meyer HJ, Briest S, Schierle K, Surov A (2019). Diffuse Muskelmetastasierung als einziger Metastasierungsort eines Mammakarzinom-Rezidivs. Rofo, 191(7), 653-654.
     
  239. Haiduk J, Liebetrau M, Kunz M, Gradistanac T, Vucinic V, Simon JC, Ziemer M (2019). Nekrobiotisches Xanthogranulom mit Multiorganbefall bei assoziiertem multiplen Myelom. J Dtsch Dermatol Ges, 17(2), 16-19.
     
  240. Mussigbrodt A, Knopp H, Czimbalmos C, Jahnke C, Richter S, Husser D, Gradistanac T, Hindricks G (2019). Exercise-related sudden cardiac death of an American football player with arrhythmogenic right ventricular dysplasia/cardiomyopathy AND sarcoidosis. Clin Case Rep, 7(4), 686-688.
     
  241. Moulla Y, Gradistanac T, Wittekind C, Eichfeld U, Gockel I, Dietrich A (2019). Correction to: Predictive risk factors for lymph node metastasis in patients with resected non-small cell lung cancer: a case control study. J Cardiothorac Surg, 14(1), 31-31.
     
  242. Moulla Y, Gradistanac T, Wittekind C, Eichfeld U, Gockel I, Dietrich A (2019). Predictive risk factors for lymph node metastasis in patients with resected non-small cell lung cancer: a case control study. J Cardiothorac Surg, 14(1), 11-11.
     
  243. Kaulen LD, Tietz F, Gradistanac T, Thiele H, Rommel KP (2019). Cardiac melanoma metastases as a cause of sudden cardiac death. Clin Res Cardiol, 108(6), 716-718.
     
  244. Meyer HJ, Hamerla G, Leifels L, Hohn AK, Surov A (2019). Histogram analysis parameters derived from DCE-MRI in head and neck squamous cell cancer - Associations with microvessel density. Eur J Radiol, 120, 108669.
     
  245. Meyer HJ, Renatus K, Hohn AK, Hamerla G, Schopow N, Fakler J, Josten C, Surov A (2019). Texture analysis parameters derived from T1-and T2-weighted magnetic resonance images can reflect Ki67 index in soft tissue sarcoma. Surg Oncol, 30, 92-97.
     
  246. Meyer HJ, Hamerla G, Hohn AK, Surov A (2019). CT Texture Analysis-Correlations With Histopathology Parameters in Head and Neck Squamous Cell Carcinomas. Front Oncol, 9, 444.
     
  247. Meyer HJ, Hamerla G, Leifels L, Hohn AK, Surov A (2019). Whole-lesion ADC histogram analysis is not able to reflect microvessel density in HNSCC. Medicine (Baltimore), 98(21), 15520.
     
  248. Surov A, Meyer HJ, Hohn AK, Wienke A, Sabri O, Purz S (2019). 18F-FDG-PET Can Predict Microvessel Density in Head and Neck Squamous Cell Carcinoma. Cancers (Basel), 11(4), 0.
     
  249. Meyer HJ, Leifels L, Hamerla G, Hohn AK, Surov A (2019). Associations between Histogram Analysis Parameters Derived from DCE-MRI and Histopathological Features including Expression of EGFR, p16, VEGF, Hif1-alpha, and p53 in HNSCC. Contrast Media Mol Imaging, 2019, 0.
     
  250. Surov A, Meyer HJ, Hohn AK, Schob S, Winter K, Sabri O, Purz S (2019). Metabolo-volumetric parameters of 18F-FDG-PET can predict expression of EGFR and HIF 1alpha in uterine cervical cancer. Cancer Biomark, 24(1), 135-140.
     
  251. Meyer HJ, Gundermann P, Hohn AK, Hamerla G, Surov A (2019). Associations between whole tumor histogram analysis parameters derived from ADC maps and expression of EGFR, VEGF, Hif 1-alpha, Her-2 and Histone 3 in uterine cervical cancer. Magn Reson Imaging, 57, 68-74.
     
  252. Meyer HJ, Hamerla G, Hohn AK, Surov A (2019). Whole Lesion Histogram Analysis Derived From Morphological MRI Sequences Might be Able to Predict EGFR- and Her2-Expression in Cervical Cancer. Acad Radiol, 26(8), 208-215.
     
  253. Meyer HJ, Leifels L, Hamerla G, Hohn AK, Surov A (2019). Histogram Analysis Parameters Derived from Conventional T1- and T2-Weighted Images Can Predict Different Histopathological Features Including Expression of Ki67, EGFR, VEGF, HIF-1?, and p53 and Cell Count in Head and Neck Squamous Cell Carcinoma. Mol Imaging Biol, 21(4), 740-746.
     
  254. Surov A, Meyer HJ, Hohn AK, Sabri O, Purz S (2019). Combined Metabolo-Volumetric Parameters of 18F-FDG-PET and MRI Can Predict Tumor Cellularity, Ki67 Level and Expression of HIF 1alpha in Head and Neck Squamous Cell Carcinoma: A Pilot Study. Transl Oncol, 12(1), 8-14.
     
  255. Surov A, Meyer HJ, Hohn AK, Winter K, Sabri O, Purz S (2019). Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1?, and p53 in Head and Neck Squamous Cell Carcinoma. Mol Imaging Biol, 21(2), 368-374.
     
  256. Prill S, Rebstock J, Tennemann A, Korfer J, Sonnichsen R, Thieme R, Gockel I, Lyros O, Monecke A, Wittekind C, Weimann A, Grosser K, Wiechmann V, Kubick C, Bechmann I, Lordick F, Kallendrusch S (2019). Tumor-associated macrophages and individual chemo-susceptibility are influenced by iron chelation in human slice cultures of gastric cancer. Oncotarget, 10(46), 4731-4742.
     
  257. Herden J, Wittekind C, Weissbach L (2019). Discrepancy between theory and practice of the clinical tumor-nodes-metastasis (TNM) classification for localized prostate cancer. Ann Transl Med, 7(11), 250.
     
  258. Gerhardt F, Benesic A, Tillmann HL, Rademacher S, Wittekind C, Gerbes AL, Henker R, Berg T, Maidhof HP, Trauer H, Wiegand J (2019). Iberogast-Induced Acute Liver Failure-Reexposure and In Vitro Assay Support Causality. Am J Gastroenterol, 114(8), 1358-1359.
     
  259. Valvo F, Ciurlia E, Avuzzi B, Doci R, Ducreux M, Roelofsen F, Roth A, Trama A, Wittekind C, Bosset JF (2019). Cancer of the anal region. Crit Rev Oncol Hematol, 135, 115-127.
     
  260. Kortekaas KE, Van de Vijver KK, van Poelgeest MIE, Gilks CB, Smit VTHBM, Arif S, Arora D, Faruqi A, Ganesan R, Griffin NR, Hale R, Hock YE, Horn LC, McCluggage WG, Mukonoweshuro P, Park KJ, Rous B, Tanchel B, Van Rompuy AS, van Schalkwyk G, Vella J, Vergine M, Singh N, Bosse T (2019). Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer. Int J Gynecol Pathol, 0, 0.
     
  261. Schaudinn A, Gawlitza J, Mucha S, Linder N, Franz T, Horn LC, Kahn T, Busse H (2019). Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard. Eur J Radiol, 116, 180-185.
     
  262. Linder N, Schaudinn A, Petersen TO, Bailis N, Stumpp P, Horn LC, Stolzenburg JU, Kahn T, Moche M, Busse H (2019). In-bore biopsies of the prostate assisted by a remote-controlled manipulator at 1.5 T. MAGMA, 32(5), 599-605.
     
  263. Schug S, Baunacke A, Goeckenjan M, Horn LC, Pretzsch G, Zimmermann G, Alexander H (2019). Endometrial human chorionic gonadotropin (hCG) expression is a marker for adequate secretory transformation of the endometrium. Arch Gynecol Obstet, 299(6), 1727-1736.
     
  264. Berndt-Paetz M, Schulze P, Stenglein PC, Weimann A, Wang Q, Horn LC, Riyad YM, Griebel J, Hermann R, Glasow A, Stolzenburg JU, Neuhaus J (2019). Reduction of Muscle-Invasive Tumors by Photodynamic Therapy with Tetrahydroporphyrin-Tetratosylat in an Orthotopic Rat Bladder Cancer Model. Mol Cancer Ther, 18(4), 743-750.
     
  265. Wyvekens N, Rechsteiner M, Fritz C, Wagner U, Tchinda J, Wenzel C, Kuithan F, Horn LC, Moch H (2019). Histological and molecular characterization of TFEB-rearranged renal cell carcinomas. Virchows Arch, 474(5), 625-631.
     
  266. Schoffer O, Neumann A, Stabenow R, Schulein S, Bohm WD, Gonsior A, Horn LC, Kriegel C, Stolzenburg JU, Wirth M, Klug SJ (2019). Penile cancer - Incidence, mortality, and survival in Saxony, Germany. Urol Oncol, 37(4), 295.
     
  267. Singh N, Hirschowitz L, Zaino R, Alvarado-Cabrero I, Duggan MA, Ali-Fehmi R, Euscher E, Hecht JL, Horn LC, Ioffe O, Matias-Guiu X, McCluggage WG, Mikami Y, Ordi J, Parkash V, Quddus MR, Quick CM, Staebler A, Zaloudek C, Nucci M, Malpica A, Oliva E (2019). Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade). Int J Gynecol Pathol, 38, 93-113.
     
  268. Hudert CA, Selinski S, Rudolph B, Blaker H, Loddenkemper C, Thielhorn R, Berndt N, Golka K, Cadenas C, Reinders J, Henning S, Bufler P, Jansen PLM, Holzhutter HG, Meierhofer D, Hengstler JG, Wiegand S (2019). Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease. Liver Int, 39(3), 540-556.
     
  269. Amitay EL, Carr PR, Jansen L, Walter V, Roth W, Herpel E, Kloor M, Blaker H, Chang-Claude J, Brenner H, Hoffmeister M (2019). Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes. J Natl Cancer Inst, 111(5), 475-483.
     
  270. Alwers E, Jia M, Kloor M, Blaker H, Brenner H, Hoffmeister M (2019). Associations Between Molecular Classifications of Colorectal Cancer and Patient Survival: A Systematic Review. Clin Gastroenterol Hepatol, 17(3), 402-410.
     
  271. Jurmeister P, Scholer A, Arnold A, Klauschen F, Lenze D, Hummel M, Schweizer L, Blaker H, Pfitzner BM, Mamlouk S, Sers C, Denkert C, Stichel D, Frost N, Horst D, von Laffert M, Capper D (2019). DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer. Mod Pathol, 32(6), 855-865.
     
  272. Hudert CA, Tzschatzsch H, Rudolph B, Blaker H, Loddenkemper C, Muller HP, Henning S, Bufler P, Hamm B, Braun J, Holzhutter HG, Wiegand S, Sack I, Guo J (2019). Tomoelastography for the Evaluation of Pediatric Nonalcoholic Fatty Liver Disease. Invest Radiol, 54(4), 198-203.
     
  273. Pevny S, Maasberg S, Rieger A, Karber M, Bluthner E, Knappe-Drzikova B, Thurmann D, Buttner J, Weylandt KH, Wiedenmann B, Muller VA, Blaker H, Pascher A, Pape UF (2019). Experience with teduglutide treatment for short bowel syndrome in clinical practice. Clin Nutr, 38(4), 1745-1755.
     
  274. Alwers E, Blaker H, Walter V, Jansen L, Kloor M, Arnold A, Sieber-Frank J, Herpel E, Tagscherer KE, Roth W, Chang-Claude J, Brenner H, Hoffmeister M (2019). External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS. BMC Cancer, 19(1), 681.
     
  275. Jia M, Zhang Y, Jansen L, Walter V, Edelmann D, Gundert M, Tagscherer KE, Roth W, Bewerunge-Hudler M, Herpel E, Kloor M, Ulrich A, Burwinkel B, Blaker H, Chang-Claude J, Brenner H, Hoffmeister M (2019). A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival. Clin Epigenetics, 11(1), 109.
     
  276. Neumeyer S, Popanda O, Edelmann D, Butterbach K, Toth C, Roth W, Blaker H, Jiang R, Herpel E, Jakel C, Schmezer P, Jansen L, Alwers E, Benner A, Burwinkel B, Hoffmeister M, Brenner H, Chang-Claude J (2019). Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancer. Epigenetics, 14(5), 477-493.
     
  277. Neumeyer S, Popanda O, Butterbach K, Edelmann D, Blaker H, Toth C, Roth W, Herpel E, Jakel C, Schmezer P, Benner A, Burwinkel B, Hoffmeister M, Brenner H, Chang-Claude J (2019). DNA methylation profiling to explore colorectal tumor differences according to menopausal hormone therapy use in women. Epigenomics, 11(16), 1765-1778.
     
  278. Lax SF, Noske A, Horn LC, Staebler A (2019). Weibliche Geschlechtsorgane In: Höfler G, Kreipe H, Moch H, Pathologie. Das Lehrbuch. (S. 759-793), München: Urban & Fischer in Elsevier.
     
  279. Horn LC (2019). Gestational Trophoblastic Disease In: Vogel M, Turowski G, Clinical Pathology of the Placenta (S. 289-340), Berlin/Bosten: deGruyter.
     


    280. 2018


  280. Horn LC (2018). Das ductale Carcinoma in situ der Mamma - eine facettenreiche Erkrankung SGK Mitteilungsblatt, 0, 10-11.
     
  281. Surov A, Meyer HJ, Winter K, Richter C, Hoehn AK (2018). Histogram analysis parameters of apparent diffusion coefficient reflect tumor cellularity and proliferation activity in head and neck squamous cell carcinoma. Oncotarget, 9(34), 23599-23607.
     
  282. Schmid KW, Synoracki S, Dralle H, Wittekind C (2018). Proposal for an extended pTNM classification of thyroid carcinoma : Commentary on deficits of the 8th edition of the TNM classification. Pathologe, 0, 0.
     
  283. Wittekind C, Gradistanac T (2018). Post-Mortem Examination as a Quality Improvement Instrument. Dtsch Arztebl Int, 115(39), 653-658.
     
  284. Horn LC, Opitz S, Handzel R, Brambs CE (2018). [Histopathology and clinical aspects of extrauterine pregnancy]. Pathologe, 39(5), 431-444.
     
  285. Braunschweig T, Schierle K (2018). [Meeting of the Working Group on the History of Pathology : 102nd Annual Congress of the German Society of Pathology]. Pathologe, 39, 324.
     
  286. Rudolph J, Just M, Trawinski H, Monecke A (2018). [A rare differential diagnosis of tonsillopharyngitis]. Laryngorhinootologie, 0, 0.
     
  287. Blaker H (2018). [Gastrointestinal tract diseases induced by medications]. Pathologe, 39(6), 571-575.
     
  288. von Laffert M, Elezkurtaj S, Sehouli J, Barinoff J, Boschetti Grutzmacher E, Arsenic R, Blaker H (2018). [Ichthyosis uteri (psoriasis uteri) : A very rare disorder]. Pathologe, 39(3), 264-268.
     
  289. Keller S, Zwingenberger G, Ebert K, Hasenauer J, Wasmuth J, Maier D, Haffner I, Schierle K, Weirich G, Luber B (2018). Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines. Mol Oncol, 12(4), 441-462.
     
  290. Kropf S, Uciteli A, Schierle K, Kruecken P, Denecke K, Herre H (2018). Querying archetype-based EHRs by search ontology-based XPath engineering. J Biomed Semantics, 9(1), 16.
     
  291. Atanasov G, Potner C, Aust G, Schierle K, Dietel C, Benzing C, Krenzien F, Bartels M, Eichfeld U, Schmelzle M, Bahra M, Pascher A, Wiltberger G (2018). TIE2-expressing monocytes and M2-polarized macrophages impact survival and correlate with angiogenesis in adenocarcinoma of the pancreas. Oncotarget, 9(51), 29715-29726.
     
  292. Beeskow AB, Meyer HJ, Schierle K, Surov A (2018). Heterotopic gastric mucosa in gallbladder-A rare differential diagnosis to gallbladder masses: A systematic review. Medicine (Baltimore), 97(10), 0058.
     
  293. Atanasov G, Dietel C, Feldbrugge L, Benzing C, Krenzien F, Brandl A, Katou S, Schierle K, Robson SC, Splith K, Wiltberger G, Reutzel-Selke A, Jonas S, Pascher A, Bahra M, Pratschke J, Schmelzle M (2018). Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinoma. Oncotarget, 9(52), 29921-29933.
     
  294. Sonnichsen R, Hennig L, Blaschke V, Winter K, Korfer J, Hahnel S, Monecke A, Wittekind C, Jansen-Winkeln B, Thieme R, Gockel I, Grosser K, Weimann A, Kubick C, Wiechmann V, Aigner A, Bechmann I, Lordi (2018). Individual Susceptibility Analysis Using Patient-derived Slice Cultures of Colorectal Carcinoma. Clin Colorectal Cancer, 17(2), 189-199.
     
  295. Kirsch K, Schone K, Jahnke C, Patzsch I, Schwarzer A, Monecke A, Thiele H, Sandri M (2018). First onset of a left-bundle-branch ventricular tachycardia in an elderly: A rare cause. Cardiol J, 25(6), 749-750.
     
  296. Roth C, Sabri O, Kluge R, Fischer L, Monecke A, Wachowiak R, Hirsch FW, Kurch L (2018). Simultaneous F18-FDG-PET/MR Optimized Treatment Planning in a Young Patient with Sacro-Coccygeal Chordoma. Klin Padiatr, 230(6), 326-327.
     
  297. Hofmann A, Opitz S, Heyde CE, von der Hoh NH (2018). Paget's disease of the lumbar spine: decompressive surgery following 17 years of bisphosphonate treatment. Eur Spine J, 27(12), 3066-3070.
     
  298. Kitz J, Fokas E, Beissbarth T, Strobel P, Wittekind C, Hartmann A, Ruschoff J, Papadopoulos T, Rosler E, Ortloff-Kittredge P, Kania U, Schlitt H, Link KH, Bechstein W, Raab HR, Staib L, Germer CT, Lie (2018). Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial. JAMA Surg, 153(8), 181607.
     
  299. Fokas E, Fietkau R, Hartmann A, Hohenberger W, Grutzmann R, Ghadimi M, Liersch T, Strobel P, Grabenbauer GG, Graeven U, Hofheinz RD, Kohne CH, Wittekind C, Sauer R, Kaufmann M, Hothorn T, Rodel C (2018). Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial. Ann Oncol, 29(7), 1521-1527.
     
  300. von den Grun JM, Hartmann A, Fietkau R, Ghadimi M, Liersch T, Hohenberger W, Weitz J, Sauer R, Wittekind C, Strobel P, Rodel C, Fokas E (2018). Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials. Radiother Oncol, 128(3), 557-563.
     
  301. Herden J, Heidenreich A, Wittekind C, Weissbach L (2018). Predictive value of the UICC and AJCC 8th edition tumor-nodes-metastasis (TNM) classification for patients treated with radical prostatectomy. Cancer Epidemiol, 56, 126-132.
     
  302. Schroeder L, Wichmann G, Willner M, Michel A, Wiesenfarth M, Flechtenmacher C, Gradistanac T, Pawlita M, Dietz A, Waterboer T, Holzinger D (2018). Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor. Int J Cancer, 142(7), 1361-1368.
     
  303. Kaulen LD, Tietz F, Gradistanac T, Thiele H, Rommel KP (2018). Cardiac melanoma metastases as a cause of sudden cardiac death. Clin Res Cardiol, 0, 0.
     
  304. McCluggage WG, Judge MJ, Alvarado-Cabrero I, Duggan MA, Horn LC, Hui P, Ordi J, Otis CN, Park KJ, Plante M, Stewart CJR, Wiredu EK, Rous B, Hirschowitz L (2018). Data Set for the Reporting of Carcinomas of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR). Int J Gynecol Pathol, 37(3), 205-228.
     
  305. Juhasz-Boss I, Gabriel L, Bohle RM, Horn LC, Solomayer EF, Breitbach GP (2018). Uterine Leiomyosarcoma. Oncol Res Treat, 41(11), 680-686.
     
  306. Schoffer O, Neumann A, Stabenow R, Schulein S, Bohm WD, Gonsior A, Horn LC, Kriegel C, Stolzenburg JU, Wirth M, Klug SJ (2018). Penile cancer - Incidence, mortality, and survival in Saxony, Germany. Urol Oncol, 0, 0.
     
  307. Emons G, Steiner E, Vordermark D, Uleer C, Bock N, Paradies K, Ortmann O, Aretz S, Mallmann P, Kurzeder C, Hagen V, van Oorschot B, Hocht S, Feyer P, Egerer G, Friedrich M, Cremer W, Prott FJ, Horn LC (2018). Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer. Geburtshilfe Frauenheilkd, 78(10), 949-971.
     
  308. Emons G, Steiner E, Vordermark D, Uleer C, Bock N, Paradies K, Ortmann O, Aretz S, Mallmann P, Kurzeder C, Hagen V, van Oorschot B, Hocht S, Feyer P, Egerer G, Friedrich M, Cremer W, Prott FJ, Horn LC (2018). Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities. Geburtshilfe Frauenheilkd, 78(11), 1089-1109.
     
  309. Hockel M, Trott S, Dornhofer N, Horn LC, Hentschel B, Wolf B (2018). Vulvar field resection based on ontogenetic cancer field theory for surgical treatment of vulvar carcinoma: a single-centre, single-group, prospective trial. Lancet Oncol, 19(4), 537-548.
     
  310. Cao K, Arthurs C, Atta-Ul A, Millar M, Beltran M, Neuhaus J, Horn LC, Henrique R, Ahmed A, Thrasivoulou C (2018). Quantitative Analysis of Seven New Prostate Cancer Biomarkers and the Potential Future of the 'Biomarker Laboratory'. Diagnostics (Basel), 8(3), 0.
     
  311. Kurz S, Thieme R, Amberg R, Groth M, Jahnke HG, Pieroh P, Horn LC, Kolb M, Huse K, Platzer M, Volke D, Dehghani F, Buzdin A, Engel K, Robitzki A, Hoffmann R, Gockel I, Birkenmeier G (2018). Correction: The anti-tumorigenic activity of A2M-A lesson from the naked mole-rat. PLoS One, 13(3), 0195169.
     
  312. Surov A, Meyer HJ, Hohn AK, Winter K, Sabri O, Purz S (2018). Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1?, and p53 in Head and Neck Squamous Cell Carcinoma. Mol Imaging Biol, 0, 0.
     
  313. Meyer HJ, Leifels L, Hamerla G, Hohn AK, Surov A (2018). ADC-histogram analysis in head and neck squamous cell carcinoma. Associations with different histopathological features including expression of EGFR, VEGF, HIF-1?, Her 2 and p53. A preliminary study. Magn Reson Imaging, 54, 214-217.
     
  314. Meyer HJ, Leifels L, Hamerla G, Hohn AK, Surov A (2018). Histogram Analysis Parameters Derived from Conventional T1- and T2-Weighted Images Can Predict Different Histopathological Features Including Expression of Ki67, EGFR, VEGF, HIF-1?, and p53 and Cell Count in Head and Neck Squamous Cell Carcinoma. Mol Imaging Biol, 0, 0.
     
  315. Surov A, Meyer HJ, Leifels L, Hohn AK, Richter C, Winter K (2018). Histogram analysis parameters of dynamic contrast-enhanced magnetic resonance imaging can predict histopathological findings including proliferation potential, cellularity, and nucleic areas in head and neck squamous cell carcinoma. Oncotarget, 9(30), 21070-21077.
     
  316. Schulz D, Lein A, Nicula AP, Schierle K, Solovan C (2018). Lymphangioma Circumscriptum Post Radiotherapy for Penile Cancer Treated with CO? Laser. Acta Dermatovenerol Croat, 26(1), 53-57.
     
  317. Gockel I, Jansen-Winkel B, Haase L, Rhode P, Mehdorn M, Niebisch S, Moulla Y, Lyros O, Lordick F, Schierle K, Wittekind C, Thieme R (2018). Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Cancer Patients with Peritoneal Metastasis (PM): Results of a Single-Center Experience and Register Study J Gastric Cancer, 18(4), 379-391.
     
  318. Steiner E, Horn LC, Menke J, Mayr D, Lax S, Cremer W, Prompeler H, Reinhardt M (2018). Early screening, diagnosis, imaging, and pathology of endometrial cancer GYNAEKOLOGE , 51, 1009-1017.
     
  319. Hockel M, Horn LC, Fritsch H (2018). Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in stage IB-IIB cervical carcinoma: a prospective study (vol 6, pg 751, 2005) LANCET ONCOLOGY , 14(7), 335-335.
     
  320. Lim J, Park JH, Baude A, Fellenberg J, Zustin J, Haller F, Krucken I, Kang HG, Park YJ, Plass C, Lindroth AM (2018). Transcriptome and protein interaction profiling in cancer cells with mutations in histone H3.3. Sci Data, 5, 180283.
     
  321. Troyanova-Slavkova, S, Eickenscheidt L, Aust D, Gradistanac T, Kowalzick L (2018). Palmar Located HPV16 positive Bowen's disease AKTUELLE DERMATOLOGIE , 44, 385-387.
     
  322. Gerressen CI, Noroozi, N, Monecke A, Opitz S, Gerressen M (2018). Uncertain Osteolysis of the Mandible MKG-CHIRURG , 11, 42-48.
     
  323. Troyanova-Slavkova, S, Opitz S, Eickenscheidt L, Kowalzick L (2018). Occurrence of Genital Lichen sclerosus et atrophicus during Pembrolizumab-therapy of Metastatic Malignant Melanoma AKTUELLE DERMATOLOGIE, 44, 378-381.
     
  324. Meyer HJ, Gundermann P, Höhn AK, Hamerla G (2018). Associations between whole tumor histogram analysis parameters derived from ADC maps and expression of EGFR, VEGF, Hif 1-alpha Her-2 and Histone 3 in uterine cervical cancer Magnetic Resonance Imaging, 57, 0.
     
  325. Ahadova A, Gallon R, Gebert J, Ballhausen A, Endris V, Kirchner M, Stenzinger A, Burn J, von Knebel Doeberitz M, Blaker H, Kloor M (2018). Three molecular pathways model colorectal carcinogenesis in Lynch syndrome. Int J Cancer, 143(1), 139-150.
     
  326. Gul-Klein S, Sinn M, Jurmeister PS, Biebl M, Weiss S, Rau B, Blaker H, Pratschke J, Aigner F (2018). Two patients with rare mixed adenoneuroendocrine carcinomas of the rectum. SAGE Open Med Case Rep, 6, 0.
     
  327. Lohneis P, Sinn M, Klein F, Bischoff S, Striefler JK, Wislocka L, Sinn BV, Pelzer U, Oettle H, Riess H, Denkert C, Blaker H, Juhling A (2018). Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma. Br J Cancer, 118(11), 1485-1491.
     
  328. Hudert CA, Tzschatzsch H, Guo J, Rudolph B, Blaker H, Loddenkemper C, Luck W, Muller HP, Baumgart DC, Hamm B, Braun J, Holzhutter HG, Wiegand S, Sack I (2018). US Time-Harmonic Elastography: Detection of Liver Fibrosis in Adolescents with Extreme Obesity with Nonalcoholic Fatty Liver Disease. Radiology, 288(1), 99-106.
     
  329. Horn LC (2018). Primäre und sekundäre Tumoren von Nabelschnur und Plazenta In: Huppertz B & Schleußner , Die Plazenta. Grundlagen und klinische Bedeutung (S. 171-185), Berlin: Springer.
     
  330. Horn LC (2018). Pathologie der vulvären intraepithelialen Neoplasien (VIN) und des vulvären M. Paget In: Schnürch HG, Hampl M, Wölber L , Tumorerkrankungen der Vulva und Vagina. Leitlinienbasiertes Handbuch (S. 33-49), Berlin: Springer.
     
  331. Horn LC (2018). Pathologie des Vulvakarzinoms und der mesenchymalen Tumoren der Vulva In: Schnürch HG, Hampl M, Wölber L , Tumorerkrankungen der Vulva und Vagina. Leitlinienbasiertes Handbuch (S. 63-79), Berlin: Springer.
     
  332. Horn LC (2018). Pathologie des Vaginalkarzinoms und der Sarkome der Vagina In: Schnürch HG, Hampl M, Wölber L , Tumorerkrankungen der Vulva und Vagina. Leitlinienbasiertes Handbuch. (S. 231-6), Berlin: Springer.
     
  333. Horn LC, Höhn AK (2018). Processing and Histopathological Workup of Hysterectomy Specimens In: Alkatout I, Mettler L , Hysterectomy. A Comprehensive Surgical Approach (S. 259-295), Cham: Springer.
     
  334. Blaeker H (2018). Histopathologie und Tumorbiologie In: Messmann H, Tannapfel A, Werner J, Gastrointestinale Onkologie (S. 0-0), New York: Georg Thieme Verlag KG Stuttgart.
     


    335. 2017


  335. Wittekind C, Burrig KF (2017). Requirements of clinicians on pathology : A viewpoint from pathology. Pathologe, 38(5), 394-395.
     
  336. Gockel I, Wittekind C (2017). R1 resection of esophageal carcinoma. Chirurg, 88(9), 748-755.
     
  337. Horn LC, Angermann K, Hentschel B, Einenkel J, Hoehn AK (2017). Frequency of papillary tubal hyperplasia (PTH), salpingoliths and transition from adenoma to borderline ovarian tumors (BOT): A systematic analysis of 74 BOT with different histologic types. Pathol Res Pract, 213(4), 305-309.
     
  338. Hockel M, Wolf B, Hentschel B, Horn LC (2017). Surgical treatment and histopathological assessment of advanced cervicovaginal carcinoma: A prospective study and retrospective analysis. Eur J Cancer, 70, 99-110.
     
  339. Arnold A, Kloor M, Jansen L, Chang-Claude J, Brenner H, von Winterfeld M, Hoffmeister M, Blaker H (2017). The association between microsatellite instability and lymph node count in colorectal cancer. Virchows Arch, 471(1), 57-64.
     
  340. Chen HH, Handel N, Ngeow J, Muller J, Huhn M, Yang HT, Heindl M, Berbers RM, Hegazy AN, Kionke J, Yehia L, Sack U, Blaser F, Rensing-Ehl A, Reifenberger J, Keith J, Travis S, Merkenschlager A, Kiess W (2017). Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol, 139(2), 607-620.
     
  341. Sano T, Coit DG, Kim HH, Roviello F, Kassab P, Wittekind C, Yamamoto Y, Ohashi Y (2017). Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer, 20(2), 217-225.
     
  342. Atanasov G, Schierle K, Hau HM, Dietel C, Krenzien F, Brandl A, Wiltberger G, Englisch JP, Robson SC, Reutzel-Selke A, Pascher A, Jonas S, Pratschke J, Benzing C, Schmelzle M (2017). Prognostic Significance of Tumor Necrosis in Hilar Cholangiocarcinoma. Ann Surg Oncol, 24(2), 518-525.
     
  343. Kunz K, Seidel F, Weidhase L, Hepp P, Strocka S, Gradistanac T, Petros S (2017). An atypical presentation of necrotising fasciitis. Ann R Coll Surg Engl, 99(2), e83-e84.
     
  344. Fokas E, Strobel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer GG, Hartmann A, Kaufmann M, Sauer R, Graeven U, Hoffmanns H, Raab HR, Hothorn T, Wittekind C, Rodel C (2017). Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer. J Natl Cancer Inst, 109(12), 1-10.
     
  345. Synoracki S, Wittekind C, Dralle H, Schmid KW (2017). Definition of R1 resection in thyroid carcinoma. Chirurg, 88(9), 740-747.
     
  346. Atanasov G, Dietel C, Feldbrugge L, Benzing C, Krenzien F, Brandl A, Mann E, Englisch JP, Schierle K, Robson SC, Splith K, Morgul MH, Reutzel-Selke A, Jonas S, Pascher A, Bahra M, Pratschke J, Schmelz (2017). Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma. Oncoimmunology, 6(8), 1331806.
     
  347. Blank V, Schierle K, Hacker U, Herta T, Vucinic V, Hoffmeister A, Mossner J, Jansen-Winkeln B, Keim V, Karlas T (2017). An unusual hypoechoic solid mass in the pancreatic head. Z Gastroenterol, 55(4), 375-378.
     
  348. Zajonz D, von der Hoh N, Moche M, Lingscheidt T, Josten C, Heyde CE, Spiegl UJA (2017). [Necrosis with mummification of the foot in a 33-year-old man with anxiety disorder]. Chirurg, 88(8), 702-706.
     
  349. Wittlinger J, Stankovic P, Girrbach U, Gradistanac T, Guldner C, Teymoortash A, Hoch S, Gunzel T, Wilhelm T (2017). Hyperplasia and the degree and activity of inflammation in chronic recurrent tonsillitis: a histopathological study. Eur Arch Otorhinolaryngol, 274(7), 2927-2932.
     
  350. Surov A, Meyer HJ, Schob S, Hohn AK, Bremicker K, Exner M, Stumpp P, Purz S (2017). Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer. Oncotarget, 8(17), 28285-28296.
     
  351. Surov A, Meyer HJ, Hoehn AK, Behrmann C, Wienke A, Spielmann RP, Garnov N (2017). Correlations between intravoxel incoherent motion (IVIM) parameters and histological findings in rectal cancer: preliminary results. Oncotarget, 8(13), 21974-21983.
     
  352. Schob S, Meyer HJ, Dieckow J, Pervinder B, Pazaitis N, Hoehn AK, Garnov N, Horvath-Rizea D, Hoffmann KT, Surov A (2017). Histogram Analysis of Diffusion Weighted Imaging at 3T is Useful for Prediction of Lymphatic Metastatic Spread, Proliferative Activity, and Cellularity in Thyroid Cancer. Int J Mol Sci, 18(4), E821.
     
  353. Schob S, Meyer HJ, Pazaitis N, Schramm D, Bremicker K, Exner M, Hoehn AK, Garnov N, Surov A (2017). ADC Histogram Analysis of Cervical Cancer Aids Detecting Lymphatic Metastases-a Preliminary Study. Mol Imaging Biol, 19(6), 953-962.
     
  354. Surov A, Meyer HJ, Gawlitza M, Hoehn AK, Boehm A, Kahn T, Stumpp P (2017). Correlations Between DCE MRI and Histopathological Parameters in Head and Neck Squamous Cell Carcinoma. Transl Oncol, 10(1), 17-21.
     
  355. Meyer HJ, Schob S, Hoehn AK, Surov A (2017). MRI Texture Analysis Reflects Histopathology Parameters in Thyroid Cancer - A First Preliminary Study. Transl Oncol, 10(6), 911-916.
     
  356. Lyros O, Schickel S, Schierle K, Hoffmeister A, Gockel I (2017). [Gastric schwannoma: rare differenzial diagnosis of acute upper gastrointestinal (GI) bleeding]. Z Gastroenterol, 55(8), 761-765.
     
  357. Sonnichsen R, Hennig L, Blaschke V, Winter K, Korfer J, Hahnel S, Monecke A, Wittekind C, Jansen-Winkeln B, Thieme R, Gockel I, Grosser K, Weimann A, Kubick C, Wiechmann V, Aigner A, Bechmann I, Lordi (2017). Individual Susceptibility Analysis Using Patient-derived Slice Cultures of Colorectal Carcinoma. Clin Colorectal Cancer, 0, 0-0.
     
  358. Schroeder L, Wichmann G, Willner M, Michel A, Wiesenfarth M, Flechtenmacher C, Gradistanac T, Pawlita M, Dietz A, Waterboer T, Holzinger D (2017). Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor. Int J Cancer, 0, 0-0.
     
  359. Huebner H, Strick R, Wachter DL, Kehl S, Strissel PL, Schneider-Stock R, Hartner A, Rascher W, Horn LC, Beckmann MW, Ruebner M, Fahlbusch FB (2017). Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma. J Exp Clin Cancer Res, 36(1), 165.
     
  360. McCluggage WG, Judge MJ, Alvarado-Cabrero I, Duggan MA, Horn LC, Hui P, Ordi J, Otis CN, Park KJ, Plante M, Stewart CJR, Wiredu EK, Rous B, Hirschowitz L (2017). Data Set for the Reporting of Carcinomas of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR). Int J Gynecol Pathol, 0, 0-0.
     
  361. Wolf B, Kunert C, Horn LC, Einenkel J (2017). Management of Primary Retroperitoneal Mucinous Tumors: A Retrospective Meta-Analysis. Int J Gynecol Cancer, 27(6), 1064-1071.
     
  362. Gonsior A, Neuhaus J, Horn LC, Bschleipfer T, Stolzenburg JU (2017). [Interstitial cystitis : Diagnosis and pharmacological and surgical therapy]. Urologe A, 56(6), 811-827.
     
  363. Wolf B, Ganzer R, Stolzenburg JU, Hentschel B, Horn LC, Hockel M (2017). Extended mesometrial resection (EMMR): Surgical approach to the treatment of locally advanced cervical cancer based on the theory of ontogenetic cancer fields. Gynecol Oncol, 146(2), 292-298.
     
  364. Neuhaus J, Schiffer E, Mannello F, Horn LC, Ganzer R, Stolzenburg JU (2017). Protease Expression Levels in Prostate Cancer Tissue Can Explain Prostate Cancer-Associated Seminal Biomarkers-An Explorative Concept Study. Int J Mol Sci, 18(5), E976.
     
  365. Wolf B, Horn LC, Hockel M (2017). Anogenital lichen sclerosus: Change of tissue position as pathogenetic factor. Gynecol Oncol Rep, 20, 73-74.
     
  366. Chiang S, Snuderl M, Kojiro-Sanada S, Quer Pi-Sunyer A, Daya D, Hayashi T, Bosincu L, Ogawa F, Rosenberg AE, Horn LC, Wang L, Iafrate AJ, Oliva E (2017). Primitive Neuroectodermal Tumors of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Study of 19 Cases. Am J Surg Pathol, 41(6), 761-772.
     
  367. Gawlitza J, Reiss-Zimmermann M, Thormer G, Schaudinn A, Linder N, Garnov N, Horn LC, Minh DH, Ganzer R, Stolzenburg JU, Kahn T, Moche M, Busse H (2017). Impact of the use of an endorectal coil for 3 T prostate MRI on image quality and cancer detection rate. Sci Rep, 7, 40640.
     
  368. Ravichandran-Chandra A , Arthanareeswaran VKA ,Do HM ,Dietel A ,Franz T ,Kyriazis I ,Liatsikos E ,Rassler J ,Horn LC ,Stolzenburg JU (2017). Minimally invasive partial cystectomy with bilateral vesico-ureteric junction resection and reimplantation for a large paraganglioma involving urinary bladder trigone. Centr Eur J Urol, 70, 378-381.
     
  369. Wolf B ,Monecke A ,Horn LC ,Thome U ,Stepan H ,Schrey-Petersen S (2017). Acute lymphoblastic congenital leukemia as a cause of perinatal death following massive cerebral hemorrhage. Case Reports in Perinatal Medicine, 6(1), 1-4.
     
  370. Troyanova-Slavkova S ,Stassart R ,Slavkov D ,Beloia SD ,Monecke A ,Hammerschmidt D ,Bielfeld C ,Ziegler H ,Soos L ,Eickenscheidt L ,Kowalzick L (2017). Specific Skin Involvement as First Clinical Sign of Hodgkins Lymphoma. AKT DERMATOL, 43(12), 532-536.
     
  371. Haiduk J, Ponitzsch I, Monecke A, Dumann K, Ziemer M (2017). Pitfall cutaneous Squamous Cell Carcinoma. Abstract. JDDG, 15(S3), 40-41.
     
  372. Lim J, Park JH, Baude A, Yoo Y, Lee YK, Schmidt CR, Park JB, Fellenberg J, Zustin J, Haller F, Kruecken I, Kang HG, Park YJ, Plass C, Lindroth AM (2017). The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing. Sci Rep, 7(1), 13459.
     
  373. Carr PR, Jansen L, Bienert S, Roth W, Herpel E, Kloor M, Blaker H, Chang-Claude J, Brenner H, Hoffmeister M (2017). Associations of red and processed meat intake with major molecular pathological features of colorectal cancer. Eur J Epidemiol, 32(5), 409-418.
     
  374. Mamlouk S, Childs LH, Aust D, Heim D, Melching F, Oliveira C, Wolf T, Durek P, Schumacher D, Blaker H, von Winterfeld M, Gastl B, Mohr K, Menne A, Zeugner S, Redmer T, Lenze D, Tierling S, Mobs M, Weichert W, Folprecht G, Blanc E, Beule D, Schafer R, Morkel M, Klauschen F, Leser U, Sers C (2017). DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer. Nat Commun, 8, 14093.
     
  375. Lohneis P, Sinn M, Bischoff S, Juhling A, Pelzer U, Wislocka L, Bahra M, Sinn BV, Denkert C, Oettle H, Blaker H, Riess H, Johrens K, Striefler JK (2017). Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. Eur J Cancer, 83, 290-301.
     
  376. Sinn M, Sinn BV, Striefler JK, Lindner JL, Stieler JM, Lohneis P, Bischoff S, Blaker H, Pelzer U, Bahra M, Dietel M, Dorken B, Oettle H, Riess H, Denkert C (2017). SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study. Ann Oncol, 28(11), 2900.
     
  377. Horn LC, Hoehn AK, Fend F, Schmidt D (2017). Pathologie. In: Wallwiener D, Grischke E, Brucker S, Taran F, Bastert G, Gynäkologische Onkologie. (S. 135-150), Stuttart: Schattauer.
     
  378. Singh N, Horn LC (2017). Squamous Cell Carcinoma of the Cervix. In: Herrington C S, Pathology of the Cervix. (S. 115-148), Cham: Springer.
     
  379. Horn LC, Hoehn AK (2017). Processing and Histopathological Workup of Hysterectomy Specimens. In: Ibrahim A, Liselotte M, Hysterectomy. (S. 250-295), Cham: Springer.
     
  380. Singh N, Horn LC (2017). Squamous Cell Carcinoma oft he Cervix In: Herrington S, Pathology of the Cervix (S. 115-148), London: Springer.
     
  381. Singh N, Horn LC (2017). Surgical Cut Up of Cervical Specimens In: Herrington S, Pathology of the Cervix (S. 237-251), London: Springer.
     
  382. Singh N, Horn LC (2017). : Dataset for Reporting Cervical Neoplasia In: Herrington S, Pathology of the Cervix (S. 253-5), London: Springer.
     
  383. Singh N, Horn LC (2017). Frozen Section Analysis in Cervical Carcinoma In: Herrington S, Pathology of the Cervix (S. 257-259), London: Springer.
     


    384. 2016


  384. Wittekind C (2016). [General aspects of tumor grading]. Einführung. Pathologe, 37(4), 283-284.
     
  385. Merkel S, Weber K, Croner RS, Golcher H, Gohl J, Agaimy A, Semrau S, Siebler J, Wein A, Hohenberger W, Wittekind C (2016). Distant metastases in colorectal carcinoma: A proposal for a new M1 subclassification. Eur J Surg Oncol, 42(9), 1337-1342.
     
  386. Schierle K, Gockel I, Wittekind C (2016). [What Surgeons Need to Know About the Histopathological Processing of a Specimen]. Zentralbl Chir, 141(4), 370-374.
     
  387. Unger T, Sandig I, Wittekind C (2016). [Molecular Pathological Aspects in Visceral Surgery]. Zentralbl Chir, 141(2), 220-228.
     
  388. van den Tweel JG, Wittekind C (2016). The medical autopsy as quality assurance tool in clinical medicine: dreams and realities. Virchows Arch, 468(1), 75-81.
     
  389. Horn LC, Brambs CE, Handzel R, Lax S, Sandig I, Schmidt D, Schierle K (2016). [Cervical cancer : Update on morphology]. Pathologe, 37(6), 542-548.
     
  390. Horn LC, Brambs CE, Handzel R, Mehlhorn G, Schmidt D, Schierle K (2016). [Nomenclature of squamous cell precursor lesions of the lower female genital tract : Current aspects]. Pathologe, 37(6), 526-533.
     
  391. Horn LC, Mayr D, Brambs CE, Einenkel J, Sandig I, Schierle K (2016). [Grading of gynecological tumors : Current aspects]. Pathologe, 37(4), 337-351.
     
  392. Wittekind C (2016). Besonderheiten der Pathologie von Kopf-Hals-Tumoren. Forum Hals-, Nasen-,Ohrenheilkunde, 18(6), 278-282.
     
  393. Wittekind C (2016). Notes on the 7th edition on TNM Classifikation of skin Tumors. Oncology and Dermato-Oncology, 3(1), 8-12.
     
  394. Wittekind C, Tannapfel A (2016). Neue Auflage der TNM-Klassifikation und Implementierungen. Forum, 31(2), 110-111.
     
  395. Lordick F, Haffner I, Luber B, Maier D, Kretzschmar A, von Weikersthal LF, Riera-Knorrenschild J, Ahlborn M, Schierle K, Wittekind C (2016). Response and resistance factor candidates to HER2 targeted therapy in gastric cancer (GC) ANNALS OF ONCOLOGY, 27(Suppl), 103.
     
  396. Blaker H (2016). [Grading of tumors in the tubular digestive tract : Esophagus, stomach, colon and rectum]. Pathologe, 37(4), 293-298.
     
  397. Ahadova A, von Knebel Doeberitz M, Blaker H, Kloor M (2016). CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome. Fam Cancer, 15(4), 579-586.
     
  398. Exner M, Kuhn A, Stumpp P, Hockel M, Horn LC, Kahn T, Brandmaier P (2016). Value of diffusion-weighted MRI in diagnosis of uterine cervical cancer: a prospective study evaluating the benefits of DWI compared to conventional MR sequences in a 3T environment. Acta Radiol, 57(7), 869-77.
     
  399. Hiegel T, Zajonz D, Baum P, Lingscheidt T, Brandmaier P, Winkler D, Prietzel T (2016). [Unusual finding in a 50-year-old patient with lumboischialgia and unilateral foot drop]. Chirurg, 87(2), 157-161.
     
  400. Schoffer O, Schulein S, Arand G, Arnholdt H, Baaske D, Bargou RC, Becker N, Beckmann MW, Bodack Y, Bohme B, Bozkurt T, Breitsprecher R, Buchali A, Burger E, Burger U, Dommisch K, Elsner G, Fernschild (2016). Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011. BMC Cancer, 16(1), 936-936.
     
  401. Koerfer J, Kallendrusch S, Merz F, Wittekind C, Kubick C, Kassahun WT, Schumacher G, Moebius C, Gassler N, Schopow N, Geister D, Wiechmann V, Weimann A, Eckmann C, Aigner A, Bechmann I, Lordick F (2016). Organotypic slice cultures of human gastric and esophagogastric junction cancer. Cancer Med, 5(7), 1444-1453.
     
  402. Sprenger T, Rothe H, Conradi LC, Beissbarth T, Kauffels A, Kitz J, Homayounfar K, Wolff H, Strobel P, Ghadimi M, Wittekind C, Sauer R, Rodel C, Liersch T (2016). Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup. Dis Colon Rectum, 59(5), 377-385.
     
  403. Vardarli MC, Mokan P, Hupfer U, Gerressen M, Hansch A, Schierle K, Boicev AD, Kohler TK (2016). [Unilateral Gigantic Exophthalmos in Haemorrhagic Exacerbation of an Orbital Meningioma]. Klin Monbl Augenheilkd, 233(8), 965-966.
     
  404. Atanasov G, Hau HM, Dietel C, Benzing C, Krenzien F, Brandl A, Englisch JP, Wiltberger G, Schierle K, Robson SC, Reutzel-Selke A, Jonas S, Pascher A, Pratschke J, Schmelzle M (2016). Prognostic significance of TIE2-expressing monocytes in hilar cholangiocarcinoma. J Surg Oncol, 114(1), 91-98.
     
  405. Surov A, Meyer HJ, Gawlitza M, Hohn AK, Boehm A, Kahn T, Stumpp P (2016). Correlations Between DCE MRI and Histopathological Parameters in Head and Neck Squamous Cell Carcinoma. Transl Oncol, 10(1), 17-21.
     
  406. Lax SF, Horn LC, Loning T (2016). [Categorization of uterine cervix tumors : Whats new in the 2014 WHO classification]. Pathologe, 37(6), 573-584.
     
  407. Schnurch HG, Ackermann S, Alt CD, Barinoff J, Boing C, Dannecker C, Gieseking F, Gunthert A, Hantschmann P, Horn LC, Kurzl R, Mallmann P, Marnitz S, Mehlhorn G, Hack CC, Koch MC, Torsten U, Weikel W, (2016). Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015. Geburtshilfe Frauenheilkd, 76(10), 1035-1049.
     
  408. Neis KJ, Zubke W, Romer T, Schwerdtfeger K, Schollmeyer T, Rimbach S, Holthaus B, Solomayer E, Bojahr B, Neis F, Reisenauer C, Gabriel B, Dieterich H, Runnenbaum IB, Kleine W, Strauss A, Menton M, Myl (2016). Indications and Route of Hysterectomy for Benign Diseases. Guideline of the DGGG, OEGGG and SGGG (S3 Level, AWMF Registry No.?015/070, April 2015) Geburtshilfe Frauenheilkd, 76(4), 350-364.
     
  409. Walch-Ruckheim B, Pahne-Zeppenfeld J, Fischbach J, Wickenhauser C, Horn LC, Tharun L, Buttner R, Mallmann P, Stern P, Kim YJ, Bohle RM, Rube C, Stroder R, Juhasz-Boss I, Solomayer EF, Smola S (2016). STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs. Cancer Res, 76(13), 3872-3883.
     
  410. Tempfer C, Horn LC, Ackermann S, Beckmann MW, Dittrich R, Einenkel J, Gunthert A, Haase H, Kratzsch J, Kreissl MC, Polterauer S, Ebert AD, Schneider KT, Strauss HG, Thiel F (2016). Gestational and Non-gestational Trophoblastic Disease. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No.?032/049, December 2015). Geburtshilfe Frauenheilkd, 76(2), 134-144.
     
  411. Troyanova-Slavkova S, Meisel C, Klinger S, Gradistanac T, Eickenscheidt L, Kowalzick L (2016). Gorlin-Goltz-Syndrom mit assoziiertem Hypophysenadenom. Akt Dermatol, 42, 96-98.
     
  412. Kowalzick L, Schaarschmidt E, Gradistanac T, Bortkevicius P, Baumann C, Ziegler H, Eickenscheidt L (2016). Vesikulobullöses Granuloma anulare unter Etanercept- bzw. Abatacept-Therapie. Akt Dermatol , 42, 38-40.
     
  413. Schob S, Voigt P, Bure L, Meyer HJ, Wickenhauser C, Behrmann C, Hohn A, Kachel P, Dralle H, Hoffmann KT, Surov A (2016). Diffusion-Weighted Imaging Using a Readout-Segmented, Multishot EPI Sequence at 3 T Distinguishes between Morphologically Differentiated and Undifferentiated Subtypes of Thyroid Carcinoma-A Preliminary Study. Transl Oncol, 9(5), 403-410.
     
  414. Surov A, Stumpp P, Meyer HJ, Gawlitza M, Hohn AK, Boehm A, Sabri O, Kahn T, Purz S (2016). Simultaneous (18)F-FDG-PET/MRI: Associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma. Oral Oncol, 58, 14-20.
     
  415. Kowalzick L, Baumann C, Monecke A, Bielfeld C, Eickenscheidt L (2016). Extensive Swimming Pool Vesiculobullous Granuloma During Adalimumab Therapy of Rheumatoid Arthritis. AKTUELLE DERMATOLOGIE, 42, 8-9.
     
  416. Rossner F, Gieseler C, Morkel M, Royer HD, Rivera M, Blaker H, Dietel M, Schafer R, Sers C (2016). Uncoupling of EGFR-RAS signaling and nuclear localization of YBX1 in colorectal cancer. Oncogenesis, 5, 187.
     
  417. Jia M, Jansen L, Walter V, Tagscherer K, Roth W, Herpel E, Kloor M, Blaker H, Chang-Claude J, Brenner H, Hoffmeister M (2016). No association of CpG island methylator phenotype and colorectal cancer survival: population-based study. Br J Cancer, 115(11), 1359-1366.
     
  418. Walter V, Jansen L, Ulrich A, Roth W, Blaker H, Chang-Claude J, Hoffmeister M, Brenner H (2016). Alcohol consumption and survival of colorectal cancer patients: a population-based study from Germany. Am J Clin Nutr, 103(6), 1497-1506.
     
  419. Walter V, Jansen L, Hoffmeister M, Ulrich A, Roth W, Blaker H, Chang-Claude J, Brenner H (2016). Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer. Am J Clin Nutr, 104(4), 1110-1120.
     
  420. Carr PR, Jansen L, Walter V, Kloor M, Roth W, Blaker H, Chang-Claude J, Brenner H, Hoffmeister M (2016). Associations of red and processed meat with survival after colorectal cancer and differences according to timing of dietary assessment. Am J Clin Nutr, 103(1), 192-200.
     
  421. Striefler JK, Sinn M, Pelzer U, Juhling A, Wislocka L, Bahra M, Sinn BV, Denkert C, Dorken B, Oettle H, Riess H, Blaker H, Lohneis P (2016). P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatment. Pathol Res Pract, 212(8), 726-734.
     
  422. Lemos C, Hardt MS, Juneja M, Voss C, Forster S, Jerchow B, Haider W, Blaker H, Stein U (2016). MACC1 Induces Tumor Progression in Transgenic Mice and Colorectal Cancer Patients via Increased Pluripotency Markers Nanog and Oct4. Clin Cancer Res, 22(11), 2812-2824.
     
  423. Treese C, Sanchez P, Grabowski P, Berg E, Blaker H, Kruschewski M, Haase O, Hummel M, Daum S (2016). Poorly Differentiated Medullary Phenotype Predicts Poor Survival in Early Lymph Node-Negative Gastro-Esophageal Adenocarcinomas. PLoS One, 11(12), 0.
     
  424. Ahadova A, von Knebel Doeberitz M, Blaker H, Kloor M (2016). CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome. Fam Cancer, 15(4), 579-586.
     


    425. 2015


  425. Jeuck T, Wittekind C (2015). Gastric carcinoma: stage migration by immunohistochemically detected lymph node micrometastases. Gastric cancer, 18(1), 100-108.
     
  426. Wittekind C (2015). [New aspects for staging and grading of tumor metastases]. Pathologe, 36 (Suppl 2), 153-157.
     
  427. Wittekind C (2015). The development of the TNM classification of gastric cancer. Pathol Int, 65(8), 399-403.
     
  428. Horn LC, Beckmann MW, Follmann M, Koch MC, Mallmann P, Marnitz S, Schmidt D (2015). [S3 guidelines on diagnostics and treatment of cervical cancer: Demands on pathology]. Pathologe, 36(6), 585-593.
     
  429. Hentschel J, Sändig I, Unger T, Lemke JR, Wittekind C (2015). Molekulargenetische und molekularpathologische Analysen. Forum, 30, 118-121.
     
  430. Moehler M, Baltin CT, Ebert M, Fischbach W, Gockel I, Grenacher L, Holscher AH, Lordick F, Malfertheiner P, Messmann H, Meyer HJ, Palmqvist A, Rocken C, Schuhmacher C, Stahl M, Stuschke M, Vieth M, Wi (2015). International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. Gastric Cancer, 18(3), 550-563.
     
  431. Boehm A, Lindner F, Wichmann G, Bauer U, Wittekind C, Knoedler M, Lordick F, Dietzsch S, Scholz M, Kortmann R, Dietz A (2015). Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol, 272(8), 2017-2025.
     
  432. Kowalzick L, Marcus EL, Gradistanac T, Truhm B, Kehler B, Budzisiak P, Eickenscheidt L, Pönnighaus JM, Driesch P (2015). Persistierende Wundheilungsstörungen nach Lokaltherapie von Feldkanzerisierung des Capillitiums mit Imiquimod oder Diclofenac. Aktuelle Dermatologie, 41(1-2), 50-54.
     
  433. Schirrmacher S, Kallidonis P, Horn LC, Nenning H, Rassler J, Rai B, Do M, Liatsikos E, Stolzenburg JU (2015). Stage pT0 after radical prostatectomy: a diagnostic dilemma. World J Urol, 33(9), 1291-1296.
     
  434. Ueberham E, Glockner P, Gohler C, Straub BK, Teupser D, Schonig K, Braeuning A, Höhn AK, Jerchow B, Birchmeier W, Gaunitz F, Arendt T, Sansom O, Gebhardt R, Ueberham U (2015). Global Increase of p16INK4a in APC-deficient Mouse Liver Drives Clonal Growth of p16INK4a Negative Tumors. Mol Cancer Res, 13(2), 239-49.
     
  435. Pirlich M, Fischer M, Mozet C, Horn IS, Monecke A, Dietz A (2015). [A 4-year-old Boy with an Unknown Tumor in the Nasopharyngeal Space.] Laryngorhinootologie, 94(2), 102-104.
     
  436. Frydrychowicz C, Holland H, Hantmann H, Gradistanac T, Hoffmann KT, Mueller W, Meixensberger J, Krupp W (2015). Two cases of atypical meningioma with pulmonary metastases: A comparative cytogenetic analysis of chromosomes 1p and 22 and a review of the literature. Neuropathology, 35(2), 175-183.
     
  437. Blanke A, Aupperle H, Seeger J, Kubick C, Schusser GF (2015). Histological Study of the External, Middle and Inner Ear of Horses. Anat Histol Embryol, 44(6), 401-409.
     
  438. Kretschmer A, Wittekind C, Stief CG, Gratzke C (2015). [Neuroendocrine prostate cancer]. Urologe A, 54(12), 1779-1783.
     
  439. Karlas T, Dietrich A, Peter V, Wittekind C, Lichtinghagen R, Garnov N, Linder N, Schaudinn A, Busse H, Prettin C, Keim V, Troltzsch M, Schutz T, Wiegand J (2015). Evaluation of Transient Elastography, Acoustic Radiation Force Impulse Imaging (ARFI), and Enhanced Liver Function (ELF) Score for Detection of Fibrosis in Morbidly Obese Patients. PLoS One, 10(11), e0141649.
     
  440. Rodel C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, Hofheinz RD, Ghadimi M, Wolff HA, Lang-Welzenbach M, Raab HR, Wittekind C, Strobel P, Staib L, Wilhelm M, Grabenbauer GG, Hoffmanns H (2015). Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol, 16(8), 979-989.
     
  441. Wichmann G, Rosolowski M, Krohn K, Kreuz M, Boehm A, Reiche A, Scharrer U, Halama D, Bertolini J, Bauer U, Holzinger D, Pawlita M, Hess J, Engel C, Hasenclever D, Scholz M, Ahnert P, Kirsten H, Hempri (2015). The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer. Int J Cancer, 137(12), 2846-2857.
     
  442. Fokas E, Liersch T, Fietkau R, Hohenberger W, Hess C, Becker H, Sauer R, Wittekind C, Rodel C (2015). Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: the reverse of the Will Rogers phenomenon? Cancer, 121(11), 1724-1727.
     
  443. Denschlag D, Thiel FC, Ackermann S, Harter P, Juhasz-Boess I, Mallmann P, Strauss HG, Ullrich U, Horn LC, Schmidt D, Vordermark D, Vogl T, Reichardt P, Gass P, Gebhardt M, Beckmann MW (2015). Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015). Geburtshilfe Frauenheilkd, 75(10), 1028-1042.
     
  444. Reich O, Regauer S, Marth C, Schmidt D, Horn LC, Dannecker C, Menton M, Beckmann MW (2015). Precancerous Lesions of the Cervix, Vulva and Vagina According to the 2014 WHO Classification of Tumors of the Female Genital Tract. Geburtshilfe Frauenheilkd, 75(10), 1018-1020.
     
  445. Wolf B, Horn LC, Handzel R, Einenkel J (2015). Ultrasound plays a key role in imaging and management of genital angiomyofibroblastoma: a case report. J Med Case Rep, 9, 248.
     
  446. Schwalenberg T, Berger FP, Horn LC, Thi PH, Stolzenburg JU, Neuhaus J (2015). Intravesical Glycosaminoglycan Replacement with Chondroitin Sulphate (Gepan(®) instill) in Patients with Chronic Radiotherapy- or Chemotherapy-Associated Cystitis. Clin Drug Investig, 35(8), 505-512.
     
  447. Otto J, Sorge I, Horn LC, Sterker I (2015). Magnetic resonance imaging of a phakomatous choristoma. Pediatr Radiol, 45(11), 1712-1715.
     
  448. Thormer G, Otto J, Horn LC, Garnov N, Do M, Franz T, Stolzenburg JU, Moche M, Kahn T, Busse H (2015). Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 T. Acta Radiol, 56(1), 121-128.
     
  449. Zebralla V, Horn IS, Gradistanac T, Dietz A (2015). [Raumforderung im Bereich des Sinus ethmoidalis mit ossärer Destruktion - benigne oder maligne?]. Laryngorhinootologie, 94(11), 769-771.
     
  450. Koehler A, Hubert K, Lange T, Siebolts U, Wickenhauser C, Gopalakrishna P, Niederwieser D, Monecke A, Al-Ali HK (2015). JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib. Ann Hematol, 94(11), 1929-1930.
     
  451. Atanasov G, Hau HM, Dietel C, Benzing C, Krenzien F, Brandl A, Wiltberger G, Matia I, Prager I, Schierle K, Robson SC, Reutzel-Selke A, Pratschke J, Schmelzle M, Jonas S (2015). Prognostic significance of macrophage invasion in hilar cholangiocarcinoma. BMC Cancer, 15, 790.
     
  452. Spindler N, Hanske S, Schierle K, Aydogan E, Bohme J, Langer S, Josten C (2015). [Glomuvenous malformations]. Orthopade, 44(9), 716-719.
     
  453. Koch H, Hammer N, Ossmann S, Schierle K, Sack U, Hofmann J, Wecks M, Boldt A (2015). Tissue Engineering of Ureteral Grafts: Preparation of Biocompatible Crosslinked Ureteral Scaffolds of Porcine Origin. Front Bioeng Biotechnol, 3, 89.
     
  454. Dietel M, Wittekind C, Bussolati G, Winterfeld M (2015). Pre-Analytics of Pathological Specimens in Oncology. Recent Results in Cancer Research, 199, 1-13.
     
  455. Ulrich U, Wunschel A, Reichert VM, Darb-Esfahani S, Denschlag D, Horn LC, Noack F, Renner SP, Sillem M, Schweppe KW, Wardelmann E, Schmidt D (2015). Endometrioseassoziierte maligne Tumoren. Der Gynäkologe, 48(3), 221-227.
     
  456. Kowalzick L, Schaarschmidt E, Gradistanac T, Bortkevicius P, Baumann C, Ziegler H, Eickenscheidt L (2015). Vesikulobullöses Granuloma anulare unter Etanercept- bzw. Abatacept-Therapie" Akt Dermatolog, 41(1-2), 48-50.
     
  457. Händel C, Schmidt S, Schiller J, Dietrich U, Möhn T, Kießling TR, Pawlizak S, Fritsch AW, Horn LC, Bries S (2015). Cell membrane softening in human breast and cervical cancer cells. New Journal of Physics, 17, e083008.
     
  458. Zajonz D, Kohler L, Pretzsch M, Lingscheidt T, Moche M, Heyde CE, Scholz R (2015). [Surgical treatment of tibialis anterior tendon rupture]. Orthopade, 44(4), 303-313.
     
  459. Zajonz D, Pfraenger JR, Dubitzki S, Panzert S, Seider D, Lingscheidt T, Hammer N, Prietzel T (2015). [Subtotal Segment Resection, Augmenting Angle-Stable Plate Osteosynthesis and Allogenic Bone Graft as Treatment Option for Juxtacortical Osteosarcoma in the Knee Region]. Z Orthop Unfall, 153(3), 299-305.
     
  460. Zajonz D, Pfranger J, Fuchs J, Tiepolt S, Lingscheidt T, Farag M, Prietzel T (2015). [Cardiac fibromyxosarcoma with bone metastases : palliative surgical treatment]. Orthopade, 44(1), 80-84.
     


    461. 2014


  461. Petros K, Wittekind C (2014). [Autopsy-a procedure of medical history?] Med Klin Intensivmed Notfmed, 109(2), 115-20.
     
  462. Wittekind C (2014). [New TNM classification of lung tumors]. Pathologe, 35(6), 578-585.
     
  463. Hoehn AK, Einenkel J, Wittekind C, Horn LC (2014). [New FIGO classification of ovarian, fallopian tube and primary peritoneal cancer]. Pathologe, 35(4), 322-326.
     
  464. Wittekind C (2014). [TNM classification of testicular tumors. Definitions and prerequisites for correct application]. Pathologe, 35(3), 252-255.
     
  465. Wittekind C, Habeck JO, Gradistanac T (2014). [Proposals for standardization of autopsy reports]. Pathologe, 35(2), 182-190.
     
  466. Meier F, Oltmanns A, Brandmaier P, Wittekind C (2014). [Case report about a 35 year old patient with cystic fibrosis and metastatic pancreatic cancer]. Z Gastroenterol, 52(1), 55-57.
     
  467. Horn LC, Hohn AK, Einenkel J, Siebolts U (2014). Monoclonal origin of peritoneal implants and lymph node deposits in serous borderline ovarian tumors (s-BOT) with high intratumoral homogeneity. Int J Gynecol Pathol, 33(6), 592-597.
     
  468. Horn LC, Einenkel J, Handzel R, Hohn AK (2014). [Morphology of secondary ovarian tumors and metastases]. Pathologe, 35(4), 336-347.
     
  469. Horn LC, Bilek K, Fischer U, Einenkel J, Hentschel B (2014). A cut-off value of 2 cm in tumor size is of prognostic value in surgically treated FIGO stage IB cervical cancer. Gynecol Oncol, 134(1), 42-46.
     
  470. Horn LC, Bauerfeind UK, Strau HG, Karbe I (2014). Vulval intestinal/enteric heterotopia with a 10-yr follow-up: a case report and review of the literature. Int J Gynecol Pathol, 33(3), 258-262.
     
  471. Kakies Ch, Lopez-Beltran A, Comperat E, Erbersdobler A, Grobholz R, Hakenberg OW, Hartmann A, Horn LC, Hohn AK, Kollermann J, Kristiansen G, Montironi R, Scarpelli M, Protzel Ch (2014). Reproducibility of histopathologic tumor grading in penile cancer-results of a European project. Virchows Arch, 464(4), 453-461.
     
  472. Wittekind C (2014). [Pathology and classification of oesophageal carcinoma.] Onkologe, 20(12), 1180-1186.
     
  473. Wittekind C (2014). [Pathology and classifikation of carcinomas of the oesophagus and stomach - Aspects of current tumor classifikation.] Klinikarzt, 43(7-8), 344-347.
     
  474. Horn LC, Einenkel J, Hoehn AK (2014). Classification and morphology of gestational trophoblastic disease. Curr Obstet Gynecol Rep, 3(1), 44-54.
     
  475. Hockel M, Hentschel B, Horn LC (2014). Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis. Lancet Oncol, 15(4), 445-456.
     
  476. Gerlach MM, Merz F, Wichmann G, Kubick C, Wittekind C, Lordick F, Dietz A, Bechmann I (2014). Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance. Br J Cancer, 110(2), 479-488.
     
  477. Runge J, Reichert T, Fritsch A, Kas J, Bertolini J, Remmerbach T (2014). Evaluation of single-cell biomechanics as potential marker for oral squamous cell carcinomas: a pilot study. Oral Dis, 20(3), e120-127.
     
  478. Schoniger S, Horn LC, Schoon HA (2014). Tumors and Tumor-like Lesions in the Mammary Gland of 24 Pet Rabbits: A Histomorphological and Immunohistochemical Characterization. Vet Pathol, 51(3), 569-80.
     
  479. von der Hoeh NH, Tschoeke SK, Gulow J, Voelker A, Siebolts U, Heyde CE (2014). Total spondylectomy for solitary bone plasmacytoma of the lumbar spine in a young woman: a case report and review of literature. Eur Spine J, 23(1), 35-39.
     
  480. Pausch NC, Gradistanac T, Halama D (2014). [Differential diagnosis of chronic maxillary sinusitis.] HNO, 62(2), 124-126.
     
  481. Jaekel N, Behre G, Behning A, Wickenhauser C, Lange T, Niederwieser D, Al-Ali HK (2014). Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib. Bone Marrow Transplant, 49(2), 179-184.
     
  482. Webber C, Gospodarowicz M, Sobin LH, Wittekind C, Greene FL, Mason MD, Compton C, Brierley J, Groome PA (2014). Improving the TNM classification: findings from a 10-year continuous literature review. Int J Cancer, 135(2), 371-378.
     
  483. Fokas E, Liersch T, Fietkau R, Hohenberger W, Beissbarth T, Hess C, Becker H, Ghadimi M, Mrak K, Merkel S, Raab HR, Sauer R, Wittekind C, Rodel C (2014). Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial. J Clin Oncol, 32(15), 1554-1562.
     
  484. Karlas T, Petroff D, Garnov N, Bohm S, Tenckhoff H, Wittekind C, Wiese M, Schiefke I, Linder N, Schaudinn A, Busse H, Kahn T, Mossner J, Berg T, Troltzsch M, Keim V, Wiegand J (2014). Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. PLoS One, 9(3), e91987.
     
  485. Vrachimis A, Gerss J, Stoyke M, Wittekind C, Maier T, Wenning C, Rahbar K, Schober O, Riemann B (2014). No significant difference in the prognostic value of the 5th and 7th editions of AJCC staging for differentiated thyroid cancer. Clin Endocrinol (Oxf), 80(6), 911-917.
     
  486. Vochem R, Einenkel J, Horn LC, Ruschpler P (2014). [Importance of the tumor stem cell hypothesis for understanding ovarian cancer]. Pathologe, 35(4), 361-370.
     
  487. Otto J, Thormer G, Seiwerts M, Fuchs J, Garnov N, Franz T, Horn LC, Do MH, Stolzenburg JU, Kahn T, Moche M, Busse H (2014). Value of endorectal magnetic resonance imaging at 3T for the local staging of prostate cancer. Rofo, 186(8), 795-802.
     
  488. Baunacke M, Horn LC, Trettner S, Engel KM, Hemdan NY, Wiechmann V, Stolzenburg JU, Bigl M, Birkenmeier G (2014). Exploring glyoxalase 1 expression in prostate cancer tissues: targeting the enzyme by ethyl pyruvate defangs some malignancy-associated properties. Prostate, 74(1), 48-60.
     
  489. Weber T, Wickenhauser C, Monecke A, Glaser C, Stadler M, Desole M, Ligeti K, Behrmann C, Muller-Tidow C, Muller LP (2014). Treatment of rare co-occurrence of Epstein-Barr virus-driven post-transplant lymphoproliferative disorder and hemophagocytic lymphohistiocytosis after allogeneic stem cell transplantation. Transpl Infect Dis, 16(6), 988-992.
     
  490. Möhler M, Thuß-Patience P, Fischbach W, Grenacher L, Hölscher AH, Messmann H, Palmqvist A, Stahl M, Wittekind C, Meyer HJ (2014). [Aktuelle Diagnostik und Therapie des Magenkarzinoms.] J Gastroenterol Hepatol Erkr, 12(2), 10-16.
     
  491. Lordick F, Dietz A, Briest S, Kortmann R-D, Wittekind C (2014). [Personalisierte Krebstherapie.] Ärzteblatt Sachsen, 2, 62-64.
     
  492. Rodel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, Graeven U, Arnold D, Raab HR ,Wittekind C, Staib L, Hess C, Grabenbauer G, Sauer R (2014). Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: Results of the German CAO/ARO/AIO-04 randomized phase III trial Strahlenther Onkol, 190, 5.
     
  493. Fokas E, Liersch T, Fietkau R, Hohenberger W, Beissbarth T, Hess C, Becker H, Ghadimi M, Mrak K, Merkel S , Raab HR, Sauer R, Wittekind C, Roedel C (2014). The prognostic role of tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: 11-year median follow-up results of the CAO/ARO/AIO-94 trial Strahlenther Onkol, 190(Suppl. 1), 88.
     
  494. Schonherr M, Bhattacharya A, Kottek T, Szymczak S, Koberle M, Wickenhauser C, Siebolts U, Saalbach A, Koczan D, Magin TM, Simon JC, Kunz M (2014). Genomewide RNAi screen identifies protein kinase Cb and new members of mitogen-activated protein kinase pathway as regulators of melanoma cell growth and metastasis. Pigment Cell Melanoma Res, 27(3), 418-430.
     
  495. Rabenhorst A, Christopeit B, Leja S, Gerbaulet A, Kleiner S, Forster A, Raap U, Wickenhauser C, Hartmann K (2014). Novel insights into mastocytosis-associated osteoporosis: mast cells in indolent systemic mastocytosis produce bone cytokines EXP DERMATOL, 23(3), e2.
     


    496. 2013


  496. Bertolini J, Wittekind C (2013). [Large Adenomas of the Colon and Rectum - Specific Features of the Diagnostics.] Zentralbl Chir, 138 (Suppl 2), e70-4.
     
  497. Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, Cathomas R, Cavallin-Stahl E, Clarke NW, Classen J, Cohn-Cedermark G, Dahl AA, Daugaard G, De Giorgi U, De Santis M, De Wit M, ..., Wittekind C (2013). Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol, 24(4), 878-88.
     
  498. Lordick F, Holscher AH, Haustermans K, Wittekind C (2013). Multimodal treatment of esophageal cancer. Langenbecks Arch Surg, 398(2), 177-87.
     
  499. Wittekind C, Karl A (2013). [Uropathology - requirements for standards and quality]. Urologe A, 52(7), 958-964.
     
  500. Horn LC, Schreiter C, Canzler A, Leonhardt K, Einenkel J, Hentschel B (2013). CD34(low) and SMA(high) represent stromal signature in uterine cervical cancer and are markers for peritumoral stromal remodeling. Ann Diagn Pathol, 17(6), 531-535.
     
  501. Horn LC, Kafkova S, Leonhardt K, Kellner C, Einenkel J (2013). Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas. Int J Gynecol Pathol, 32(4), 339-344.
     
  502. Hockel M, Horn LC (2013). The puzzle of close surgical margins is not puzzling. Gynecol Oncol, 130(1), 224-225.
     
  503. Lange T, Edelmann A, Siebolts U, Krahl R, Nehring C, Jakel N, Cross M, Maier J, Niederwieser D, Wickenhauser C (2013). JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse. Haematologica, 98(5), 722-728.
     
  504. Riemann B, Schober O, Wittekind C (2013). Molecular imaging and pathological diagnostics Indications and course control of targeted therapy. ONKOLOGE, 19(19), 809-820.
     
  505. Horn LC, Einenkel J, Höhn AK (2013). Histologie und molekulare Pathogenese des Ovarialkarzinoms. Ärzteblatt Sachsen, 24(5), 187-191.
     
  506. Wittekind C, Höhn AK (2013). Mikroskopische Erkrankungen des Gastrointestinaltraktes. Gastroenterologe, 8(6), 525-528.
     
  507. Wittekind C (2013). [New developments in the classification of malign tumors]. Dtsch Med Wochenschr, 138(20), 1054-1058.
     
  508. Wittekind C , Petros K , Gradistanac T (2013). [Autopsies in oncology]. ONKOLOGE, 19(1), 69-77.
     
  509. Wittekind C (2013). Aktuelle Entwicklungen des TNM-Systems Forum der Medizin_Dokumentation und Medizin_Informatik, 15(2), 48-51.
     
  510. Franz T, Hafner T, Horn LC, Kassahun W, Stolzenburg JU (2013). [Huge retrovesical tumor as an incidental finding : Desmoid-type fibromatosis: a case report.] Urologe A, 52(1), 74-8.
     
  511. Maurer K, Eschrich K, Schellenberger W, Bertolini J, Rupf S, Remmerbach TW (2013). Oral brush biopsy analysis by MALDI-ToF Mass Spectrometry for early cancer diagnosis. Oral Oncol, 49(2), 152-6.
     
  512. Flemming GM, Oberschmid B, Siebolts U, Hirsch W, Schuster V (2013). Abdominal tuberculosis in children and adolescents: to this day a diagnostic challenge. Klin Padiatr, 225(1), 47-49.
     
  513. Greten TF, Malek NP, Schmidt S, Arends J, Bartenstein P, Bechstein W, Bernatik T, Bitzer M, Chavan A, Dollinger M, Domagk D, Drognitz O, Dux M, Farkas S, Folprecht G, Galle P, Geissler M, Gerken G, Ha (2013). [Diagnosis of and therapy for hepatocellular carcinoma]. Z Gastroenterol, 51(11), 1269-1326.
     
  514. Mai M, Tonjes A, Trantakis C, Wittekind C, Stumvoll M, Fuhrer D (2013). [Hirsutism and multinodular goiter in a 40-year-old female watchmaker]. Internist (Berl), 54(9), 1137-1140.
     
  515. Atanasov G, Benckert C, Thelen A, Tappe D, Frosch M, Teichmann D, Barth TF, Wittekind C, Schubert S, Jonas S (2013). Alveolar echinococcosis-spreading disease challenging clinicians: a case report and literature review. World J Gastroenterol, 19(26), 4257-4261.
     
  516. Maier M, Liebert UG, Wittekind C, Kaiser T, Berg T, Wiegand J (2013). Clinical Relevance of Minimal Residual Viremia during Long-Term Therapy with Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B. PLoS One, 8(6), e67481.
     
  517. Wolff HA, Conradi LC, Beissbarth T, Leha A, Hohenberger W, Merkel S, Fietkau R, Raab HR, Tschmelitsch J, Hess CF, Becker H, Wittekind C, Sauer R, Rodel C, Liersch T (2013). Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase III trial. Radiother Oncol, 108(1), 48-54.
     
  518. Thelen A, Benckert C, Tautenhahn HM, Hau HM, Bartels M, Linnemann J, Bertolini J, Moche M, Wittekind C, Jonas S (2013). Liver resection for hepatocellular carcinoma in patients without cirrhosis. Br J Surg, 100(1), 130-137.
     
  519. Dimitrova K, Stoehr M, Dehghani F, Dietz A, Wichmann G, Bertolini J, Mozet C (2013). Overexpression of the Hedgehog signalling pathway in head and neck squamous cell carcinoma. Onkologie, 36(5), 279-286.
     
  520. Kowalzick L, Bertolini J, Baumann C, Walther B, Truhm B, Eickenscheidt L (2013). Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis. J Dtsch Dermatol Ges, 11(5), 447-449.
     
  521. Neuhaus J, Schiffer E, Siwy J, Mannello F, Horn LC, Stolzenburg JU (2013). [Proteome-based diagnostic and prognostic biomarkers of prostate cancer]. Urologe A, 52(9), 1251-1255.
     
  522. Neuhaus J, Schiffer E, von Wilcke P, Bauer HW, Leung H, Siwy J, Ulrici W, Paasch U, Horn LC, Stolzenburg JU (2013). Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease. PLoS One, 8(6), e67514.
     
  523. Starke S, Meinke P, Camozzi D, Mattioli E, Pfaeffle R, Siekmeyer M, Hirsch W, Horn LC, Paasch U, Mitter D, Lattanzi G, Wehnert M, Kiess W (2013). Progeroid laminopathy with restrictive dermopathy-like features caused by an isodisomic LMNA mutation p.R435C. Aging (Albany NY), 5(6), 445-459.
     
  524. Mayer A, Hockel M, Schlischewsky N, Schmidberger H, Horn LC, Vaupel P (2013). Lacking hypoxia-mediated downregulation of E-cadherin in cancers of the uterine cervix. Br J Cancer, 108(2), 402-408.
     
  525. Rehfeld C, Munz S, Krogdahl A, Jensen EM, Siebolts U, Ferraz C, Bosenberg E, Hegedus L, Paschke R, Eszlinger M (2013). Impact of different methodologies on the detection of point mutations in routine air-dried fine needle aspiration (FNA) smears. Horm Metab Res, 45(7), 513-517.
     
  526. Rosendahl J, Hoffmeister A, Schierle K, Maiwald B, Kahn T, Mossner J, Wittenburg H (2013). When in doubt, take it out? Cholestasis and obstructive gastric outlet syndrome in a patient with suspected chronic pancreatitis. Pancreatology, 13(4), 458-460.
     
  527. Emmrich JV, Kamprad M, Sorge I, Hammerschmidt S, Gradistanac T, Schille R, Kiess W, Prenzel F (2013). Extensive fibrosis caused by Pleural Tuberculosis: a lesson from a case without post-exposure-prophylaxis. Pediatr Pulmonol, 48(2), 206-209.
     
  528. Halama D, Hierl T, Wickenhauser C, Pausch NC (2013). Psammomatoid Juvenile Ossifying Fibroma of the Maxilla: Radical Surgery with Maxillary Resection in a 7-year-old Girl. Klin Padiatr, 225(7), 418-419.
     
  529. Rabenhorst A, Christopeit B, Leja S, Gerbaulet A, Kleiner S, Forster A, Raap U, Wickenhauser C, Hartmann K (2013). Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis. J Allergy Clin Immunol, 132(5), 1234-1237.
     
  530. Maier J, Lange T, Kerle I, Specht K, Bruegel M, Wickenhauser C, Jost P, Niederwieser D, Peschel C, Duyster J, von Bubnoff N (2013). Detection of mutant free circulating tumor DNA in the plasma of patients with gastrointestinal stromal tumor harboring activating mutations of CKIT or PDGFRA. Clin Cancer Res, 19(17), 4854-4867.
     
  531. Schwede K, Wetzig T, Simon JC, Fischer L, Wickenhauser C, Scharer L, Ziemer M (2013). Cutaneous clear cell sarcoma in a 12-year-old boy. J Dtsch Dermatol Ges, 11(8), 757-759.
     
  532. Protzel C, Kakies C, Erbersdobler A, Lopez-Beltran A , Horn LC, Hoehn AK, Christiansen G, Grobholz R, Koellermann J, Comperat E, Hakenberg OW (2013). HOW RELIABLE IS TUMORGRADING IN PENILE CANCER-RESULTS OF AN INTERNATIONAL GRADING STUDY. (Abstract) JOURNAL OF UROLOGY , 189(4), 310.
     
  533. Vollrath J, Miehe U , Gradistanac T, Siekmeyer M, Kunze A, Metzger R, Hirsch, W, Prenzel, F (2013). One-sided mediastinal Mass - an unusual pneumological Case. Abstract ALLERGOLOGIE, 36(4), 191.
     
  534. Möhler M, Thuß-Patience P, Fischbach W, Grenacher L, Hölscher AH, Messmann H, Palmqvist A, Stahl M, Wittekind C, Meyer HJ (2013). Aktuelle Diagnostik und Therapie des Magenkarzinoms. Gastroenterol Hepatol Erkr, 11(4), 1-7.
     
  535. Halama D, Hierl T, Wickenhauser C, Pausch NC (2013). Psammomatoid Juvenile Ossifying Fibroma of the Maxilla: Radical Surgery with Maxillary Resection in a 7-year-old Girl. Erratum Klin Padiatr, 225(7), 420.
     
  536. Wittekind C, Compton CC, Brierley J, Sobin LH (2013). TNM-Supplement Erläuterungen zur einheitlichen Anwendung Deutsche Übersetzung In: Wittekind C, Compton CC, Brierley J, Sobin LH, TNM-Supplement Erläuterungen zur einheitlichen Anwendung Deutsche Übersetzung (S. 1-299), Weinheim: Wiley-VCH Verlag .
     
  537. Wickenhauser C, Wittekind C (2013). Molekulare Pathologie und Entstehungswege der kolorektalen Karzinome. In: Lordick F, Hacker UT , Zielgerichtete Therapie des kolorektalen Karzinoms. (S. 22-27), Bremen: UniMed Buch .
     


    538. 2012


  538. Horn LC, Kellner C, Scherling R, Hockel M, Einenkel J (2012). Ultrastaging for micrometastases in para-aortic lymph nodes in patients with carcinoma of the uterine cervix. Gynecol Oncol, 124(2), 374-5.
     
  539. Hockel M, Horn LC (2012). Three-dimensional classification of radical hysterectomy: New saddle for an old horse. Gynecol Oncol, 124(1), 173-174.
     
  540. Oberschmid B, Dietrich A, Wittekind C (2012). [Frozen sections diagnostics in visceral surgery. Stomach and intestines]. Pathologe, 33(5), 407-412.
     
  541. Wittekind C, Oberschmid B (2012). [Pathological staging and response evaluation of rectal carcinoma]. Chirurg, 83(5), 423-429.
     
  542. Wittekind C (2012). [Lymph nodes, tumour deposits, and TNM: are we getting better? 7th edition of UICC 2010 TNM classification of malignant tumors]. Strahlenther Onkol, 188(2), 191-192.
     
  543. Wittekind C, Gradistanac T (2012). Current TNM classification of neuroendocrine tumours. Onkologe, 18(9), 815-823.
     
  544. Hockel M, Einenkel J, Horn LC (2012). Paraaortic lymphatic spread in cervical cancer. Gynecol Oncol, 127(3), 677.
     
  545. Horn LC, Hommel N, Roschlau U, Bilek K, Hentschel B, Einenkel J (2012). Peritumoral stromal remodeling, pattern of invasion and expression of c-met/HGF in advanced squamous cell carcinoma of the cervix uteri, FIGO stages III and IV. Eur J Obstet Gynecol Reprod Biol, 163(1), 76-80.
     
  546. Einenkel J, Braumann UD, Steller W, Binder H, Horn LC (2012). Suitability of infrared microspectroscopic imaging for histopathology of the uterine cervix. Histopathology, 60(7), 1084-1098.
     
  547. Horn LC, Meinel A, Hentschel B (2012). c-kit/CD 117 positive cells in the myometrium of pregnant women and those with uterine endometriosis. Arch Gynecol Obstet, 286(1), 105-107.
     
  548. Steiner E, Einenkel J, Schmidt D, Horn LC (2012). Predictive and prognostic markers of endometrial cancer. Onkologe, 18(10), 853-865.
     
  549. Horn LC, Leonhardt K, Kafkova S, Einenkel J (2012). Serous tubal in situ carcinoma (STIC) in tubal and primary peritoneal carcinomas (Abstract). Virchows Archiv, 461 (Suppl.), 308-309.
     
  550. Horn LC, Kellner C, Scherling R, Hoeckel M, Einenkel J (2012). Detection of micrometastases in para-aortic lymph nodes in patients with carcinoma of the uterine cervix after negative frozen section analysis (Abstract) Virchows Archiv, 461(Suppl.), 308.
     
  551. Terpe F, Siekmeyer M, Bierbach U, Siekmeyer W, Kratzsch J, Till H, Wittekind C, Kiess W (2012). Fulminant and Fatal Course of Acute Lymphoblastic Leukemia Due to Lactic Acidosis and Suspected Abdominal Compartment Syndrome. J Pediatr Hematol Oncol, 34(2), e80-3.
     
  552. Hockel M, Horn LC, Tetsch E, Einenkel J (2012). Pattern analysis of regional spread and therapeutic lymph node dissection in cervical cancer based on ontogenetic anatomy. Gynecol Oncol, 125(1), 168-74.
     
  553. Neuhaus J, Schulte-Baukloh H, Stolzenburg JU, Speroni di Fenizio P, Horn LC, Ruffert H, Hartenstein S, Burger M, Schulze M, Schwalenberg T (2012). Individual receptor profiling as a novel tool to support diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC). World J Urol, 30(5), 693-700.
     
  554. Hoffmeister A, Mayerle J, Dathe K, Mossner J, Lerch MM (2012). [Method report to the S3 guideline chronic pancreatitis: definition, etiology, diagnostics and conservative, interventional endoscopic and surgical therapy of the chronic pancreatitis]. Z Gastroenterol, 50(11), 1225-1236.
     
  555. Hoffmeister A, Mayerle J, Beglinger C, Buchler MW, Bufler P, Dathe K, Folsch UR, Friess H, Izbicki J, Kahl S, Klar E, Keller J, Knoefel WT, Layer P, Loehr M, Meier R, Riemann JF, Runzi M, Schmid RM, S (2012). [S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS)]. Z Gastroenterol, 50(11), 1176-1224.
     
  556. Rodel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, Graeven U, Arnold D, Lang-Welzenbach M, Raab HR, Sulberg H, Wittekind C, Potapov S, Staib L, Hess C, Weigang-Kohler K, et al. (2012). Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol, 13(7), 679-687.
     
  557. Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, Wittekind C, Beissbarth T, Rodel C (2012). Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol, 30(16), 1926-1933.
     
  558. Heindl M, Handel N, Ngeow J, Kionke J, Wittekind C, Kamprad M, Rensing-Ehl A, Ehl S, Reifenberger J, Loddenkemper C, Maul J, Hoffmeister A, Aretz S, Kiess W, Eng C, Uhlig HH (2012). Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome. Gastroenterology, 142(5), 1093-1096.
     
  559. Hockel M, Horn LC, Einenkel J (2012). (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy. Gynecol Oncol, 127(2), 297-302.
     
  560. Thormer G, Otto J, Reiss-Zimmermann M, Seiwerts M, Moche M, Garnov N, Franz T, Do M, Stolzenburg JU, Horn LC, Kahn T, Busse H (2012). Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values. Eur Radiol, 22(8), 1820-1828.
     
  561. Hockel M, Horn LC, Einenkel J (2012). Laterally extended parametrectomy in nodal positive early stage cervical cancer: Right direction, wrong track. Gynecol Oncol, 125(3), 765-6.
     
  562. Schwalenberg T, Stolzenburg JU, Ho TP, Mallock T, Hartenstein S, Alexander H, Zimmermann G, Hohenfellner R, Denzinger S, Burger M, Horn LC, Neuhaus J (2012). Enhanced urothelial expression of human chorionic gonadotropin beta (hCGß) in bladder pain syndrome/interstitial cystitis (BPS/IC). World J Urol, 30(3), 411-417.
     
  563. Sperling T, Oldak M, Walch-Ruckheim B, Wickenhauser C, Doorbar J, Pfister H, Malejczyk M, Majewski S, Keates AC, Smola S (2012). Human papillomavirus type 8 interferes with a novel C/EBPß-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration. PLoS Pathog, 8(7), 1002833.
     
  564. Zajonz D, Langsieb C, Chavdarova L, Kellermann S, Baum P, Wickenhauser C, von Salis-Soglio G, Prietzel T (2012). [Multilocular Paget's disease in IBMPFD syndrome. A case report with 14-year follow-up]. Orthopade, 41(6), 482-487.
     
  565. Peters T, Bloch W, Pabst O, Wickenhauser C, Uthoff-Hachenberg C, Schmidt SV, Varga G, Grabbe S, Kess D, Oreshkova T, Sindrilaru A, Addicks K, Forster R, Muller W, Scharffetter-Kochanek K (2012). Adaptive immune response to model antigens is impaired in murine leukocyte-adhesion deficiency-1 revealing elevated activation thresholds in vivo. Clin Dev Immunol, 2012, 450738.
     
  566. Vester K, Treudler R, Paasch U, Becker C, Liebmann A, Simon JC, Wickenhauser C, Kunz M (2012). Specific bilateral ear infiltration as an early manifestation of chronic lymphocytic leukaemia. Eur J Dermatol, 22(2), 265-266.
     
  567. Mueller S, Wichmann G, Dornheim L, Roessling I, Bertolini J, Preim B, Dietz A, Boehm A (2012). Different approaches to volume assessment of lymph nodes in computer tomography scans of head and neck squamous cell carcinoma in comparison with a real gold standard. ANZ J Surg, 82(10), 737-741.
     
  568. Pitak-Arnnop P, Bertolini J, Dhanuthai K, Hendricks J, Hemprich A, Pausch NC (2012). Intracranial extension of Schneiderian inverted papilloma: a case report and literature review. Ger Med Sci, 10, doc12.
     
  569. Schneider M, Eichfeld U, Beller A, Baum P, Classen J, Then Bergh F (2012). [Myasthenia gravis and thymolipoma: a rare variation of a well-known theme]. Nervenarzt, 83(8), 1035-1038.
     
  570. Karger S, Krause K, Gutknecht M, Schierle K, Graf D, Steinert F, Dralle H, Fuhrer D (2012). ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours. Br J Cancer, 106(3), 562-568.
     
  571. Rassler B, Marx G, Schierle K, Zimmer HG (2012). Catecholamines Can Induce Pulmonary Remodeling in Rats. Cell Physiol Biochem, 30(5), 1134-1147.
     
  572. Koch H, Graneist C, Emmrich F, Till H, Metzger R, Aupperle H, Schierle K, Sack U, Boldt A (2012). Xenogenic esophagus scaffolds fixed with several agents: comparative in vivo study of rejection and inflammation. J Biomed Biotechnol, 2012, 948320.
     
  573. Weißflog G, Singer S, Meyer A, Wittekind C, Dietrich A, Weimann A, Brähler E, Ernst J (2012). Quality of Life of Colorectal Cancer Patients in Certified Centers versus Non-Certified Hospitals. Onkologie, 35(4), 162-168.
     
  574. Kowalzick L, Wickenhauser C, Hammerschmidt D, Pfeiffer AK, Schirmer V, Pönnighaus JM (2012). Generalisiertes anuläres elastolytisches Riesenzellgranulom bei hochmalignem B-Zell-Lymphom. Aktuelle Dermatologie, 38(5), 173-176.
     


    575. 2011


  575. Horn LC, Schierle K, Schmidt D, Ulrich U, Liebmann A, Wittekind C (2011). [Current TNM/FIGO classification for cervical and endometrial cancer as well as malignant mixed Müllerian tumors: Facts and background.] Pathologe, 32(3), 239-243.
     
  576. Meinel A, Fischer U, Bilek K, Hentschel B, Horn LC (2011). Morphological Parameters Associated With Perineural Invasion (PNI) in Carcinoma of the Cervix Uteri. Int J Surg Pathol, 19(2), 159-163.
     
  577. Gradistanac T, Wittekind C (2011). [Autopsy as a tool for quality assurance: Leipzig]. Pathologe, 32(Suppl.2), 287-291.
     
  578. Wittekind C (2011). [Pathology in Leipzig]. Pathologe, 32(Suppl. 2), 162-165.
     
  579. Wittekind C (2011). [Opening speech of the Congress President of the German Society for Pathology inc. Model roles in pathology]. Pathologe, 32(Suppl.2), 157-161.
     
  580. Horn LC, Klostermann K, Hautmann S, Hohn AK, Beckmann MW, Mehlhorn G (2011). [HPV-associated alterations of the vulva and vagina. Morphology and molecular pathology]. Pathologe, 32(6), 467-475.
     
  581. Horn LC, Klostermann K (2011). [Precancerous lesions of the uterine cervix: morphology and molecular pathology]. Pathologe, 32(Suppl.2), 242-254.
     
  582. Leonhardt K, Einenkel J, Sohr S, Engeland K, Horn LC (2011). p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Int J Gynecol Pathol, 30(5), 417-424.
     
  583. Hockel M, Horn LC (2011). Cervical cancer: balancing obstetrical and oncological outcomes. Lancet Oncol, 12(5), 422.
     
  584. Horn LC, Einenkel J (2011). Uterine perivascular epitheloid cell tumor (PEComa) with CD117 and PNL2 positivity and entrapped endometriotic glands, mimicking sex-cordlike differentiation. Ann Diagn Pathol, 15(3), 216-218.
     
  585. Horn LC, Teichmann G, Einenkel J (2011). PEComa of the uterus - a rare mesenchymal tumor: case report and review of the literature. Geburtsh Frauenheilk, 71(2), 140-143.
     
  586. von Bubnoff D, Scheler M, Wilms H, Wenzel J, von Bubnoff N, Hacker G, Schultze J, Popov A, Racz P, Bieber T, Wickenhauser C (2011). Indoleamine 2,3-dioxygenase-expressing myeloid dendritic cells and macrophages in infectious and noninfectious cutaneous granulomas. J Am Acad Dermatol, 65(4), 819-832.
     
  587. Oberschmid B, Siebolts U, Mechtel D, Kreibich U, Beller A, Wickenhauser C (2011). M protein deposition in the skin: a rare manifestation of Waldenström macroglobulinemia. Int J Hematol, 93(3), 403-405.
     
  588. Mayer A, Hockel M, Horn LC, Schmidberger H, Vaupel P (2011). GLUT-1 staining of squamous cell carcinomas of the uterine cervix identifies a novel element of invasion. Int J Oncol, 38(1), 145-150.
     
  589. Gerbaulet A, Wickenhauser C, Scholten J, Peschke K, Drube S, Horny HP, Kamradt T, Naumann R, Muller W, Krieg T, Waskow C, Hartmann K, Roers A (2011). Mast cell hyperplasia, B cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit. Blood, 117(6), 2012-2021.
     
  590. Fischer M, Horn IS, Bertolini J, Dietzsch S, Fuchs M, Dietz A (2011). [Laryngeal MALT lymphoma with known Sjögren syndrome.] HNO, 59(1), 111-1140.
     
  591. Gessner K, Wichmann G, Boehm A, Reiche A, Bertolini J, Brus J, Sterker I, Dietzsch S, Dietz A (2011). Therapeutic options for treatment of Merkel cell carcinoma. Eur Arch Otorhinolaryngol, 268(3), 443-448.
     
  592. Roth A, Schleyer E, Schoppmeyer K, Kluge R, Wittekind C, Mossner J, Wiedmann M (2011). Imatinib mesylate for palliative second-line treatment of advanced biliary tract cancer: a bicentric phase II study. Onkologie, 34(8-9), 469-470.
     
  593. Karlas T, Pfrepper C, Wiegand J, Wittekind C, Neuschulz M, Mossner J, Berg T, Troltzsch M, Keim V (2011). Acoustic radiation force impulse imaging (ARFI) for non-invasive detection of liver fibrosis: examination standards and evaluation of interlobe differences in healthy subjects and chronic liver disease. Scand J Gastroenterol, 46(12), 1458-1467.
     
  594. Ernst J, Weissflog G, Hohlfeld S, Wittekind C, Brahler E (2011). [Patient participation in medical decision making among breast cancer patients-a comparison of breast centre care units and non-centre hospitals]. Psychother Psychosom Med Psychol, 61(8), 377-382.
     
  595. Quante M, Benckert C, Thelen A, Uhlmann D, Bartels M, Moche M, Dollinger M, Wittekind C, Jonas S (2011). Liver transplantation to treat suspected hepatocellular carcinoma in iron-free foci in congenital hemochromatosis: case report. Transplant Proc, 43(5), 2066-2069.
     
  596. Karlas TF, Pfrepper C, Rosendahl J, Benckert C, Wittekind C, Jonas S, Moessner J, Troltzsch M, Tillmann HL, Berg T, Keim V, Wiegand J (2011). Acoustic radiation force impulse (ARFI) elastography in acute liver failure: necrosis mimics cirrhosis. Z Gastroenterol, 49(4), 443-448.
     
  597. Neuhaus J, Schwalenberg T, Horn LC, Alexander H, Stolzenburg JU (2011). New aspects in the differential diagnosis and therapy of bladder pain syndrome/interstitial cystitis. Adv Urol, 2011, e639479.
     
  598. Hockel M, Horn LC, Illig R, Dornhofer N, Fritsch H (2011). Ontogenetic anatomy of the distal vagina: relevance for local tumor spread and implications for cancer surgery. Gynecol Oncol, 122(2), 313-318.
     
  599. Ruger RD, Horn LC, Helbig D, Simon JC, Wetzig T, Briest S (2011). [Perimamillar located ulcerous skin lesion in a 75-year old patient]. J Dtsch Dermatol Ges, 9(2), 162-166.
     
  600. Beyer M, Thabet Y, Muller RU, Sadlon T, Classen S, Lahl K, Basu S, Zhou X, Bailey-Bucktrout SL, Krebs W, Schonfeld EA, Bottcher J, Golovina T, Mayer CT, Hofmann A, Sommer D, Debey-Pascher S, Endl E, L (2011). Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nat Immunol, 12(9), 898-907.
     
  601. Rappl G, Pabst S, Riemann D, Schmidt A, Wickenhauser C, Schutte W, Hombach AA, Seliger B, Grohe C, Abken H (2011). Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation. Clin Immunol, 140(1), 71-83.
     
  602. Klose A, Waerzeggers Y, Monfared P, Vukicevic S, Kaijzel EL, Winkeler A, Wickenhauser C, Lowik CW, Jacobs AH (2011). Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas. Neoplasia, 13(3), 276-285.
     
  603. Schroer N, Pahne J, Walch B, Wickenhauser C, Smola S (2011). Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression. Cancer Res, 71(1), 87-97.
     
  604. Moehler M, Al-Batran SE, Andus T, Anthuber M, Arends J, Arnold D, Aust D, Baier P, Baretton G, Bernhardt J, Boeing H, Bohle E, Bokemeyer C, Bornschein J, Budach W, Burmester E, Caca K et al. (2011). [German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol, 49(4), 461-531.
     
  605. Remmerbach TW, Maurer K, Janke S, Schellenberger W, Eschrich K, Bertolini J, Hofmann H, Rupf S (2011). Oral brush biopsy analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry profiling-a pilot study. Oral Oncol, 47(4), 278-281.
     
  606. Krause K, Prawitt S, Eszlinger M, Ihling C, Sinz A, Schierle K, Gimm O, Dralle H, Steinert F, Sheu SY, Schmid KW, Fuhrer D (2011). Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma. Am J Pathol, 179(6), 3066-3074.
     
  607. Singer J, Koch CA, Kassahun W, Lamesch P, Eisenhofer G, Kluge R, Lincke T, Seiwerts M, Borte G, Schierle K, Paschke R (2011). A patient with a large recurrent pheochromocytoma demonstrating the pitfalls of diagnosis. Nat Rev Endocrinol, 7(12), 749-755.
     


    608. 2010


  608. Tchernev G, Nenoff P, Patterson JW, Horn LC (2010). Sarcoidosis and sarcoid-like pathologies of the skin: result of a common pathological (immunodeficiency) process? - Authors' reply to the comment of Dr Luis Ignacio Gonzalez-Granado. J Eur Acad Dermatol Venereol, 24(4), 498-499.
     
  609. Tchernev G, Patterson JW, Nenoff P, Horn LC (2010). Sarcoidosis of the skin - A dermatological puzzle: important differential diagnostic aspects and guidelines for clinical and histopathological recognition. J Eur Acad Dermatol Venereol, 24(2), 125-137.
     
  610. Horn LC, Beckmann MW, Beller A, Schmidt D, Ulrich U, Hantschmann P, Wittekind C (2010). [Changes in the TNM classification of gynecological tumors]. Pathologe, 31(5), 367-373.
     
  611. Weber A, Schmid KW, Tannapfel A, Wittekind C (2010). [Changes in the TNM classification of head and neck tumors]. Pathologe, 31(5), 339-343.
     
  612. Tannapfel A, Wittekind C (2010). [The current TNM system for gastrointestinal tumors part II]. Pathologe, 31(5), 348-352.
     
  613. Wittekind C (2010). [TNM 2010. What's new?]. Pathologe, 31, Suppl. 2, 153-160.
     
  614. Wittekind C, Tannapfel A (2010). [The current TNM system for gastrointestinal tumors part I]. Pathologe, 31(5), 344-347.
     
  615. Sinn HP, Helmchen B, Wittekind CH (2010). [TNM classification of breast cancer: changes and comments on the 7th edition]. Pathologe, 31(5), 361-366.
     
  616. Sobin LH, Compton CA, Gospodarowicz M, Greene FL, Gunderson LL, Jessup JM, Wittekind C (2010). 'Evidence-based medicine: the time has come to set standards for staging'. Is a radical overhaul really needed? J Pathol, 221(4), 361-362.
     
  617. Wittekind C, Oberschmid B (2010). [Gastrointestinal tumors: New N classification of the UICC]. Chirurg, 81(2), 95-8.
     
  618. Goldstraw P, Sobin LH, Wittekind C (2010). Persistent Confusion on the Clinical and Pathologic Nodal Staging in Lung Cancer Respone. J Thorac Oncol, 5(2), 286-287.
     
  619. Wittekind C, Bertolini J (2010). TNM system 2010 Amendments in the new 7th edition of the TNM classification of malignant tumours. Onkologe, 16(2), 175-180.
     
  620. Wittekind C, Oberschmid B (2010). Pathology and new UICC classification of esophageal carcinoma. Onkologe, 16(5), 453-461.
     
  621. Wittekind C, Oberschmid B (2010). Anatomy and pathology of perihilar extrahepatic bile duct tumors (Klatskin tumors). Onkologe, 16(9), 841-848.
     
  622. Wittekind C, Oberschmid B (2010). New Aspects of TNM Classification of Tumors of the Intra- and Extrahepatic Bile Ducts. Viszeralmedizin, 26(3), 158-162.
     
  623. Einenkel J, Handzel R, Horn LC (2010). Persisting pregnancy of unknown location--keep your eyes peeled for choriocarcinoma. Eur J Obstet Gynecol Reprod Biol, 153(2), 229-231.
     
  624. Meinel A, Hentschel B, Horn LC (2010). Expression of COX-2 in intestinal endometriosis to: Tokyol C, et al. Int J Gynecol Pathol 2009;28:148-56. Int J Gynecol Pathol, 29(4), 341-342.
     
  625. Horn LC, Hentschel B, Einenkel J (2010). Topographic distribution of pelvic lymph node metastases in cervical cancer patients with FIGO stages IB1 to IIB [Cibula D, Abu-Rustum NR. Pelvic lymphadenectomy in cervical cancer-surgical anatomy and proposal for a new classification system. Gynecol Oncol. 2010 Jan;116(1):33-7]. Gynecol Oncol, 118(1), 93-4.
     
  626. Hockel M, Kahn T, Einenkel J, Manthey N, Braumann UD, Hildebrandt G, Leo C, Hentschel B, Vaupel P, Horn LC (2010). Local spread of cervical cancer revisited: a clinical and pathological pattern analysis. Gynecol Oncol, 117(3), 401-408.
     
  627. Horn LC, Wagner S (2010). Frozen section analysis of vulvectomy specimens: results of a 5-year study period. Int J Gynecol Pathol, 29(2), 165-172.
     
  628. Horn LC, Meinel A, Fischer U, Bilek K, Hentschel B (2010). Perineural invasion in carcinoma of the cervix uteri--prognostic impact. J Cancer Res Clin Oncol, 136(10), 1557-1562.
     
  629. Horn LC, Trost M, Bilek K (2010). Staging of endometrial carcinoma: aspects of ovarian and cervical involvement. Int J Gynecol Pathol, 29(1), 63-66.
     
  630. Klostermann K, Fahr K, Kornhofer N, Kuhndel K, Horn LC (2010). Young Women in a Center for Cervical Dysplasia. Geburtsh Frauenheilk, 70(2), 117-122.
     
  631. Siebolts U, Lange T, Niederwieser D, Wickenhauser C (2010). Allele-specific wild-type blocker quantitative PCR for highly sensitive detection of rare JAK2 p.V617F point mutation in primary myelofibrosis as an appropriate tool for the monitoring of molecular remission following therapy. J Clin Pathol, 63(4), 370-372.
     
  632. Dornauer K, Soder S, Inwards CY, Bovee JV, Aigner T (2010). Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas. Pathol Int, 60(5), 365-372.
     
  633. Krenauer A, Moll A, Ponisch W, Schmitz N, Niedobitek G, Niederwieser D, Aigner T (2010). EBV-associated post-transplantation B-cell lymphoproliferative disorder following allogenic stem cell transplantation for acute lymphoblastic leukaemia: tumor regression after reduction of immunosuppression--a case report. Diagn Pathol, 5, 21ff.
     
  634. Drienko E, Ulrich UA, Horn LC (2010). Therapie des Endometriumkarzinoms - die neue TNM- Klassifikation. Ärztl J Onkol, 6, 30-32.
     
  635. Kowalzick l, Bertolini J, Eickenscheidt L, Ehrich D, Hammerschmidt D, Schwarz M, Pännighaus JM, Wickenhauser C (2010). Wolf's isotopische Antwort: Lokale kutane B-Zell-Lymphom-Infiltration nach H. Zoster N. Trigeminus 1 Aktuelle Dermatologie, 38(12), 513-515.
     
  636. Ottaviano L, Schaefer KL, Gajewski M, Huckenbeck W, Baldus S, Rogel U, Mackintosh C, de Alava E, Myklebost O, Kresse SH, Meza-Zepeda LA, Serra M, Cleton-Jansen AM, Hogendoorn PC, Buerger H, Aigner T, (2010). Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort. Genes Chromosomes Cancer, 49(1), 40-51.
     
  637. Baranowsky A, Mokkapati S, Bechtel M, Krugel J, Miosge N, Wickenhauser C, Smyth N, Nischt R (2010). Impaired wound healing in mice lacking the basement membrane protein nidogen 1. Matrix Biol, 29(1), 15-21 .
     
  638. Do M, Haefner T, Liatsikos E, Kallidonis P, Hicks J, Dietel A, Horn LC, Rabenalt R, Stolzenburg JU (2010). Endoscopic Extraperitoneal Radical Prostatectomy After Previous Transurethral Resection of Prostate: Oncologic and Functional Outcomes of 100 Cases. Urology, 75(6), 1348-1352.
     
  639. Martin M, Mory C, Prescher A, Wittekind C, Fiedler M, Uhlmann D (2010). Protective Effects of Early CD4(+) T Cell Reduction in Hepatic Ischemia/Reperfusion Injury. J Gastrointest Surg, 14(3), 511-519.
     
  640. Wohlschlager J, Wittekind C, Theegarten D (2010). [New TNM classification of malignant lung tumours]. Pathologe, 31(5), 355-360.
     
  641. Fassnacht M, Wittekind C, Allolio B (2010). [Current TNM classification systems for adrenocortical carcinoma]. Pathologe, 31(5), 374-378.
     
  642. Teupser D, Baber R, Ceglarek U, Scholz M, Illig T, Gieger C, Holdt LM, Leichtle A, Greiser KH, Huster D, Linsel-Nitschke P, Schafer A, Braund PS, Tiret L, Stark K, Raaz-Schrauder D, Fiedler GM, Wilfer (2010). Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet, 3(4), 331-339.
     
  643. Frank H, Wittekind C, Liebert UG, Siekmeyer M, Siekmeyer W, Schuster V, Kiess W (2010). Lethal influenza B myocarditis in a child and review of the literature for pediatric age groups. Infection, 38(3), 231-235.
     
  644. Dietz A, Boehm A, Horn IS, Kruber P, Bechmann I, Golusinski W, Niederwieser D, Dollner R, Remmerbach TW, Wittekind C, Dietzsch S, Hildebrandt G, Wichmann G (2010). Assay-based response evaluation in head and neck oncology: requirements for better decision making. Eur Arch Otorhinolaryngol, 267(4), 483-494.
     
  645. Janssen MW, Druckrey-Fiskaaen KT, Omidi L, Sliwinski G, Thiele C, Donaubauer B, Polze N, Kaisers UX, Thiery J, Wittekind C, Hauss JP, Schon MR (2010). Indocyanine green R15 ratio depends directly on liver perfusion flow rate. J Hepatobiliary Pancreat Sci, 17(2), 180-185.
     
  646. Hockel M, Schmidt K, Bornmann K, Horn LC, Dornhofer N (2010). Vulvar field resection: novel approach to the surgical treatment of vulvar cancer based on ontogenetic anatomy. Gynecol Oncol, 119(1), 106-113.
     
  647. Stolzenburg JU, Kallidonis P, Do M, Dietel A, Hafner T, Rabenalt R, Sakellaropoulos G, Ganzer R, Paasch U, Horn LC, Liatsikos E (2010). A comparison of outcomes for interfascial and intrafascial nerve-sparing radical prostatectomy. Urology, 76(3), 743-748.
     
  648. Schwalenberg T, Neuhaus J, Horn LC, Alexander H, Zimmermann G, Ho Thi P, Mallock T, Stolzenburg JU (2010). [New insights in the differential diagnosis of bladder pain syndrome]. Aktuelle Urol, 41(2), 107-118.
     
  649. Mayer A, Hoeckel M, von Wallbrunn A, Horn LC, Wree A, Vaupel P (2010). HIF-mediated hypoxic response is missing in severely hypoxic uterine leiomyomas. Adv Exp Med Biol, 662, 399-405.
     
  650. Basara N, Rasche FM, Schwalenberg T, Wickenhauser C, Maier M, Ivovic J, Niederwieser D, Lindner TH (2010). Hydronephrosis Resulting from Bilateral Ureteral Stenosis: A Late Complication of Polyoma BK Virus Cystitis? J Transplant, 2010, e297358.
     
  651. Marquass B, Somerson JS, Hepp P, Aigner T, Schwan S, Bader A, Josten C, Zscharnack M, Schulz RM (2010). A novel MSC-seeded triphasic construct for the repair of osteochondral defects. J Orthop Res, 28(12), 1586-1599.
     
  652. Giovannini S, Diaz-Romero J, Aigner T, Heini P, Mainil-Varlet P, Nesic D (2010). Micromass co-culture of human articular chondrocytes and human bone marrow mesenchymal stem cells to investigate stable neocartilage tissue formation in vitro. Eur Cell Mater, 20, 245-259.
     
  653. Adler D, Aigner T, von Salis-Soglio G, Gutberlet M, Heyde CE (2010). [Nora's lesion. Discussion of a rare bone proliferation]. Orthopade, 39(11), 1065-1070.
     
  654. Wachowiak R, Till H, Metzger R, Bierbach U, Simon T, Sattler B, Aigner T, Sabri O, Kluge R (2010). Residual lymph node metastasis in stage 4 neuroblastoma - advantage of radio-guided surgery? Pediatr Hematol Oncol, 27(6), 471-475.
     
  655. Zscharnack M, Hepp P, Richter R, Aigner T, Schulz R, Somerson J, Josten C, Bader A, Marquass B (2010). Repair of chronic osteochondral defects using predifferentiated mesenchymal stem cells in an ovine model. Am J Sports Med, 38(9), 1857-1869.
     
  656. Bohm B, Hess S, Krause K, Schirner A, Ewald W, Aigner T, Burkhardt H (2010). ADAM15 exerts an antiapoptotic effect on osteoarthritic chondrocytes via up-regulation of the X-linked inhibitor of apoptosis. Arthritis Rheum, 62(5), 1372-1382.
     
  657. Singer J, Werner F, Koch CA, Bartels M, Aigner T, Lincke T, Fasshauer M, Paschke R (2010). Ectopic Cushing's syndrome caused by a well differentiated ACTH-secreting neuroendocrine carcinoma of the ileum. Exp Clin Endocrinol Diabetes, 118(8), 524-529.
     
  658. Giovannini S, Diaz-Romero J, Aigner T, Mainil-Varlet P, Nesic D (2010). Population doublings and percentage of S100-positive cells as predictors of in vitro chondrogenicity of expanded human articular chondrocytes. J Cell Physiol, 222(2), 411-420.
     
  659. Pausch NC, Bertolini J, Hemprich A, Hierl T (2010). Inclusion mucous cysts of the nose: a late complication after septorhinoplasty in two cleft lip patients. Cleft Palate Craniofac J, 47(6), 668-672.
     
  660. Mozet C, Bertolini J, Dietz A (2010). [Obstruction of the upper respiratory tract by a subglottic expansive lesion - a case of emergency]. Laryngorhinootologie, 89(1), 34-35.
     
  661. Klagge A, Krause K, Schierle K, Steinert F, Dralle H, Fuhrer D (2010). Somatostatin receptor subtype expression in human thyroid tumours. Horm Metab Res, 42(4), 237-240.
     
  662. Weidinger C, Karger S, Krause K, Schierle K, Steinert F, Gimm O, Dralle H, Fuhrer D (2010). Distinct regulation of intrinsic apoptosis in benign and malignant thyroid tumours. Horm Metab Res, 42(8), 553-556.
     
  663. Karlas T, Markuske M, Schierle K, Mossner J, Bartels M, Bodeker H (2010). [Jejunocolic fistulae after pylorus-preserving pancreatic head resection: an uncommon cause of chronic diarrhea]. Med Klin (Munich), 105(4), 253-257.
     
  664. Schwalenberg T, Neuhaus J, Alexander H, Horn LC, Stolzenburg JU (2010). Problemfall interstitielle Zystitis. Frühe Diagnose und kausale Therapie in Greifweite. Gynäkologie und Geburtshilfe , 12, 2-12.
     
  665. Wittekind C, Meyer HJ (2010). TNM Klassifikation maligner Tumoren. In: Wittekind C, Meyer HJ, TNM Klassifikation maligner Tumoren. (S. 1-295), Weinheim: Wiley-VCH.
     
  666. Bertolini J, Neid M, Wittekind C (2010). Tumorbiologische Besonderheiten des Larynx/- Hypopharynxkarzinoms - Pathologische Charakterisierung. In: Dietz A, Kopf- Hals- Tumoren - Therapie des Larynx-/Hypopharynxkarzinoms unter besonderer Berücksichtigung des Larynxorganerhalts. (S. 41-43), Bremen - London - Boston: UNI-MED- Verlag.
     


    667. 2009


  667. Horn LC, Schierle K, Klostermann K, Schnurch HG, Hantschmann P (2009). [Pathoanatomical preparation and reporting of specimens from precancerous lesions and carcinomas of the vulva] Pathologe, 30(1), 56-64.
     
  668. Prietzel T, Haferkorn I, Macher A, Schumann E, von Salis-Soglio G, Aigner T (2009). [Metastatic malignant choroidal melanoma: a case report about 18 years with palliative operative treatment] Orthopade, 38(3), 278-282.
     
  669. Sesselmann S, Soder S, Voigt R, Haag J, Grogan SP, Aigner T (2009). DNA methylation is not responsible for p21WAF1/CIP1 down-regulation in osteoarthritic chondrocytes. Osteoarthritis Cartilage, 17(4), 507-512.
     
  670. Haag J, Voigt R, Soeder S, Aigner T (2009). Efficient non-viral transfection of primary human adult chondrocytes in a high-throughput format. Osteoarthritis Cartilage, 17(6), 813-817.
     
  671. Siebolts U, Varnholt H, Drebber U, Dienes HP, Wickenhauser C, Odenthal M (2009). Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR. J Clin Pathol, 62(1), 84-88.
     
  672. Siebolts U, Breuhahn K, Hennecke A, Schultze JL, Wickenhauser C (2009). Imbalance of DNA-dependent protein kinase subunits in polycythemia vera peripheral blood stem cells. Int J Cancer, 124(3), 600-607.
     
  673. Markert E, Siebolts U, Habbig S, Odenthal M, Dienes HP, Stippel DL, Hoppe B, Wickenhauser C (2009). Evolution of PTLD following renal transplantation in a child. Pediatr Transplant, 13(3), 379-383.
     
  674. Markert E, Siebolts U, Odenthal M, Kreuzer KA, Wickenhauser C (2009). High diagnostic value of morphologic examination and molecular analysis of bone marrow biopsies in a case of BCR-ABL+ CML with clusters of blasts. Int J Hematol, 89(3), 294-297.
     
  675. Moll A, Krenauer A, Bierbach U, Till H, Hirsch W, Leuschner I, Schmitz N, Wittekind C, Aigner T (2009). Mixed hepatoblastoma and teratoma of the liver in a 3-year-old child: a unique combination and clinical challenge. Diagn Pathol, 4, 37.
     
  676. Zustin J, Aigner T (2009). [Osteoarthritis--histopathologic diagnosis: typing, grading, and staging] Orthopade, 38(6), 491-500.
     
  677. Aigner T, Schmitz N, Haag J (2009). Nanomedicine: AFM tackles osteoarthritis. Nat Nanotechnol, 4(3), 144-145.
     
  678. Wittekind C, Horn LC (2009). [Pathohistology and molecular genetic diagnostics in CUP syndrome] Pathologe, 30(2), 125-130.
     
  679. Horn LC, Dallacker M, Bilek K (2009). [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors] Pathologe, 30(4), 292-301.
     
  680. Horn LC, Schmidt D, Fathke C, Ulrich U (2009). [New FIGO staging for uterine sarcomas] Pathologe, 30(4), 302-303.
     
  681. Horn LC, Einenkel J, Vogel M (2009). [Histopathology of gestational trophoblastic disease. An update] Pathologe, 30(4), 313-323.
     
  682. Horn LC, Vogel M, Schmidt D, Ulrich U (2009). [Trophoblastic tumor registry of the German Gynecological Oncology Working Group (AGO)] Pathologe, 30(4), 324-325.
     
  683. Einenkel J, Ott R, Handzel R, Braumann UD, Horn LC (2009). Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube, or peritoneal cancer. Int J Gynecol Cancer, 19(7), 1288-1297.
     
  684. Horn LC, Hentschel B, Meinel A, Alexander H, Leo C (2009). Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions. Ann Diagn Pathol, 13(6), 373-377.
     
  685. Horn LC, Schierle K, Schmidt D, Ulrich U, Wittekind C (2009). Neues TNM/FIGO-Staging-System für das Zervix- und Endometriumkarzinom sowie maligne Müller´sche Mischtumoren (MMMT) des Uterus Geburtsh Frauenheilk, 69(12), 1078-1081.
     
  686. Horn LC, Vogel M, Schmidt D, Ulrich U (2009). Trophoblasttumorregister der Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) Geburtsh Frauenheilk, 69(9), 834-835.
     
  687. Horn LC, Klostermann K, Schnürch H-G, Hantschmann P (2009). Präkanzerosen der Vulva: Klassifikation, Morphologie und molekulare Pathogenese Geburtsh Frauenheilk, 69(2), 101-107.
     
  688. Horn LC, Schierle K (2009). Pathologie der Präkanzerosen und der Karzinome von Vulva und Vagina sowie morpholigsche Prognosefaktoren Onkologe, 15(1), 15-27.
     
  689. Horn LC, Vogel M, Schmidt D, Ulrich U (2009). Trophoblasttumorregister der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ärzteblatt Sachsen, 20(11), 584.
     
  690. Wittekind C, Oberschmid B (2009). Nutzung von Tumorklassifikationen nach neoadjuvanter Therapie Onkologe, 15(11), 1155-1166.
     
  691. Wittekind C, Compton C, Quirke P, Nagtegaal I, Merkel S, Hermanek P, Sobin LH (2009). A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status. Cancer, 115(15), 3483-3488.
     
  692. Wittekind C (2009). [Residual tumor classification in oncology -- applications and problems] Zentralbl Chir, 134(1), 3-6.
     
  693. Harms K, Wittekind C (2009). Prognosis of women with pT4b breast cancer: the significance of this category in the TNM system. Eur J Surg Oncol, 35(1), 38-42.
     
  694. Horn LC, Schierle K, Klostermann K (2009). Histologie und Molekularpathologie der vulvären Präkanzerosen. Gyn Praktische Gynäkologie, 14, 33-37.
     
  695. Horn LC, Halpick W, Bilek K, Fahr K, Hohlfeld S, Müller-Briel D, Klostermann K (2009). Das mikroinvasive Plattenepithelkarzinom der Cervix uteri - eine morphologische Herausforderung. Gyn Praktische Gynäkologie, 14, 38-41.
     
  696. Mozet C, Marin DG, Bertolini J, Tannapfel A, Wichmann G, Dietz A (2009). Nitric oxide synthase (NOS2/3) expression in head and neck squamous cell carcinomas in correlation with clinical patterns. Onkologie, 32(11), 655-660.
     
  697. Karlas T, Schierle K, Mossner J (2009). [26-year-old woman with strong, partly crampy pains in upper abdomen] Dtsch Med Wochenschr, 134(1-2), 27-28.
     
  698. Ressler S, Radhi J, Aigner T, Loo C, Zwerschke W, Sergi C (2009). Insulin-like growth factor-binding protein-3 in osteosarcomas and normal bone tissues. Anticancer Res, 29(7), 2579-2587.
     
  699. Prietzel T, Hitzler P, Wojan M, Aigner T, von Salis-Soglio G (2009). [Painful enlargement of the 2nd toe due to an osteoid osteoma in the distal phalanx] Z Orthop Unfall, 147(3), 362-365.
     
  700. Karger S, Weidinger C, Krause K, Sheu SY, Aigner T, Gimm O, Schmid KW, Dralle H, Fuhrer D (2009). FOXO3a: a novel player in thyroid carcinogenesis? Endocr Relat Cancer, 16(1), 189-199.
     
  701. Hepp P, Osterhoff G, Niederhagen M, Marquass B, Aigner T, Bader A, Josten C, Schulz R (2009). Perilesional changes of focal osteochondral defects in an ovine model and their relevance to human osteochondral injuries. J Bone Joint Surg Br, 91(8), 1110-1119.
     
  702. Eefting D, Schrage YM, Geirnaerdt MJ, Le Cessie S, Taminiau AH, Bovee JV, Hogendoorn PC (2009). Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors. Am J Surg Pathol, 33(1), 50-57.
     
  703. Braunlich J, Seyfarth HJ, Gessner C, Gradistanac T, Wirtz H (2009). [Lymphomatoid granulomatosis--a short description of an unusual case of the disease] Pneumologie, 63(12), 697-701.
     
  704. Ramirez-Backhaus M, Rabenalt R, Jain S, Do M, Liatsikos E, Ganzer R, Horn LC, Burchardt M, Jimenez-Cruz F, Stolzenburg JU (2009). Value of frozen section biopsies during radical prostatectomy: significance of the histological results. World J Urol, 27(2), 227-234.
     
  705. Emons G, Kimmig R (2009). Interdisciplinary S2k guidelines on the diagnosis and treatment of endometrial carcinoma. J Cancer Res Clin Oncol, 135(10), 1387-1391.
     
  706. Meier H, Bullinger J, Marx G, Deten A, Horn LC, Rassler B, Zimmer HG, Briest W (2009). Crucial role of interleukin-6 in the development of norepinephrine-induced left ventricular remodeling in mice. Cell Physiol Biochem, 23(4-6), 327-334.
     
  707. Schwock J, Dhani N, Cao MP, Zheng J, Clarkson R, Radulovich N, Navab R, Horn LC, Hedley DW (2009). Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts. Cancer Res, 69(11), 4750-4759.
     
  708. Hockel M, Horn LC, Manthey N, Braumann UD, Wolf U, Teichmann G, Frauenschlager K, Dornhofer N, Einenkel J (2009). Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol, 10(7), 683-692.
     
  709. Ehrhardt N, Kujat A, Faber R, Horn LC, Froster UG (2009). Potential errors with rapid analysis techniques: partial duplication 21q resulting from a paternal paracentric insertion uncovered in chorionic villus sampling by fluorescence in situ hybridization. Fetal Diagn Ther, 26(4), 219-222.
     
  710. Weis S, Wittekind C, Benckert C, Mossner J, Wittenburg H (2009). Budd Chiari syndrome without evidence for thrombosis. Is it still a Budd Chiari ? Ann Hepatol, 8(4), 388-389.
     
  711. Hein W, Kronert H, Falk V, Wittekind C, Hasenfuss G (2009). [A 17-year-old with cardiac mass and pulmonary embolism.] Internist (Berl), 50(12), 1408-1414.
     
  712. Grundmann RT, Holscher AH, Bembenek A, Bollschweiler E, Drognitz O, Feuerbach S, Gastinger I, Hermanek P, Hopt UT, Hunerbein M, Illerhaus G, Junginger T, Kraus M, Meining A, Merkel S, Meyer HJ, Monig (2009). [Diagnosis of and therapy for gastric cancer--work-flow] Zentralbl Chir, 134(4), 362-374.
     
  713. Kalata P, Martus P, Zettl H, Rodel C, Hohenberger W, Raab R, Becker H, Liersch T, Wittekind C, Sauer R, Fietkau R (2009). Differences between clinical trial participants and patients in a population-based registry: the German Rectal Cancer Study vs. the Rostock Cancer Registry. Dis Colon Rectum, 52(3), 425-437.
     
  714. Remmerbach TW, Wottawah F, Dietrich J, Lincoln B, Wittekind C, Guck J (2009). Oral cancer diagnosis by mechanical phenotyping. Cancer Res, 69(5), 1728-1732.
     
  715. Hartmann M, Siener R, Krege S, Schmelz H, Dieckmann KP, Heidenreich A, Kwasny P, Pechoel M, Lehmann J, Kliesch S, Kohrmann KU, Fimmers R, Weissbach L, Loy V, Wittekind C, Albers P (2009). [Results of the randomised phase III study of the German Testicular Cancer Study Group. Retroperitoneal lymphadenectomy versus one cycle BEP as adjuvant therapy for non-seminomatous testicular tumours in clinical stage I] Urologe A, 48(5), 523-528.
     
  716. Schmiegel W, Pox C, Arnold D, Porschen R, Rodel C, Reinacher-Schick A (2009). Colorectal carcinoma: the management of polyps, (neo)adjuvant therapy, and the treatment of metastases. Dtsch Arztebl Int, 106(51-52), 843-848.
     
  717. Sobin L H, Gospodarowicz MK, Wittekind C (2009). TNM Classification of Malignant Tumours. In: Wittekind C, TNM Classification of Malignant Tumours. (S. 0-336), Hoboken, New Jersey: John Wiley & Sons.
     
  718. Wiedammn M, Wittekind Ch, Tröltzsch M, Mössner J (2009). Benign tumours oft he Gallbaldder. In: Dancygier, H, Clinical Hepatology. Principles and Practice of Hepatobiliary Diseases. (S. 1505-1517), Heidelberg: Springer.
     


    719. 2008


  719. Horn LC, Hentschel B, Galle D, Bilek K (2008). Extracapsular extension of pelvic lymph node metastases is of prognostic value in carcinoma of the cervix uteri. Gynecol Oncol, 108(1), 63-67.
     
  720. Haag J, Gebhard PM, Aigner T (2008). SOX gene expression in human osteoarthritic cartilage. Pathobiology, 75(3), 195-199.
     
  721. Fundel K, Haag J, Gebhard PM, Zimmer R, Aigner T (2008). Normalization strategies for mRNA expression data in cartilage research. Osteoarthritis Cartilage, 16(8), 947-955.
     
  722. Aigner T, Soder S (2008). [Typing, grading and staging of osteoarthritis: histopathological assessment of joint degeneration] Z Rheumatol, 67(1), 32-36.
     
  723. Aigner T, Neureiter D, Campean V, Soder S, Amann K (2008). Expression of cartilage-specific markers in calcified and non-calcified atherosclerotic lesions. Atherosclerosis, 196(1), 37-41.
     
  724. Horn LC, Hentschel B, Braumann UD (2008). Malignancy grading, pattern of invasion, and juxtatumoral stromal response (desmoplastic change) in squamous cell carcinoma of the uterine cervix. Int J Gynecol Pathol, 27(4), 606-607.
     
  725. Horn LC, Hentschel B, Fischer U, Peter D, Bilek K (2008). Detection of micrometastases in pelvic lymph nodes in patients with carcinoma of the cervix uteri using step sectioning: Frequency, topographic distribution and prognostic impact. Gynecol Oncol, 111(2), 276-281.
     
  726. Horn LC, Liebert UG, Edelmann J, Hockel M, Einenkel J (2008). Adenoid squamous carcinoma (pseudoangiosarcomatous carcinoma) of the vulva: a rare but highly aggressive variant of squamous cell carcinoma-report of a case and review of the literature. Int J Gynecol Pathol, 27(2), 288-291.
     
  727. Horn LC, Reichert A, Oster A, Arndal SF, Trunk MJ, Ridder R, Rassmussen OF, Bjelkenkrantz K, Christiansen P, Eck M, Lorey T, Skovlund VR, Ruediger T, Schneider V, Schmidt D (2008). Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol, 32(4), 502-512.
     
  728. Horn LC, Purz S, Leo C, Stepan H (2008). Application of tissue microarrays in placental research. Ann Diagn Pathol, 12(1), 48-49.
     
  729. Horn LC, Hanel C, Bartholdt E, Dietel J (2008). Mixed serous carcinoma of the endometrium with trophoblastic differentiation: analysis of the p53 tumor suppressor gene suggests stem cell origin. Ann Diagn Pathol, 12(1), 1-3.
     
  730. Horn LC, Purz S, Krumpe C, Bilek K (2008). COX-2 and Her-2/neu are overexpressed in Paget\'s disease of the vulva and the breast: results of a preliminary study. Arch Gynecol Obstet, 277(2), 135-138.
     
  731. Nestler K, Gradistanac T, Wittekind C (2008). [Evaluation of the clinical utility of autopsy : An investigation at the Institute of Pathology, University Hospital of Leipzig.] Pathologe, 29(6), 449-454.
     
  732. Beckmann MW, Einenkel J, Thiel F, Horn LC (2008). Gestationelle und nicht-gestationelle Trophoblasterkrankungen. Frauenarzt , 49(4), 356-360.
     
  733. Einenkel J, Braumann UD, Horn LC (2008). In response to N.N. Mahajan, R.N. Soni, N.L. Gaikwad, K.N. Mahajan: Giant ovarian cysts: is a pre- and intraoperative drainage an advisable procedure? Int J Gynecol Cancer, 18(1), 206-207.
     
  734. Wittekind C, Horn LC (2008). Pathohistologische und molekulargenetische Diagnostik beim CUP-Syndrom. Onkologe, 14(9), 870-878.
     
  735. Wittekind Ch (2008). Verschiedene Aspekte des Qualitätsmanagements in der Pathologie. Onkologe, 14(12), 1268-1275.
     
  736. Wittekind Ch (2008). Biologie und Pathologie von Keimzelltumoren des Hodens. Onkologe, 14(6), 602-610.
     
  737. Neid M, Tannapfel A, Wittekind C (2008). Gastrointestinale Tumoren. Histologisches Regresionsgrading nach neoadjuvanter Therapie. Onkologe, 14(4), 409-417.
     
  738. Horn LC, Meinel A, Handzel R, Einenkel J (2008). Authors' reply to Zheng and Chambers in Annals of Diagnostic Pathology. Ann Diagn Pathol, 12(3), 232-233.
     
  739. Heinritz W, Paasch U, Sticherling M, Wittekind C, Simon JC, Froster UG, Renner R (2008). Evidence for a Founder Effect of the Germline Fumarate Hydratase Gene Mutation R58P causing Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC). Ann Hum Genet, 72(Pt1), 35-40.
     
  740. Fritzsch J, Krugel V, Aigner T, Pluta L, Schutz A (2008). Eosinophile Gastritis nach Helicobacter-pylori-Eradikation. Z Gastroenterol, 46(12), 1372-1375.
     
  741. Knerr I, Söder S, Licha E, Aigner T, Rascher W (2008). Response of HEK293 and CHO cells overexpressing fusiogenic syncytin-1 to mitochondrion-mediated apoptosis induced by antimycin A. J Cell Biochem, 105(3), 766-775.
     
  742. Ijiri K, Zerbini LF, Peng H, Otu HH, Tsuchimochi K, Otero M, Dragomir C, Walsh N, Bierbaum BE, Mattingly D, van Flandern G, Komiya S, Aigner T, Libermann TA, Goldring MB (2008). Differential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes. Arthritis Rheum, 58(7), 2075-2087.
     
  743. Krause K, Karger S, Sheu SY, Aigner T, Kursawe R, Gimm O, Schmid KW, Dralle H, Fuhrer D (2008). Evidence for a role of the amyloid precursor protein in thyroid carcinogenesis. J Endocrinol, 198(2), 291-299.
     
  744. Muehleman C, Li J, Aigner T, Rappoport L, Mattson E, Hirschmugl C, Masuda K, Rosenthal AK (2008). Association between crystals and cartilage degeneration in the ankle. J Rheumatol, 35(6), 1108-1117.
     
  745. Behnecke A, Aigner T, Rosler W, Schick B (2008). [Septal perforation and palatal defect] HNO, 56(6), 623-626.
     
  746. Duerr S, Wendler O, Aigner T, Karosi S, Schick B (2008). Metalloproteinases in juvenile angiofibroma--a collagen rich tumor. Hum Pathol, 39(2), 259-268.
     
  747. Hepp P, Engel T, Marquass B, Aigner T, Josten C, Niederhagen M (2008). Infiltration of the pes anserinus complex by an extraarticular diffuse-type giant cell tumor (D-TGCT). Arch Orthop Trauma Surg, 128(2), 155-158.
     
  748. Bigl M, Jandrig B, Horn LC, Eschrich K (2008). Aberrant methylation of human L- and M-fructose 1,6-bisphosphatase genes in cancer. Biochem Biophys Res Commun, 377(2), 720-724.
     
  749. Walther T, Jank A, Heringer-Walther S, Horn LC, Stepan H (2008). Angiotensin II type 1 receptor has impact on murine placentation. Placenta, 29(10), 905-909.
     
  750. Neuhaus J, Scholler U, Freick K, Schwalenberg T, Heinrich M, Horn LC, Stolzenburg JU (2008). [Myofibroblasts and afferent signalling in the urinary bladder. A concept] Urologe A, 47(9), 1085-1088.
     
  751. Mayer A, Hockel M, Wree A, Leo C, Horn LC, Vaupel P (2008). Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia. Cancer Res, 68(12), 4719-4726.
     
  752. Rotzoll DE, Scherling R, Etzl R, Stepan H, Horn LC, Poschl JM (2008). Immunohistochemical localization of alpha-tocopherol transfer protein and lipoperoxidation products in human first-trimester and term placenta. Eur J Obstet Gynecol Reprod Biol, 140(2), 183-191.
     
  753. Hermes M, Schormann W, Brulport M, Uhlemann K, Lupatsch F, Horn LC, Schumann A, Allgaier C, Weishaupt M, Engeland K, Muller GA, Mossner J, Bauer A, Schiffer IB, Gebhard S, Schmidt M, Lausch E, Prawitt (2008). Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model. Brit J Cancer, 98(9), 1525-1532.
     
  754. Sterker I, Hirsch W, Kortmann RD, Wittekind C, Bierbach U (2008). [Treatment strategies and results of orbital malignancies in childhood] Klin Monatsbl Augenheilkd, 225(10), 843-856.
     
  755. Haefner M, Bluethner T, Niederhagen M, Moebius C, Wittekind C, Mossner J, Caca K, Wiedmann M (2008). Experimental treatment of pancreatic cancer with two novel histone deacetylase inhibitors. World J Gastroenterol, 14(23), 3681-3692.
     
  756. Mobius C, Aust G, Wiedmann M, Wittekind C, Mossner J, Hauss J, Witzigmann H (2008). Prognostic value of eicosanoid pathways in extrahepatic cholangiocarcinoma. Anticancer Res, 28(2A), 873-878.
     
  757. Schlaak M, Renner R, Treudler R, Harth W, Poenisch W, Kauer F, Grunewald S, Wittekind C, Simon JC (2008). CD30+ anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with an unusual translocation t(11;22). Brit J Dermatol, 159(1), 240-242.
     
  758. Albers P, Siener R, Krege S, Schmelz HU, Dieckmann KP, Heidenreich A, Kwasny P, Pechoel M, Lehmann J, Kliesch S, Kohrmann KU, Fimmers R, Weissbach L, Loy V, Wittekind C, Hartmann M (2008). Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. J Clin Oncol, 26(18), 2966-2972.
     
  759. Wiedmann M, Zeh J, Schoppmeyer K, Moebius C, Niederhagen M, Wittekind C, Mossner J, Caca K (2008). Bendamustine--a new approach to the treatment of advanced hepatocellular carcinoma? J Chemother, 20(1), 112-118.
     
  760. Austinat M, Dunsch R, Wittekind C, Tannapfel A, Gebhardt R, Gaunitz F (2008). Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma. Mol Cancer, 7, 21-.
     
  761. Allum WH, Meyer HJ, Garofalo A, Schuhmacher C, de Manzoni G, Degiuli M, Kulig J, van de Velde C, Roukos D, Barr H, Nowak W, Wittekind C, Sendler A, Park K, Hartgrink H, Haringsma J, Seruca R (2008). Gastric cancer in Europe. Brit J Surg, 95(4), 406-408.
     
  762. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Stahl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, (2008). European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol, 53(3), 478-496.
     
  763. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Stahl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, (2008). European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol, 53(3), 497-513.
     
  764. Thai AC, Mohan V, Khalid BA, Cockram CS, Pan CY, Zimmet P, Yeo JP, Xing ZX, Li SH, Juming L, Mohamud WN, Ismail IS, Nadior N, Letchuman GR, Singaraveloo D, Bebaker WM, Mohan R, Cheow SP, Chuan L, Horn (2008). Islet autoimmunity status in Asians with young-onset diabetes (12-40 years): association with clinical characteristics, beta cell function and cardio-metabolic risk factors. Diabetes Res Clin Pract, 80(2), 224-230.
     
  765. Witzigmann H, Wiedmann M, Wittekind C, Mössner J, Hauss J (2008). Therapiekonzepte und Ergebnisse bei Klatskin-Tumoren Deutsches Ärzteblatt, 105(9), 156-161.
     
  766. Linke A, Höllriegel R, Walther T, Schierle K, Wittekind C, Ender J, Mohr F, Schuler G (2008). Ingrowths of a Percutaneously Implanted Aortic Valve Prosthesis (CoreValve) in a Patient With Severe Aortic Stenosis. Circ Cardiovasc Intervent, 1(2), 155-158.
     
  767. Weidenbach M, Daehnert I, Razek V, Beller A, Janousek J, Kostelka M, Anderson RH (2008). Interruption of the ascending aorta: a hitherto undescribed lesion. Ann Thorac Surg, 85(4), 1451-1453.
     
  768. Maschke J, Kluge R, Schuster V, Merkenschlager A, Neid M, Treudler R, Sabri O, Simon JC (2008). [Multilocular osteo-articular pain combined with pustular skin eruptions in an adolescent] J Dtsch Dermatol Ges, 6(8), 682-684.
     
  769. Mozet C, Wuttke P, Bertolini J, Horn LC, Dietz A (2008). Zervikale und axilläre Metastasen unbekannten Ursprungs als CUP-Syndrom. Onkologe, 14(9), 898-907.
     
  770. Thiel F, Horn LC, Jud S, Beckmann MW, Einenkel J (2008). Gestationsbedingte Trophoblasterkrankungen. Frauenheilkunde up2date, 2(4), 327-334.
     
  771. Pallasch CP, Schulz A, Kutsch N, Schwamb J, Hagist S, Kashkar H, Ultsch A, Wickenhauser C, Hallek M, Wendtner CM (2008). Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease. Blood, 112(10), 4213-4219.
     
  772. Vehr S, Nestler A, Schutz A, Halm U, Meier P (2008). [Uveitis intermedia in Whipple's disease.] Ophthalmologe, 105(11), 1046-1051.
     
  773. Kassahun WT, Lamesch P, Wittekind Ch, Neid M, Schneider JP, Mössner J, Hauss J (2008). Signet-Ring Cell Carcinoma Arising in the Gastric Stump After Duodenopancreatectomy for Ductal Adenocarcinoma of the Pancreas: A Case Report Clinical Medicine: Oncology, 2, 111-114.
     
  774. Gundling F, Wittenburg H, Tannapfel A, Mossner J (2008). Neurological presentation of Whipple\'s disease after long-term antibiotic treatment: a case report. J Med Case Reports, 2, 191-.
     
  775. Palavecino M, Wittekind C, Vauthey JN (2008). Treatment of stage IVA hepatocellular carcinoma. Arch Surg, 143(12), 1235-1236.
     
  776. Aigner T, van der Kraan P, van den Berg W (2008). Osteoarthritis and Inflammation - Inflammatory Changes in Osteoarthritic Synoviopathy. In: Buckwalter J, Lotz M, Stolz JF, Osteoarthritis, Inflammation and Degradation: A Continuum. (S. 219-235), Amsterdam, Berlin, Oxford, Tokyo, Washington DC: IOS.
     
  777. Wittekind C (2008). Dünn- und Dickdarm: Anatomie, Histologie, Embryologie, Entwicklungsanomalien. In: Riemann JF, Fischbach W, Galle PR, Mössner J, Gastroenterologie in Klinik und Praxis (in 2 Bdn.), Bd. 1: Intestinum, Bd. 2: Leber, Galle, Pankreas. (S. 605-618), Stuttgart: Thieme.
     
  778. Wittekind C (2008). Pathohistologie und Zytologie der Galle. In: Riemann JF, Fischbach W, Galle PR, Mössner J, Gastroenterologie in Klinik und Praxis (in 2 Bdn.), Bd. 1: Intestinum, Bd. 2: Leber, Galle, Pankreas. (S. 1661-1771), Stuttgart : Thieme.
     
  779. Wittekind C (2008). Dünn- und Dickdarm: Anatomie, Histologie, Embryologie, Entwicklungsanomalien. In: Riemann JF, Fischbach W, Galle PR, Mössner J, Gastroenterologie in Klinik und Praxis (in 2 Bdn.) Bd. 1: Intestinum, Bd. 2: Leber, Galle, Pankreas (S. 605-618), Stuttgart: Thieme Verlag.
     
  780. Wittekind C (2008). Pathohistologie und Zytologie der Galle. In: Riemann JF, Fischbach W, Galle PR, Mössner J, Gastroenterologie in Klinik und Praxis (in 2 Bdn.) Bd. 1: Intestinum, Bd. 2: Leber, Galle, Pankreas (S. 1661-1771), Stuttgart: Thieme Verlag.
     
  781. Wittekind C (2008). WHO und UICC Classification of Gastric Cancer. In: Deguili M, Management of Gastric Cancer. Recent Advances. (S. 111-119), Turin: Edizinione Minerva Medica.
     


    782. 2007


  782. Horn LC, Einenkel J, Hockel M, Kolbl H, Kommoss F, Lax SF, Reich O, Riethdorf L, Schmidt D (2007). [Pathoanatomical preparation and reporting for dysplasias and cancers of the cervix uteri: cervical biopsy, conization, radical hysterectomy and exenteration.] Pathologe, 28(4), 249-260.
     
  783. Horn LC, Fischer U, Raptis G, Bilek K, Hentschel B (2007). Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol, 107(2), 310-315.
     
  784. Horn LC, Meinel A, Handzel R, Einenkel J (2007). Histopathology of endometrial hyperplasia and endometrial carcinoma: an update. Ann Diagn Pathol, 11(4), 297-311.
     
  785. Horn LC, Hauptmann S, Leo C (2007). pRb, p16, and cyclin D1 in small cell carcinoma of the uterine cervix. Int J Gynecol Pathol, 26(3), 269.
     
  786. Muller S, Schwarze J, Aigner T (2007). Massive purulent peritonitis can cause a picture of fat necrosis similar to acute pancreatitis-type fat necrosis. Histopathology, 51(5), 727-728.
     
  787. Haag J, Aigner T (2007). Identification of calponin 3 as a novel Smad-binding modulator of BMP signaling expressed in cartilage. Exp Cell Res, 313(16), 3386-3394.
     
  788. Aigner T, Haag J, Zimmer R (2007). Functional genomics, evo-devo and systems biology: a chance to overcome complexity? Curr Opin Rheumatol, 19(5), 463-470.
     
  789. Fan Z, Soder S, Oehler S, Fundel K, Aigner T (2007). Activation of interleukin-1 signaling cascades in normal and osteoarthritic articular cartilage. Am J Pathol, 171(3), 938-946.
     
  790. Aigner T, Rau T, Niederhagen M, Zaucke F, Schmitz M, Pohls U, Stoss H, Rauch A, Thiel CT (2007). Achondrogenesis Type IA (Houston-Harris): a still-unresolved molecular phenotype. Pediatr Dev Pathol, 10(4), 328-334.
     
  791. Melling N, Bruder E, Dimmler A, Hohenberger W, Aigner T (2007). Localised massive tumourous xanthomatosis of the small intestine. Int J Colorectal Dis, 22(11), 1401-1404.
     
  792. Aigner T, Soder S, Gebhard PM, McAlinden A, Haag J (2007). Mechanisms of disease: role of chondrocytes in the pathogenesis of osteoarthritis--structure, chaos and senescence. Nat Clin Pract Rheumatol, 3(7), 391-399.
     
  793. Mueller S, Aigner T, Haag J, Schwarz R, Niedobitek G (2007). Senile EBV-associated B-cell lymphoproliferative disorder of prepatellar bursa in an elderly patient with multifocal urate arthropathy. Hematol Oncol, 25(3), 140-142.
     
  794. Aigner T, Gerwin N (2007). Growth plate cartilage as developmental model in osteoarthritis research--potentials and limitations. Curr Drug Targets, 8(2), 377-385.
     
  795. Aigner T, Haag J, Martin J, Buckwalter J (2007). Osteoarthritis: aging of matrix and cells--going for a remedy. Curr Drug Targets, 8(2), 325-331.
     
  796. Roach HI, Aigner T, Soder S, Haag J, Welkerling H (2007). Pathobiology of osteoarthritis: pathomechanisms and potential therapeutic targets. Curr Drug Targets, 8(2), 271-282.
     
  797. Roach HI, Aigner T (2007). DNA methylation in osteoarthritic chondrocytes: a new molecular target. Osteoarthritis Cartilage, 15(2), 128-137.
     
  798. Wittekind C (2007). [Problems with residual tumor classification, particularly R1.] Chirurg, 78(9), 785-791.
     
  799. Aigner T (2007). Editorial. Curr Opin Rheumatol, 19(5), 427-428.
     
  800. Unversucht A, Einenkel J, Horn LC (2007). Intermittierende Unterbauchschmerzen bei zystischer Raumforderung im Becken. Gynäkologe, 40(12), 1006-1008.
     
  801. Neid M, Wittekind Ch (2007). TTF-1 in der Differenzialdiagnose zwischen Lungenkarzinom und Lungenkarzinom. Möglichkeiten und Grenzen der immunologischen Diagnostik. Onkologe, 13(1), 81-89.
     
  802. Wittekind Ch, Müller S (2007). Von der Biopsieentnahme zum Pathologiebefund - Möglichkeiten und Fehler bei der Tumorklassifikation an Biopsien. Endoskopie heute, 20(1), 55-58.
     
  803. Neid M, Wittekind Ch (2007). Epidemiologie, Pathologie, Stadieneinteilung gastrointestinaler mesenchymaler und endokriner Tumoren. Chir Gastroenterol, 23(2), 108-112.
     
  804. Wittekind C (2007). R0 oder nicht R0 - das ist die Frage. Erwiderung. Pathologe, 28(4), 309-310.
     
  805. Wegner F, Strecker K, Schwarz J, Wagner A, Heinritz W, Sommerer F, Thal DR, Schneider JP, Kendziorra K, Sabri O (2007). Vascular parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic system. J Neurol, 254(12), 1743-1745.
     
  806. Ludwig S, Hauss JP, Hohlfeld S, Hildebrandt G, Horn LC, Leinung S (2007). [The Male Breast Carcinoma - A Center Experience.] Zentralbl Chir, 132(5), 386-390.
     
  807. Uhlmann D, Lauer H, Serr F, Ludwig S, Tannapfel A, Fiedler M, Hauss J, Witzigmann H (2007). Pathophysiological role of platelets in acute experimental pancreatitis: influence of endothelin A receptor blockade. Cell Tissue Res, 327(3), 485-492.
     
  808. Al-Ali HK, Wittekind C, Niederwieser D (2007). [Complete remission of relapsed mixed cellularity Hodgkin\'s disease treated with rituximab] Dtsch Med Wochenschr, 132(33), 1688-1691.
     
  809. Stolzenburg JU, Schwalenberg T, Horn LC, Neuhaus J, Constantinides C, Liatsikos EN (2007). Anatomical landmarks of radical prostatecomy. Eur Urol, 51(3), 629-639.
     
  810. Neumann S, Schoppmeyer K, Lange T, Wiedmann M, Golsong J, Tannapfel A, Mossner J, Niederwieser D, Caca K (2007). Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease. Gastrointest Endosc, 65(3), 403-409.
     
  811. Brulport M, Schormann W, Bauer A, Hermes M, Elsner C, Hammersen FJ, Beerheide W, Spitkovsky D, Hartig W, Nussler A, Horn LC, Edelmann J, Pelz-Ackermann O, Petersen J, Kamprad M, von Mach M, Lupp A, Zu (2007). Fate of extrahepatic human stem and precursor cells after transplantation into mouse livers. Hepatology, 46(3), 861-870.
     
  812. Ueberham E, Aigner T, Ueberham U, Gebhardt R (2007). E-cadherin as a reliable cell surface marker for the identification of liver specific stem cells. J Mol Histol, 38(4), 359-368.
     
  813. Frerich B, Forster M, Schiefke F, Wittekind C, Hemprich A, Sabri O (2007). Sentinel lymph node biopsy in squamous cell carcinomas of the lips and the oral cavity - a single center experience. J Surg Oncol, 95(2), 97-105.
     
  814. Sterker I, Hagert-Winkler A, Gradistanac T, Frerich B (2007). [Granular cell tumor of the orbit] Ophthalmologe, 104(9), 803-805.
     
  815. Leo C, Horn LC, Rauscher C, Hentschel B, Richter CE, Schutz A, Leo CP, Hockel M (2007). Lack of apoptotic protease activating factor-1 expression and resistance to hypoxia-induced apoptosis in cervical cancer. Clin Cancer Res, 13(4), 1149-1153.
     
  816. Einenkel J, Braumann UD, Horn LC, Pannicke N, Kuska JP, Schutz A, Hentschel B, Hockel M (2007). Evaluation of the invasion front pattern of squamous cell cervical carcinoma by measuring classical and discrete compactness. Comput Med Imaging Graph, 31(6), 428-435.
     
  817. Wentzensen N, Braumann UD, Einenkel J, Horn LC, von Knebel Doeberitz M, Loffler M, Kuska JP (2007). Combined serial section-based 3D reconstruction of cervical carcinoma invasion using H&E/p16INK4a/CD3 alternate staining. Cytometry A, 71(5), 327-333.
     
  818. Oleszczuk A, Spannbauer M, Tannapfel A, Bluher M, Hengstler J, Pietsch UC, Schuhmacher A, Wittekind C, Hauss JP, Schon MR (2007). Regenerative capacity differs between micro- and macrovesicular hepatic steatosis. Exp Toxicol Pathol, 59(3-4), 205-213.
     
  819. Leo C, Horn LC, Einenkel J, Hentschel B, Hockel M (2007). Tumor hypoxia and expression of c-met in cervical cancer. Gynecol Oncol, 104(1), 181-185.
     
  820. Braumann UD, Scherf N, Einenkel J, Horn LC, Wentzensen N, Loeffler M, Kuska JP (2007). Large histological serial sections for computational tissue volume reconstruction. Methods Inf Med, 46(5), 614-622.
     
  821. Wirz C, Bucheler M, Neid M, Dietz A, Fuchs M (2007). [Rare sialadenoma papilliferum in the hard palate: case report and survey of the literature] HNO, 55(6), 475-480.
     
  822. Seyfarth HJ, Wirtz H, Borte G, Gradistanac T, Gessner C, Hammerschmidt S (2007). [Ultrasound guided transthoracic biopsy - safety and efficaces] Pneumologie, 61(9), 563-567.
     
  823. Neuhaus J, Schwalenberg T, Schlichting N, Schulze M, Horn LC, Stolzenburg JU (2007). [New methods of patient selection for improved anticholinergic therapy.] Urologe A, 46(9), 1202-1206.
     
  824. Neuhaus J, Heinrich M, Schlichting N, Oberbach A, Fitzl G, Schwalenberg T, Horn LC, Stolzenburg JU (2007). [Structure and function of suburothelial myofibroblasts in the human urinary bladder under normal and pathological conditions.] Urologe A, 46(9), 1197-1202.
     
  825. Einenkel J, Braumann UD, Horn LC, Kuska JP, Hockel M (2007). 3-D analysis of the invasion front in squamous cell carcinoma of the uterine cervix: histopathologic evidence for collective invasion per continuitatem. Anal Quant Cytol Histol, 29(5), 279-290.
     
  826. Weber A, Hengge UR, Stricker I, Tischoff I, Markwart A, Anhalt K, Dietz A, Wittekind C, Tannapfel A (2007). Protein microarrays for the detection of biomarkers in head and neck squamous cell carcinomas. Hum Pathol, 38(2), 228-238.
     
  827. Behrbohm J, Neid M, Stolzel U, Wittekind C, Hauss JP, Tillmann HL (2007). Improvement of multiple sclerosis on tacrolimus plus mycophenolate mofetil after liver transplantation. Clinical improvement of multiple sclerosis in a patient requiring liver transplantation for acute liver failure following interferon-beta therapy. Transpl Int, 20(12), 1077-1079.
     
  828. Mobius C, Demuth C, Aigner T, Wiedmann M, Wittekind C, Mossner J, Hauss J, Witzigmann H (2007). Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma. Eur J Surg Oncol, 33(8), 1025-1029.
     
  829. Leinung S, Horn LC, Backe J (2007). [Male breast cancer: history, epidemiology, genetic and histopathology] Zentralbl Chir, 132(5), 379-385.
     
  830. Liegl B, Leibl S, Gogg-Kamerer M, Tessaro B, Horn LC, Moinfar F (2007). Mammary and extramammary Paget\'s disease: an immunohistochemical study of 83 cases. Histopathology, 50(4), 439-447.
     
  831. Einenkel J, Steller W, Braumann UD, Horn LC, Krafft C (2007). Unrealistic expectations for IR microspectroscopic imaging. Nat Biotechnol, 25(1), 29-31.
     
  832. Appleton CT, Usmani SE, Bernier SM, Aigner T, Beier F (2007). Transforming growth factor alpha suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis. Arthritis Rheum, 56(11), 3693-3705.
     
  833. Stove J, Lehmann L, Fickert S, Aigner T, Brenner R (2007). Artificial organs: a new option for treating osteoarthritis. Curr Drug Deliv, 4(1), 77-88.
     
  834. Grogan SP, Barbero A, Diaz-Romero J, Cleton-Jansen AM, Soeder S, Whiteside R, Hogendoorn PC, Farhadi J, Aigner T, Martin I, Mainil-Varlet P (2007). Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity. Arthritis Rheum, 56(2), 586-595.
     
  835. Wuhl E, Kogan J, Zurowska A, Matejas V, Vandevoorde RG, Aigner T, Wendler O, Lesniewska I, Bouvier R, Reis A, Weis J, Cochat P, Zenker M (2007). Neurodevelopmental deficits in Pierson (microcoria-congenital nephrosis) syndrome. Am J Med Genet A, 143(4), 311-319.
     
  836. Lell M, Tudor C, Aigner T, Kessler P (2007). Primary intraosseous meningioma of the mandible: CT and MR imaging features. AJNR Am J Neuroradiol, 28(1), 129-131.
     
  837. Chubinskaya S, Hakimiyan A, Pacione C, Yanke A, Rappoport L, Aigner T, Rueger DC, Loeser RF (2007). Synergistic effect of IGF-1 and OP-1 on matrix formation by normal and OA chondrocytes cultured in alginate beads. Osteoarthritis Cartilage, 15(4), 421-430.
     
  838. Haas CS, Campean V, Kuhlmann A, Dimmler A, Reulbach U, Forster C, Aigner T, Acker T, Plate K, Amann K (2007). Analysis of glomerular VEGF mRNA and protein expression in murine mesangioproliferative glomerulonephritis. Virchows Arch, 450(1), 81-92.
     
  839. Bembenek AE, Rosenberg R, Wagler E, Gretschel S, Sendler A, Siewert JR, Nahrig J, Witzigmann H, Hauss J, Knorr C, Dimmler A, Grone J, Buhr HJ, Haier J, Herbst H, Tepel J, Siphos B, Kleespies A, Koenig (2007). Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg, 245(6), 858-863.
     
  840. Fietkau R, Rodel C, Hohenberger W, Raab R, Hess C, Liersch T, Becker H, Wittekind C, Hutter M, Hager E, Karstens J, Ewald H, Christen N, Jagoditsch M, Martus P, Sauer R (2007). Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94. Int J Radiat Oncol Biol Phys, 67(4), 1008-1019.
     
  841. Bluethner T, Niederhagen M, Caca K, Serr F, Witzigmann H, Moebius C, Mossner J, Wiedmann M (2007). Inhibition of histone deacetylase for the treatment of biliary tract cancer: a new effective pharmacological approach. World J Gastroenterol, 13(35), 4761-4770.
     
  842. Hagert-Winkler A, Gradistanac T, Sterker I (2007). [Abrikossoff\'s - granular cell tumor: intraorbital a rarity] Rofo, 179(2), 171-173.
     
  843. Grimmer C, Pfander D, Swoboda B, Aigner T, Mueller L, Hennig FF, Gelse K (2007). Hypoxia-inducible factor 1alpha is involved in the prostaglandin metabolism of osteoarthritic cartilage through up-regulation of microsomal prostaglandin E synthase 1 in articular chondrocytes. Arthritis Rheum, 56(12), 4084-4094.
     
  844. Chan JC, Deerochanawong C, Shera AS, Yoon KH, Adam JM, Ta VB, Chan SP, Fernando RE, Horn LC, Nguyen TK, Litonjua AD, Soegondo S, Zimmet P (2007). Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: an Asian-Pacific perspective. Diabetes Res Clin Pract, 75(3), 255-266.
     
  845. Leinung S, Horn LC, Backe J (2007). Das Mammakarzinom des Mannes - Historie, Epidemiologie, Ätiologie, Genetik und Histopathologie Senologie, 4(4), 260-265.
     
  846. Ludwig S, Hauss JPC, Hohlfeld S, Hildebrandt G, Horn LC, Leinung S (2007). Das männliche Mammakarzinom - Erfahrungen eines Zentrums. Senologie, 4(4), 266-269.
     
  847. Henrotin Y, Blanco FJ, Aigner T, Kurz B (2007). The significance of oxidative stress in articular cartilage ageing and degradation Current Rheumatology Reviews, 3(4), 261-274.
     
  848. Pfander D, Grimmer C, Muller L, Aigner T, Cramer T (2007). Mechanisms of chondrocyte survival and matrix synthesis during hypoxia Current Rheumatology Reviews, 3(1), 3-9.
     
  849. Wittekind C (2007). Pathology. In: Cassidy J, Johnston P, van Cutsem E, Colorectal Cancer. (S. 103-123), New York: Informa HealthCare.
     
  850. Neuhaus D, Wittekind Ch (2007). Klassifikation maligner Tumoren des Gastrointestinaltrakts II. In: Neuhaus D, Wittekind Ch., Klassifikation maligner Tumoren des Gastrointestinaltrakts II. (S. 1-385), Berlin-Heidelberg: Springer Berlin Heidelberg.
     
  851. Wittekind Ch, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH (2007). TNM Atlas 5th edition. In: Wittekind Ch, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH, TNM Atlas 5th edition. (S. 1-384), Berlin Heidelberg New York: Springer Verlag.
     
  852. Wittekind Ch (2007). Klassifikation von Tumoren. In: Siewert JR, Basiswissen Chirurgie. (S. 71-82), Berlin Heidelberg New York: Springer Verlag.
     
  853. Wittekind C, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH (2007). Atlas TNM. Guida ilustrada de la clasificion TNM y p TNM de los tumores malignos. In: Wittekind C, Greene FL´, Hutter RVP, Klimpfinger M, Sobin LH, Atlas TNM. Guida ilustrada de la clasificion TNM y p TNM de los tumores malignos. (S. 1-383), Buenos Aires: Springer Verlag.
     
  854. Wittekind Ch, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH (2007). TNM Atlas 5. Auflage. In: Wittekind Ch, Greene FL´, Hutter RVP, Klimpfinger M, Sobin LH, TNM Atlas 5. Auflage. (S. 1-383), Berlin Heidelberg: Springer.
     
  855. Aigner T, van der Kraan P, van den Berg W (2007). Osteoarthritis and Inflammation - Inflammatory Changes is Osteoarthritic Synoviopathy. In: Buckwalter J, Lotz M, Stolz JF, Osteoarthritis, Inflammation and Degradation: A Continuum. (S. 219-235), Amsterdam, Berlin, Oxford, Tokyo, Washington DC: IOS.
     


    856. 2006


  856. Saas J, Haag J, Rueger D, Chubinskaya S, Sohler F, Zimmer R, Bartnik E, Aigner T (2006). IL-1beta, but not BMP-7 leads to a dramatic change in the gene expression pattern of human adult articular chondrocytes-Portraying the gene expression pattern in two donors. Cytokine, 36(1-2), 90-99.
     
  857. Neid M (2006). Intraepitheliale Neoplasie: präkanzeröse Läsion im Kopf-Hals-Bereich neu definiert. pathologie.de, 4, 8-9.
     
  858. Haag J, Aigner T (2006). Jun activation domain-binding protein 1 binds Smad5 and inhibits bone morphogenetic protein signaling. Arthritis Rheum, 54(12), 3878-3884.
     
  859. Aigner T, Fundel K, Saas J, Gebhard PM, Haag J, Weiss T, Zien A, Obermayr F, Zimmer R, Bartnik E (2006). Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum, 54(11), 3533-3544.
     
  860. Aigner T, Soder S (2006). [Histopathological examination of joint degeneration: typing, grading and staging of osteoarthritis.] Pathologe, 27(6), 431-438.
     
  861. Aigner T, Soeder S, Haag J (2006). IL-1beta and BMPs--interactive players of cartilage matrix degradation and regeneration. Eur Cell Mater, 12, 49-56.
     
  862. Aigner T (2006). Cartilage in osteoarthritic joints is not automatically osteoarthritic cartilage. Development, 133(18), 3497-3498.
     
  863. Aigner T, Sachse A, Gebhard PM, Roach HI (2006). Osteoarthritis: pathobiology-targets and ways for therapeutic intervention. Adv Drug Deliv Rev, 58(2), 128-149.
     
  864. Aigner T, Gerwin N (2006). Drug delivery in degenerative joint disease. Adv Drug Deliv Rev, 58(2), 123-124.
     
  865. Aigner T, Gebhard PM, Kueffner R, Zhang H, Marshall KW (2006). cDNA arrays in degenerative arthritis research. Future Rheumatology, 1(1), 101-109.
     
  866. Mainil-Varlet P, Fischer R, Julke H, Aigner T (2006). [Spontaneous and post-therapeutic cartilage repair: evaluation criteria.] Pathologe, 27(6), 461-468.
     
  867. Brierley JD, Greene FL, Sobin LH, Wittekind C (2006). The "y" symbol: an important classification tool for neoadjuvant cancer treatment. Cancer, 106(11), 2526-2527.
     
  868. Edelmann J, Richter K, Hanel C, Hering S, Horn LC (2006). X chromosomal and autosomal loss of heterozygosity and microsatellite instability in human cervical carcinoma. Int J Gynecol Cancer, 16(3), 1248-1253.
     
  869. Einenkel J, Alexander H, Schotte D, Stumpp P, Horn LC (2006). Giant ovarian cysts: is a pre- and intraoperative drainage an advisable procedure? Int J Gynecol Cancer, 16(6), 2039-2043.
     
  870. Fan Z, Yang H, Bau B, Soder S, Aigner T (2006). Role of mitogen-activated protein kinases and NFkappaB on IL-1beta-induced effects on collagen type II, MMP-1 and 13 mRNA expression in normal articular human chondrocytes. Rheumatol Int, 26(10), 900-903.
     
  871. Horn LC, Fischer U, Raptis G, Bilek K, Hentschel B, Richter CE, Braumann UD, Einenkel J (2006). Pattern of invasion is of prognostic value in surgically treated cervical cancer patients. Gynecol Oncol, 103(3), 906-911.
     
  872. Horn LC, Richter CE, Hentschel B, Schutz A, Pilch H, Leo C, Hockel M (2006). Juxtatumoral desmoplastic stromal reaction is associated with high tumor cell dissociation in squamous cell carcinomas of the uterine cervix. Ann Diagn Pathol, 10(5), 253-256.
     
  873. Horn LC, Kowalzik J, Bilek K, Richter CE, Einenkel J (2006). Clinicopathologic characteristics and subsequent pregnancy outcome in 139 complete hydatidiform moles. Eur J Obstet Gynecol Reprod Biol, 128(1-2), 10-14.
     
  874. Horn LC, Richter CE, Einenkel J, Tannapfel A, Liebert UG, Leo C (2006). p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium. Ann Diagn Pathol, 10(4), 193-196.
     
  875. Horn LC, Hanel C, Bartholdt E, Dietel J (2006). Serous carcinoma of the endometrium with choriocarcinomatous differentiation: a case report and review of the literature indicate the existence of 2 prognostically relevant tumor types. Int J Gynecol Pathol, 25(3), 247-251.
     
  876. Horn LC, Hentschel B, Bilek K, Richter CE, Einenkel J, Leo C (2006). Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index. Ann Diagn Pathol, 10(3), 140-143.
     
  877. Horn LC, Lindner K, Szepankiewicz G, Edelmann J, Hentschel B, Tannapfel A, Bilek K, Liebert UG, Richter CE, Einenkel J, Leo C (2006). p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix. Int J Gynecol Pathol, 25(2), 182-186.
     
  878. Horn LC, Faber R, Stepan H, Simon E, Robel R, Wittekind C (2006). Umbilical cord hypercoiling and thinning: a rare cause of intrauterine death in the second trimester of pregnancy. Pediatr Dev Pathol, 9(1), 20-24.
     
  879. Horn LC, Kowalzik J, Bilek K, Richter CE, Einenkel J (2006). Prognostic value of trophoblastic proliferation in complete hydatidiform moles in predicting persistent disease. Pathol Res Pract, 202(3), 151-156.
     
  880. Leo C, Faber S, Hentschel B, Hockel M, Horn LC (2006). The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue. Ann Diagn Pathol, 10(6), 327-332.
     
  881. Masoudi H, Van Niekerk DJ, Gilks CB, Cheang M, Bilek K, Fischer U, Ehlen T, Miller D, Horn LC (2006). Loss of p16 INK4 expression in invasive squamous cell carcinoma of the uterine cervix is an adverse prognostic marker. Histopathology, 49(5), 542-545.
     
  882. Horn LC, Bartholdt E, Dietel J (2006). Seröses Endometriumkarzinom mit choriokarzinomatöser Komponente. Geburtsh Frauenheilk, 66(10), 988-990.
     
  883. Neid M, Tannapfel A, Wittekind C (2006). Präkanzeröse Läsionen des Platteepithels im Kopf-Hals-Bereich: neue Aspekte der WHO-Klassifikation 2005 HNO-Mitteilungen, 56(3), 96-99.
     
  884. Soder S, Oliveira AM, Inwards CY, Muller S, Aigner T (2006). Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma. Pathology, 38(1), 35-38.
     
  885. Soder S, Roach HI, Oehler S, Bau B, Haag J, Aigner T (2006). MMP-9/gelatinase B is a gene product of human adult articular chondrocytes and increased in osteoarthritic cartilage. Clin Exp Rheumatol, 24(3), 302-304.
     
  886. Tischoff I, Wittekind C, Tannapfel A (2006). Role of epigenetic alterations in cholangiocarcinoma. J Hepatobiliary Pancreat Surg, 13(4), 274-279.
     
  887. Wernicke D, Seyfert C, Gromnica-Ihle E, Stiehl P (2006). The expression of collagenase 3 (MMP-13) mRNA in the synovial tissue is associated with histopathologic type II synovitis in rheumatoid arthritis. Autoimmunity, 39(4), 307-313.
     
  888. Wetzel P, Haag J, Campean V, Goldschmeding R, Atalla A, Amann K, Aigner T (2006). Bone morphogenetic protein-7 expression and activity in the human adult normal kidney is predominantly localized to the distal nephron. Kidney Int, 70(4), 717-723.
     
  889. Wittekind C (2006). [Progression of late metastases of renal cell carcinoma] Dtsch Med Wochenschr, 131(17), 994.
     
  890. Wittekind C (2006). [Pitfalls in the classification of liver tumors] Pathologe, 27(4), 289-293.
     
  891. Wittekind C, Tischoff I (2006). [Histopathological faults and their importance for staging and therapy] Zentralbl Chir, 131(2), 157-161.
     
  892. Wittekind C (2006). Residualtumorklassifikation in der Onkologie. Anwendungen und Probleme. Onkologe, 12(8), 803-813.
     
  893. Trobs RB, Sorger I, Schutz A (2006). [Sacrococcygeal extraspinal myxopapillary ependymoma] Klin Padiatr, 218(4), 243-245.
     
  894. Aigner T, Gebhard PM, Sellelmann S, Söder S, Roach HI (2006). DNA Methylation, Chondrogenesis and Cartilage Degeneration Curr Rheumatol Rev, 2(3), 221-232.
     
  895. Rami-Porta R, Wittekind C, Goldstraw P (2006). Reply to the letter to the editor by drs. Kuzdzal and zielinski. Lung Cancer, 51(1), 133-134.
     
  896. Cernaianu G, Frank S, Erbstosser K, Leonhardt S, Cross M, McIvor Z, Scholz G, Dansranjavin T, Celik I, Tannapfel A, Wittekind C, Troebs RB, Rothe K, Bennek J, Hauss J, Witzigmann H (2006). TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease model. Int J Colorectal Dis, 21(2), 143-154.
     
  897. Aust G, Wandel E, Boltze C, Sittig D, Schutz A, Horn LC, Wobus M (2006). Diversity of CD97 in smooth muscle cells. Cell Tissue Res, 324(1), 139-147.
     
  898. Steller W, Einenkel J, Horn LC, Braumann UD, Binder H, Salzer R, Krafft C (2006). Delimitation of squamous cell cervical carcinoma using infrared microspectroscopic imaging. Anal Bioanal Chem, 384(1), 145-154.
     
  899. Stolzenburg JU, Rabenalt R, Do M, Horn LC, Liatsikos EN (2006). Modular Training for Residents with no Prior Experience with Open Pelvic Surgery in Endoscopic Extraperitoneal Radical Prostatectomy. Eur Urol, 49(3), 491-498.
     
  900. Uhlmann D, Wiedmann M, Schmidt F, Kluge R, Tannapfel A, Berr F, Hauss J, Witzigmann H (2006). Management and outcome in patients with Klatskin-mimicking lesions of the biliary tree. J Gastrointest Surg, 10(8), 1144-1150.
     
  901. Karger S, Engelhardt C, Eszlinger M, Tonjes A, Herrmann F, Muller P, Schmidt T, Weiss CL, Dralle H, Lippitzsch F, Tannapfel A, Fuhrer D (2006). Cytology and mRNA expression analysis of fine needle aspirates of thyroid nodules in an East German region with borderline iodine deficiency. Horm Metab Res, 38(10), 662-667.
     
  902. Uhlig HH, Coombes J, Mottet C, Izcue A, Thompson C, Fanger A, Tannapfel A, Fontenot JD, Ramsdell F, Powrie F (2006). Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol, 177(9), 5852-5860.
     
  903. Uhlmann D, Gaebel G, Armann B, Ludwig S, Hess J, Pietsch UC, Fiedler M, Tannapfel A, Hauss J, Witzigmann H (2006). Attenuation of proinflammatory gene expression and microcirculatory disturbances by endothelin A receptor blockade after orthotopic liver transplantation in pigs. Surgery, 139(1), 61-72.
     
  904. Tonjes A, Karger S, Koch CA, Paschke R, Tannapfel A, Stumvoll M, Fuhrer D (2006). Impaired enteral levothyroxine absorption in hypothyroidism refractory to oral therapy after thyroid ablation for papillary thyroid cancer: case report and kinetic studies. Thyroid, 16(10), 1047-1051.
     
  905. Mise N, Drosten M, Racek T, Tannapfel A, Putzer BM (2006). Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2. Oncogene, 25(50), 6637-6647.
     
  906. Rastan AJ, Lachmann N, Walther T, Doll N, Gradistanac T, Gommert JF, Lehmann S, Wittekind C, Mohr FW (2006). Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ECMO). Int J Artif Organs, 29(12), 1121-1131.
     
  907. Friedrich M, Grahnert A, Paasch U, Tannapfel A, Koch-Nolte F, Hauschildt S (2006). Expression of toxin-related human mono-ADP-ribosyltransferase 3 in human testes. Asian J Androl, 8(3), 281-287.
     
  908. Gerstner AO, Thiele A, Tarnok A, Tannapfel A, Weber A, Bootz F (2006). Prediction of upper aerodigestive tract cancer by slide-based cytometry. Cytometry A, 69(7), 582-587.
     
  909. Kamenz T, Caca K, Bluthner T, Tannapfel A, Mossner J, Wiedmann M (2006). Expression of c-kit receptor in human cholangiocarcinoma and in vivo treatment with imatinib mesilate in chimeric mice. World J Gastroenterol, 12(10), 1583-1590.
     
  910. Schug-Pass C, Tamme C, Tannapfel A, Kockerling F (2006). A lightweight polypropylene mesh (TiMesh) for laparoscopic intraperitoneal repair of abdominal wall hernias: comparison of biocompatibility with the DualMesh in an experimental study using the porcine model. Surg Endosc, 20(3), 402-409.
     
  911. Stolzenburg JU, Rabenalt R, Do M, Tannapfel A, Truss MC, Liatsikos EN (2006). Nerve-sparing endoscopic extraperitoneal radical prostatectomy: University of Leipzig technique. J Endourol, 20(11), 925-929.
     
  912. Stolzenburg JU, Rabenalt R, Tannapfel A, Liatsikos EN (2006). Intrafascial nerve-sparing endoscopic extraperitoneal radical prostatectomy. Urology, 67(1), 17-21.
     
  913. Suss A, Wetzig T, Sticherling M, Tannapfel A, Simon JC (2006). [Mycosis fungoides and B-cell chronic lymphocytic leukemia: an extremely rare coincidence] Hautarzt, 57(10), 888-892.
     
  914. Dansranjavin T, Mobius C, Tannapfel A, Bartels M, Wittekind C, Hauss J, Witzigmann H (2006). E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases. Oncol Rep, 15(5), 1125-1131.
     
  915. Einenkel J, Kuska JP, Horn LC, Wentzensen N, Hockel M, Braumann UD (2006). Combined three-dimensional microscopic visualisation of tumour-invasion front of cervical carcinoma. Lancet Oncol, 7(8), 698.
     
  916. Seyfarth HJ, Hammerschmidt S, Gessner C, Gradistanac T, Wirtz H (2006). [Pulmonary hamartoma--a rare cause of recurrent pneumonia in the course of immunosuppression] Pneumologie, 60(9), 537-538.
     
  917. Wiedmann M, Feisthammel J, Bluthner T, Tannapfel A, Kamenz T, Kluge A, Mossner J, Caca K (2006). Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib. Anticancer Drugs, 17(7), 783-795.
     
  918. Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J, Wiedmann M (2006). Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg, 244(2), 230-239.
     
  919. Wolf SC, Kempf VA, Tannapfel A, Petersen P, Risler T, Brehm BR (2006). Secondary syphilis after liver transplantation: case report and review of the literature. Clin Transplant, 20(5), 644-649.
     
  920. Ziegelhoffer-Mihalovicova B, Arnold N, Marx G, Tannapfel A, Zimmer HG, Rassler B (2006). Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats. Life Sci, 79(9), 838-846.
     
  921. Grimmer C, Balbus N, Lang U, Aigner T, Cramer T, Muller L, Swoboda B, Pfander D (2006). Regulation of type II collagen synthesis during osteoarthritis by prolyl-4-hydroxylases: possible influence of low oxygen levels. Am J Pathol, 169(2), 491-502.
     
  922. Klatt AR, Klinger G, Neumuller O, Eidenmuller B, Wagner I, Achenbach T, Aigner T, Bartnik E (2006). TAK1 downregulation reduces IL-1beta induced expression of MMP13, MMP1 and TNF-alpha. Biomed Pharmacother, 60(2), 55-61.
     
  923. Morawietz L, Classen RA, Schroder JH, Dynybil C, Perka C, Skwara A, Neidel J, Gehrke T, Frommelt L, Hansen T, Otto M, Barden B, Aigner T, Stiehl P et al (2006). Proposal for a histopathological consensus classification of the periprosthetic interface membrane. J Clin Pathol, 59(6), 591-597.
     
  924. Pelttari K, Winter A, Steck E, Goetzke K, Hennig T, Ochs BG, Aigner T, Richter W (2006). Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum, 54(10), 3254-3266.
     
  925. Pfander D, Grimmer C, Aigner T, Swoboda B, Schmidt R, Cramer T (2006). Pigment epithelium derived factor--the product of the EPC-1 gene--is expressed by articular chondrocytes and up regulated in osteoarthritis. Ann Rheum Dis, 65(7), 965-967.
     
  926. Zugor V, Frank M, Krause FS, Schott GE, Aigner T, Engehausen DG (2006). [B-cell lymphoma of the testes.] Urologe A, 45(10), 1308-1311.
     
  927. Krege S, Wittekind C, Souchon R, Honecker F, Bokemeyer C, Albers P, Gschwend J, Rubben H (2006). [In Process Citation] Urologe A, 45 (Suppl. 4), 169-175.
     
  928. Leo C, Briest S, Pilch H, Schutz A, Horn LC, Leinung S (2006). Granular cell tumor of the breast mimicking breast cancer. Eur J Obstet Gynecol Reprod Biol, 127(2), 268-270.
     
  929. Leo C, Horn LC, Hockel M (2006). Hypoxia and expression of the proapoptotic regulator BNIP3 in cervical cancer. Int J Gynecol Cancer, 16(3), 1314-1320.
     
  930. Leo C, Horn LC, Rauscher C, Hentschel B, Liebmann A, Hildebrandt G, Hockel M (2006). Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apoptosis. Clin Cancer Res, 12(23), 6894-6900.
     
  931. Schonleben F, Reck T, Tannapfel A, Hohenberger W, Schneider I (2006). Collagen foil (TissuFoil E) reduces the formation of adhesions when using polypropylene mesh for the repair of experimental abdominal wall defects. Int J Colorectal Dis, 21(8), 840-846.
     
  932. Schoppmeyer K, Lange T, Wittekind C, Niederwieser D, Caca K (2006). TIPS for veno-occlusive disease following stem cell transplantation. Z Gastroenterol, 44(6), 483-486.
     
  933. Schulz T, Prietzel T, Kluge R, Schneider JP, Tannapfel A, Kahn T (2006). [Efficient diagnosis of pathological fractures] Rontgenpraxis, 56(3), 75-92.
     
  934. Stolzenburg JU, Liatsikos EN, Rabenalt R, Do M, Sakelaropoulos G, Horn LC, Truss MC (2006). Nerve sparing endoscopic extraperitoneal radical prostatectomy--effect of puboprostatic ligament preservation on early continence and positive margins. Eur Urol, 49(1), 103-111.
     
  935. Wiegand J, Neid M, Kaiser T, Wittekind C, Mossner J, Tillmann HL, Schiefke I (2006). Coexistence of autoimmune pancreatitis and primary biliary cirrhosis in a Caucasian patient - a rare cause of cholestasis. Z Gastroenterol, 44(12), 1227-1229.
     
  936. Aust G, Krohn K, Morgenthaler NG, Schroder S, Schutz A, Edelmann J, Brylla E (2006). Graves disease and Hashimoto\'s thyroiditis in monozygotic twins: case study as well as transcriptomic and immunohistological analysis of thyroid tissues. Eur J Endocrinol, 154(1), 13-20.
     
  937. Trobs RB, Knupffer M, Schutz A, Cernaianu G, Hirsch W, Regenthal R (2006). Congenital oesophageal atresia discordant for tracheo-oesophageal fistula occurring in a set of dizygotic twins. Eur J Pediatr Surg, 16(4), 260-264.
     
  938. Zenker I, Schutz A, Sorge I, Trobs RB (2006). Nodular periorchitis masquerading as a malignant parafunicular tumor in an adolescent. J Pediatr Surg, 41(1), 33-35.
     
  939. Heinritz W, Grunewald S, Strenge S, Schutz A, Froster UG, Glander HJ, Paasch U, Simon JC (2006). A case of Brooke-Spiegler syndrome with a new mutation in the CYLD gene. Br J Dermatol, 154(5), 992-994.
     
  940. Dietrich A, Becherer L, Brinckmann U, Hauss J, Liebert UG, Gutz A, Aust G (2006). Particle-mediated cytokine gene therapy leads to antitumor and antimetastatic effects in mouse carcinoma models. Cancer Biother Radiopharm, 21(4), 333-341.
     
  941. Uhlmann D, Tannapfel A, Hauss J, Witzigmann H (2006). Diagnostik und Therapie hilärer Gallengangskarzinome (Klatskin-Tumoren Chirurgische Praxis, 65, 601-611.
     
  942. Cernaianu G, Geyer C, Sommerer F, Tannapfel A, Borte G, Hirsch W, Tröbs RB (2006). Dottersackgangsrelikte – Ursache des akuten Abdomens beim Säugling päd, 12, 305-315.
     
  943. Weidenbach M, Caffier P, Harnisch T, Daehnert I (2006). Hypoplastic left heart syndrome with intact atrial septum--attempt of an interventional palliation by ductal and interatrial stent implantation. Clin Res Cardiol, 95(2), 110-114.
     
  944. Wiegand J, Peter A, Rosendahl J, Sommerer F, Mössner J, Caca K (2006). Polypoide Metastasen im gesamten Gastrointestinaltrakt – eine ungewöhnliche Manifestation eines großzelligen neuroendokrinen Karzinoms der Lunge. Coloproctology, 28(1), 9-12.
     
  945. Kreymborg KG, Seyfarth HJ, Gessner C, Schutz A, Hammerschmidt S, Eichfeld U, Borte G, Wirtz H (2006). Diagnosis of aspergilloma in a pleural cavity (persistent pneumothorax) using classic imaging methods. Mycoses, 49(3), 210-215.
     
  946. Braumann UD, Einenkel J, Horn LC, Kuska JP, Löffler M, Scherf N, Wentzensen N (2006). Registration of histologic colour images of different staining. In: Handels H, Ehrhardt J, Horsch A, Meinzer HP, Tolxdorff T, Bildverarbeitung für die Medizin. Algorithmen, Systeme, Anwendungen ; Proceedings des Workshops vom 19.-21. März 2006 in Hamburg (S. 231-235), Berlin - Heidelberg: Springer.
     
  947. Horn LC (2006). Pathogenesis of histological types of endometrial cancer. In: Lewis MA, Dietel M, Scriba PC, Raff WK, Biology and Epidemiology of Hormone Replacement Therapy. Ernst Schering Research Foundation Workshop. Supplement 13 (S. 55-62), Berlin: Springer Verlag.
     
  948. Wittekind C (2006). Klassifikation von Tumoren. In: Siewert JR, Chirurgie. (S. 161-177), Berlin: Springer Verlag.
     
  949. Wittekind C (2006). Extrahepatic biliary tract and the Ampulla of Vater Cancers. In: Gospodarowicz MK, O’Sullivan B, Sobin LH, Prognostic Factors in Cancer. (S. 147-151), New York: Wiley& Sons.
     
  950. Wittekind C (2006). Qualitätssichernde Maßnahmen bei der Entnahme von .. In: Kirste G, Beck T, Organspende in Deutschland – gemeinsam entscheiden, gemeinsam handeln. (S. 21), Neu-Isenburg: Deutsche Stiftung Organtransplantation.
     
  951. Wittekind c (2006). TNM Perfekt – Anwendungen und Probleme bei der TNM-Klassifikation. In: Kreipe H, Verhandlungen der Deutschen Gesellschaft für Pathologie. 90. Tagung (S. 142-150), München, Jena: Urban & Fischer.
     


    952. 2005


  952. Pfisterer C, Faber R, Horn LC (2005). Chorioamnionitis-induced changes of fetal extramedullar hematopoiesis in the second trimester of gestation. Is diagnosis from fetal autopsy possible? Virchows Arch, 446(2), 150-156.
     
  953. Horn LC, Kuhndel K, Pawlowitsch T, Leo C, Einenkel J (2005). Acquired lymphangioma circumscriptum of the vulva mimicking genital warts. Eur J Obstet Gynecol Reprod Biol, 123(1), 118-120.
     
  954. Greene FL, Brierley J, O'Sullivan B, Sobin LH, Wittekind C (2005). On the use and abuse of X in the TNM classification. Cancer, 103(3), 647-649.
     
  955. Horn LC, Faber S, Bilek K, Leo C (2005). Expression of COX-2 and HER-2/neu and estrogen and progesterone receptor in primary squamous cell carcinomas of the endometrium. J Cancer Res Clin Oncol, 131(4), 226-228.
     
  956. Sommerer F, Hengge UR, Markwarth A, Vomschloss S, Stolzenburg JU, Wittekind C, Tannapfel A (2005). Mutations of BRAF and RAS are rare events in germ cell tumours. Int J Cancer, 113(2), 329-335.
     
  957. Wittekind C, Neid M (2005). Cancer invasion and metastasis. Oncology, 1, 14-16.
     
  958. Schutz A, Hartig W, Wobus M, Grosche J, Wittekind Ch, Aust G (2005). Expression of ADAM15 in lung carcinomas. Virchows Arch, 446(4), 421-429.
     
  959. Tannapfel A, Vomschloss S, Karhoff D, Markwarth A, Hengge UR, Wittekind C, Arnold R, Horsch D (2005). BRAF gene mutations are rare events in gastroenteropancreatic neuroendocrine tumors. Am J Clin Pathol, 123(2), 256-260.
     
  960. Trobs RB, Handrick W, Lotz I, Bankwitz C, Tannapfel A (2005). Vertebral osteomyelitis in an infant presenting with pseudotumor and narrowing of the spinal canal. Pediatr Surg Int, 21(4), 316-319.
     
  961. Aust DE, Haase M, Dobryden L, Markwarth A, Lohrs U, Wittekind C, Baretton GB, Tannapfel A (2005). Mutations of the BRAF gene in ulcerative colitis-related colorectal carcinoma. Int J Cancer, 115(5), 673-677.
     
  962. Tischoff I, Markwarth A, Witzigmann H, Uhlmann D, Hauss J, Mirmohammadsadegh A, Wittekind C, Hengge UR, Tannapfel A (2005). Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int J Cancer, 115(5), 684-689.
     
  963. Rodel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C (2005). Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol, 23(34), 8688-8696.
     
  964. Horn LC, Braumann UD, Fischer U, Bilek K, Richter CE, Einenkel J (2005). Occult tumor cells in pelvic lymph nodes and parametrial tissue of small-sized FIGO IB1 squamous cell carcinomas of the uterine cervix--results of a pilot study. Pathol Res Pract, 201(7), 513-516.
     
  965. Horn LC, Raptis G, Fischer U, Hentschel B, Kohler U, Richter CE, Martin R (2005). CD44-v6 concentrations in carcinoma of the uterine cervix: lack of prognostic significance. Arch Gynecol Obstet, 273(2), 104-106.
     
  966. Horn LC, Dietel M, Einenkel J (2005). Hormone replacement therapy (HRT) and endometrial morphology under consideration of the different molecular pathways in endometrial carcinogenesis. Eur J Obstet Gynecol Reprod Biol, 122(1), 4-12.
     
  967. Horn LC, Einenkel J, Hockel M, Kolbl H, Kommoss F, Lax SF, Riethdorf L, Schnurch HG, Schmidt D (2005). [Recommendations for the handling and oncologic pathology report of lymph node specimens submitted for evaluation of metastatic disease in gynecologic malignancies] Pathologe, 26(4), 266-272.
     
  968. Horn LC, Limbach A, Hoepffner W, Trobs RB, Keller E, Froster UG, Richter CE, Jakubiczka S (2005). Histologic analysis of gonadal tissue in patients with Ullrich-Turner syndrome and derivative Y chromosomes. Pediatr Dev Pathol, 8(2), 197-203.
     
  969. Stepan H, Leo C, Purz S, Hockel M, Horn LC (2005). Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome. Eur J Obstet Gynecol Reprod Biol, 122(2), 172-176.
     
  970. Fritzsch J, Hennicke G, Tannapfel A (2005). [Ten fractures in 21 years.] Unfallchirurg, 108(11), 994-997.
     
  971. Weber A, Hengge UR, Bardenheuer W, Tischoff I, Sommerer F, Markwarth A, Dietz A, Wittekind C, Tannapfel A (2005). SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene, 24(44), 6699-6708.
     
  972. Hengge UR, Roth S, Tannapfel A (2005). Topical imiquimod to treat recurrent breast cancer. Breast Cancer Res Treat, 94(1), 93-94.
     
  973. Gradistanac T, Wittekind C (2005). Gastrointestinale Stromatumoren Ärzteblatt Sachsen, 16(1), 17-19.
     
  974. Horn LC, Faber S, Einenkel J, Gilks CB, Richter CE, Stepan H, Purz S, Krumpe C, Leo C (2005). Der Einsatz von Tissue Microarrays (TMA) - eine neue Technik in der gynäkologischen Tumorforschung. Geburtsh Frauenheilk, 65(1), 23-29.
     
  975. Sack U, Sehm B, Kahlenberg F, Murr A, Lehmann J, Tannapfel A, Uberla K, Moessner A, Dietrich A, Emmrich F, Lange F, Jungel A, Braun JM, Anderegg U (2005). Investigation of arthritic joint destruction by a novel fibroblast-based model. Ann N Y Acad Sci, 1051, 291-298.
     
  976. Kornberg A, Kupper B, Tannapfel A, Hommann M, Scheele J (2005). Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation. Int Immunopharmacol, 5(1), 107-115.
     
  977. Spiesbach K, Tannapfel A, Mossner J, Engeland K (2005). TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor. Int J Cancer, 114(4), 555-562.
     
  978. Hoepffner W, Horn LC, Simon E, Sauerbrei G, Schroder H, Thamm-Mucke B, Bennek J, Kiess W (2005). Gonadoblastomas in 5 Patients with 46,XY Gonadal Dysgenesis. Exp Clin Endocrinol Diabetes, 113(4), 231-235.
     
  979. Leo C, Richter C, Horn LC, Schutz A, Pilch H, Hockel M (2005). Expression of Apaf-1 in cervical cancer correlates with lymph node metastasis but not with intratumoral hypoxia. Gynecol Oncol, 97(2), 602-606.
     
  980. Einenkel J, Stumpp P, Kosling S, Horn LC, Hockel M (2005). A misdiagnosed case of caesarean scar pregnancy. Arch Gynecol Obstet, 271(2), 178-181.
     
  981. Sack U, Hirth A, Funke B, Wiedemeyer K, Lange F, Troltzsch M, Tannapfel A, Gebhardt R, Emmrich F, Lehmann J (2005). A novel model of fibroblast-mediated cartilage destruction. Scand J Immunol, 61(1), 18-28.
     
  982. Spannbauer MM, Oleszczuk A, Tannapfel A, Bluher M, Pietsch UC, Hengstler J, Donaubauer B, Madaj-Sterba P, Furll M, Schuhmacher A, Thiery J, Hauss JP, Schon MR (2005). Micro- and macrovesicular steatotic liver model for transplantation induced by ethanol and protein-deficient diet. Transplant Proc, 37(1), 210-211.
     
  983. Gerstner AO, Thiele A, Tarnok A, Machlitt J, Oeken J, Tannapfel A, Weber A, Bootz F (2005). Preoperative detection of laryngeal cancer in mucosal swabs by slide-based cytometry. Eur J Cancer, 41(3), 445-452.
     
  984. Uhlmann D, Glasser S, Gaebel G, Armann B, Ludwig S, Tannapfel A, Hauss J, Witzigmann H (2005). Improvement of postischemic hepatic microcirculation after endothelinA receptor blockade--endothelin antagonism influences platelet-endothelium interactions. J Gastrointest Surg, 9(2), 187-197.
     
  985. Pretzsch M, Scholz R, Moche M, Thomas M, Tannapfel A, von Salis-Soglio G (2005). [Biopsies of Musculoskeletal Lesions in an Open 0.5-T-MR System.] Z Orthop Ihre Grenzgeb, 143(3), 365-374.
     
  986. Yedibela S, Schuppan D, Muller V, Schellerer V, Tannapfel A, Hohenberger W, Meyer T (2005). Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation. Liver Int, 25(4), 717-722.
     
  987. Uhlmann D, Gabel G, Ludwig S, Armann B, Hess J, Pietsch UC, Tannapfel A, Fiedler M, Kratzsch J, Hass J, Witzigmann H (2005). Effects of ET(A) receptor antagonism on proinflammatory gene expression and microcirculation following hepatic ischemia/reperfusion. Microcirculation, 12(5), 405-419.
     
  988. Kassahun WT, Kahn T, Wittekind C, Mossner J, Caca K, Hauss J, Lamesch P (2005). Caroli's disease: Liver resection and liver transplantation. Experience in 33 patients. Surgery, 138(5), 888-898.
     
  989. Schoppmeyer K, Kronberg J, Tannapfel A, Mossner J, Wittekind C, Caca K (2005). Predictive value of heparanase expression in the palliative therapy of pancreatic cancer. Pancreatology, 5(6), 570-575.
     
  990. Stoeckli SJ, Pfaltz M, Ross GL, Steinert HC, MacDonald DG, Wittekind C, Soutar DS (2005). The second international conference on sentinel node biopsy in mucosal head and neck cancer. Ann Surg Oncol, 12(11), 919-924.
     
  991. Rami-Porta R, Wittekind C, Goldstraw P (2005). Complete resection in lung cancer surgery: proposed definition. Lung Cancer, 49(1), 25-33.
     
  992. Rastan AJ, Gummert JF, Lachmann N, Walther T, Schmitt DV, Falk V, Doll N, Caffier P, Richter MM, Wittekind C, Mohr FW (2005). Significant value of autopsy for quality management in cardiac surgery. J Thorac Cardiovasc Surg, 129(6), 1292-1300.
     
  993. Weidenhiller M, Muller S, Schwab D, Hahn EG, Raithel M, Winterkamp S (2005). Microscopic (collagenous and lymphocytic) colitis triggered by food allergy. Gut, 54(2), 312-313.
     
  994. Vinokurova S, Wentzensen N, Einenkel J, Klaes R, Ziegert C, Melsheimer P, Sartor H, Horn LC, Hockel M, von Knebel Doeberitz M (2005). Clonal history of papillomavirus-induced dysplasia in the female lower genital tract. J Natl Cancer Inst, 97(24), 1816-1821.
     
  995. Einenkel J, Braumann UD, Baier D, Kuska JP, Horn LC, Hockel M (2005). [Topographical anatomy of the female pelvis in ultrasound] Ultraschall Med, 26(5), 385-398.
     
  996. Braumann UD, Kuska JP, Einenkel J, Horn LC, Loffler M, Hockel M (2005). Three-dimensional reconstruction and quantification of cervical carcinoma invasion fronts from histological serial sections. IEEE Trans Med Imaging, 24(10), 1286-1307.
     
  997. Hockel M, Horn LC, Fritsch H (2005). Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in stage IB-IIB cervical carcinoma: a prospective study. Lancet Oncol, 6(10), 751-756.
     
  998. Neuhaus J, Pfeiffer F, Wolburg H, Horn LC, Dorschner W (2005). Alterations in connexin expression in the bladder of patients with urge symptoms. BJU Int, 96(4), 670-676.
     
  999. Liegl B, Horn LC, Moinfar F (2005). Androgen receptors are frequently expressed in mammary and extramammary Paget's disease. Mod Pathol, 18(10), 1283-1288.
     
  1000. Schmidt D, Horn LC, Kommoss F (2005). [Neuroendocrine carcinomas of the cervix] Pathologe, 26(4), 262-265.
     
  1001. Machlitt J, Tannapfel A, Dietz A, Weber A (2005). [Massive space requirement by the parotid gland.] HNO, 53(11), 966-968.
     
  1002. Hassan M, Mirmohammadsadegh A, Selimovic D, Nambiar S, Tannapfel A, Hengge UR (2005). Identification of functional genes during Fas-mediated apoptosis using a randomly fragmented cDNA library. Cell Mol Life Sci, 62(17), 2015-2026.
     
  1003. Mirmohammadsadegh A, Hassan M, Gustrau A, Doroudi R, Schmittner N, Nambiar S, Tannapfel A, Ruzicka T, Hengge UR (2005). Constitutive expression of epidermal growth factor receptors on normal human melanocytes. J Invest Dermatol, 125(2), 392-394.
     
  1004. Karger S, Berger K, Eszlinger M, Tannapfel A, Dralle H, Paschke R, Fuhrer D (2005). Evaluation of Peroxisome Proliferator-Activated Receptor-gamma Expression in Benign and Malignant Thyroid Pathologies. Thyroid, 15(9), 997-1003.
     
  1005. Stolzenburg JU, Rabenalt R, DO M, Ho K, Dorschner W, Waldkirch E, Jonas U, Schutz A, Horn L, Truss MC (2005). Endoscopic extraperitoneal radical prostatectomy: oncological and functional results after 700 procedures. J Urol, 174(4), 1271-1275.
     
  1006. Rastan AJ, Lachmann N, Walther T, Doll N, Gradistanac T, Wittekind C, Gummert JF, Mohr FW (2005). Reevaluierung des EuroScores durch die autoptische Untersuchung CardioNews, 8, 43-44.
     
  1007. Wirtz HR, Kroegel C, Caffier P, Bittner H (2005). Bilateral lung transplantation for severe persistent and difficult asthma. J Heart Lung Transplant, 24(10), 1700-1703.
     
  1008. Wilde F, Neid M, Schulz T, Sterker I, Hemprich A, Frerich B (2005). [Hemangiopericytoma (extrapleural solitary fibrous tumour). Exemplified and discussed on the basis of two cases] Mund Kiefer Gesichtschir, 9(6), 404-408.
     
  1009. Kassahun WT, Gunl B, Tannapfel A, Ungemach FR, Hauss J, Abraham G (2005). Alpha1-and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma: density and coupling to adenylate cyclase and phospholipase C. Naunyn Schmiedebergs Arch Pharmacol, 372(3), 171-181.
     
  1010. Rossbach C, Tannapfel A, Troebs RB, Hirsch W, Koerholz D (2005). Successful treatment of relapsed multifocal nonvisceral infantile myofibromatosis. Pediatr Hematol Oncol, 22(8), 695-698.
     
  1011. Fuhrer D, Koch CA, Trantakis C, Tannapfel A, Paschke R (2005). TSHoma with low alpha subunit in a patient with long-standing asymptomatic hyperthyroidism. Thyroid, 15(5), 489-490.
     
  1012. Rassler B, Rohling M A, Reissig C, Briest W, Tannapfel A, Zimmer H-G (2005). Involvement of Cytokines and Inflammation in Catecholamine-Induced Pulmonary Injury in Rats. Vascular Disease Prevention, 2(1), 1-9.
     
  1013. Emmrich P, Ogunlade V, Gradistanac T, Daneschnejad S, Koch MC, Schober R (2005). [Facioscapulohumeral muscle dystrophy and heart disease] Z Kardiol, 94(5), 348-354.
     
  1014. Wittekind C, Klimpfinger M, Sobin LH (2005). TNM-Atlas : illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren / UICC. In: Wittekind C, TNM-Atlas : illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren / UICC. (S. 383 S), Heidelberg: Springer-Medizin-Verlag.
     
  1015. Wittekind C (2005). TNM atlas : illustrated guide to the TNM/pTNM classification of malignant tumours / UICC, International Union Against Cancer. In: Wittekind C, TNM atlas : illustrated guide to the TNM/pTNM classification of malignant tumours. (S. 383), Berlin: Springer Verlag.
     


    1016. 2004


  1016. Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, Fossa SD, Skakkebaek NE, de Wit R, Fizazi K, Droz JP, Pizzocaro G, Daugaard G, de Mulder PH, Horwich A, Oliver T, Huddart R et al. (2004). European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol, 15(9), 1377-1399.
     
  1017. Hoheisel G, Sack U, Hui DS, Lai F, Chan KS, Choi CH, Schauer J, Tannapfel A (2004). Immunhistochemische Lokalisation von Matrixmetalloproteinasen (MMP) und ihrer Inhibitoren (tissue inhibitors of metalloproteinases, TIMP) bei tuberkulöser Pleuritis Pneumologie, 58(5), 305-308.
     
  1018. Fritzsch J, Richter M, Edelmann C, Lange R, Tannapfel A (2004). 35-jähriger Mann mit Fieber und Rundherd in der Leber Internist (Berl), 45(6), 713-716.
     
  1019. Tannapfel A, Wittekind C (2004). Gallbladder and bile duct carcinoma. Biology and pathology Internist (Berl), 45(1), 33-41.
     
  1020. Wittekind C, Rogler G (2004). Histopathologische Diagnostik Z Gastroenterol, 42(9), 994-996.
     
  1021. Kuhn T, Bembenek A, Buchels H, Decker T, Dunst J, Mullerleile U, Munz DL, Ostertag H, Sautter-Bihl ML, Schirrmeister H, Tulusan AH, Untch M, Winzer KJ, Wittekind C (2004). Sentinel-Node-Biopsie beim Mammakarzinom Pathologe, 25(3), 238-43.
     
  1022. Horn LC, Langner A, Stiehl P, Wittekind C, Faber R (2004). Identification of the causes of intrauterine death during 310 consecutive autopsies. Eur J Obstet Gynecol Reprod Biol, 113(2), 134-138.
     
  1023. Kuhn T, Bembenek A, Buchels H, Decker T, Dunst J, Mullerleile U, Munz DL, Ostertag H, Sautter-Bihl ML, Schirrmeister H, Tulusan AH, Untch M, Winzer KJ, Wittekind C (2004). [Sentinel node biopsy in breast cancer] Nuklearmedizin, 43(1), 4-9.
     
  1024. Horn LC, Schutz A, Heinemann K, Schneider JP, Einenkel J (2004). Multicystic peritoneal mesothelioma of the omentum. Eur J Obstet Gynecol Reprod Biol, 116(2), 246-247.
     
  1025. Horn LC, Do Minh M, Stolzenburg JU (2004). Intrinsic form of ureteral endometriosis causing ureteral obstruction and partial loss of kidney function. Urol Int, 73(2), 181-184.
     
  1026. Vogel M, Horn LC (2004). [Gestational trophoblastic disease, Villous gestational trophoblastic disease] Pathologe, 25(4), 269-279.
     
  1027. Horn LC, Vogel M (2004). [Gestational trophoblastic disease. Non-villous forms of gestational trophoblastic disease] Pathologe, 25(4), 281-291.
     
  1028. Horn LC, Schnurrbusch U, Bilek K, Hentschel B, Einenkel J (2004). Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment. Int J Gynecol Cancer, 14(2), 348-353.
     
  1029. Wittekind C, Gradistanac T (2004). [Is autopsy, the oldest tool of quality assurance, obsolete?] Z Arztl Fortbild Qualitatssich, 98, 715-720.
     
  1030. Wittekind C, Tischoff I (2004). Tumor classifications Pathologe, 25(6), 481-490.
     
  1031. Hoffmann JC, Zeitz M, Bischoff SC, Brambs HJ, Bruch HP, Buhr HJ, Dignass A, Fischer I, Fleig W, Folsch UR, Herrlinger K, Hohne W, Jantschek G, Kaltz B, Keller KM, Knebel U, Kroesen AJ, Kruis W et al. (2004). Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease Z Gastroenterol, 42(9), 979-983.
     
  1032. Tannapfel A (2004). Molecular findings in Barrett's epithelium. Dig Dis, 22(2), 126-133.
     
  1033. Sommerer F, Vieth M, Markwarth A, Rohrich K, Vomschloss S, May A, Ell C, Stolte M, Hengge UR, Wittekind C, Tannapfel A (2004). Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma. Oncogene, 23(2), 554-558.
     
  1034. Vieth M, Schneider-Stock R, Rohrich K, May A, Ell C, Markwarth A, Roessner A, Stolte M, Tannapfel A (2004). INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma. Virchows Arch, 445, 135-141.
     
  1035. Neid M, Datta K, Stephan S, Khanna I, Pal S, Shaw L, White M, Mukhopadhyay D (2004). Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells. J Biol Chem, 279(6), 3941-3948.
     
  1036. Wittekind C, Neid M (2004). Hodentumoren. Pathophysiologische Klassifikation und molekulare Pathogenese. Onkologe, 9, 937-942.
     
  1037. Wittekind C (2004). Darstellung und Interpretation von Tumorstrukturen mit Verfahren der Pathologie. Nova Acta Leopoldina NF, 337, 43-46.
     
  1038. Kühn T, Bembenek A, Buchels H, Decker T, Dunst J, Müllerleile U, Munz DL, Ostertag H, Sautte-Bihl ML, Schirrmeister H, Tulusan AH, Untch M, Winzer KJ, Wittekind C (2004). Sentinel-Node-Biopsie beim Mammakarzinom. Interdisziplinär Konsensus der deutschen Gesellschaft für Serologie für eine qualitätsgesicherte Anwendung in der klinischen Routine. Chirurgische Allgemeine, 5, 29-34.
     
  1039. Briest S, Pawelka MK, Leinung S, Horn LC (2004). Die Sentinel-Lymphknoten-Biopsie beim Mammakarzinom Konzept und Management Ärzteblatt Sachsen, 15(10), 480-483.
     
  1040. Wittekind C, Tannapfel A (2004). Gallenblasen- und Gallengangkarzinome – Biologie und Pathologie Chir Gastroenterol, 20(4), 242-249.
     
  1041. Braumann UD, Kuska JP, Einenkel J, Horn LC and Höckel M (2004). 3D-Reconstruction and quantification of tumour invasion for squamous cell carcinoma of the uterine cervix. Biomed Tech (Berl), 49(Suppl 2/1), 206-207.
     
  1042. Uhlmann D, Pietsch UC, Ludwig S, Hess J, Armann B, Gaebel G, Escher E, Schaffranietz L, Tannapfel A, Fiedler M, Hauss J, Witzigmann H (2004). Assessment of hepatic ischemia-reperfusion injury by simultaneous measurement of tissue pO2, pCO2, and pH. Microvasc Res, 67(1), 38-47.
     
  1043. Scheidbach H, Tannapfel A, Schmidt U, Lippert H, Kockerling F (2004). Influence of titanium coating on the biocompatibility of a heavyweight polypropylene mesh. An animal experimental model. Eur Surg Res, 36(5), 313-317.
     
  1044. Briest W, Homagk L, Baba H, Deten A, Rassler B, Tannapfel A, Wagner K, Wenger R, Zimmer H (2004). cardiac remodeling in Erythropoietin-transgenic mice. Cell Physiol Biochem, 14(4-6), 277-284.
     
  1045. Schirmacher P, Fleig WE, Tannapfel A, Langner C, Dries V, Terracciano L, Denk H, Dienes HP (2004). Bioptische Diagnostik der chronischen Hepatitis Ergebnisse einer evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft für Pathologie (DGP), der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und des Kompetenznetzes Hepatitis (HepNet) Pathologe, 25(5), 337-348.
     
  1046. Miehle K, Tannapfel A, Lamesch P, Borte G, Schenker E, Kluge R, Ott RA, Wiechmann V, Koch M, Kassahun W, Paschke R, Koch CA (2004). Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrence. J Clin Endocrinol Metab, 89(8), 3731-3736.
     
  1047. Schiefke I, Klecker C, Maier M, Oesen U, Etzrodt G, Tannapfel A, Liebert UG, Berr F (2004). Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a. Liver Int, 24(2), 98-104.
     
  1048. Stiewe T, Tuve S, Peter M, Tannapfel A, Elmaagacli AH, Putzer BM (2004). Quantitative TP73 transcript analysis in hepatocellular carcinomas. Clin Cancer Res, 10(2), 626-633.
     
  1049. Scheidbach H, Tamme C, Tannapfel A, Lippert H, Kockerling F (2004). In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: an experimental study in pigs. Surg Endosc, 18(2), 211-220.
     
  1050. Mueller P, Horn LC, Buehrdel P, Boehme HJ (2004). Hydropericardium causing sudden infant death in glycogenosis type I: osmotic injury due to percutaneous silastic catheterization. Klin Padiatr, 216(5), 294-296.
     
  1051. Trobs RB, Hoepffner W, Buhligen U, Limbach A, Keller E, Schutz A, Horn LC, Kiess W, Bennek J (2004). Video-assisted gonadectomy in children with Ullrich Turner syndrome or 46,XY gonadal dysgenesis. Eur J Pediatr Surg, 14(3), 179-184.
     
  1052. Froster UG, Heinritz W, Bennek J, Horn LC, Faber R (2004). Another case of autosomal dominant exstrophy of the bladder. Prenat Diagn, 24(5), 375-377.
     
  1053. Schmidt R, Baumann F, Knupfer H, Brauckhoff M, Horn LC, Schonfelder M, Kohler U, Preiss R (2004). CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes. Br J Cancer, 90(4), 911-916.
     
  1054. Uhlmann D, Gaebel G, Teupser D, Armann B, Tannapfel A, Ludwig S, Pietsch UC, Fiedler GM, Hauss J, Witzigmann H (2004). Changes of Vasoregulatory Gene Expression Following Hepatic Ischemia/Reperfusion and Treatment with Endothelin-A Receptor Blockade. J Cardiovasc Pharmacol, 44 Suppl 1, S100-S102.
     
  1055. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R (2004). Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 351, 1731-1740.
     
  1056. Junker A, Kretzschmar A, Bohm U, Tannapfel A, Langenbahn D, Pieck AC, Jaehde U (2004). Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis Med Monatsschr Pharm, 27(10), 349-352.
     
  1057. Müller V, Brummer D, Kissler H, Yedibela S, Bauer M, Erhardt W, Henke J, Amann K, Tannapfel A, Hohenberger W, Ott R (2004). Effects of portal vein arterialization on regeneration and morphology in liver transplantation: investigations using the rat model. Transplantation, 78(8), 1159-1165.
     
  1058. Gundling F, Kreth F, Troltzsch M, Tannapfel A, Bodeker H, Mössner J (2004). Unclear liver fibrosis in a 42-year-old patient with polycythemia vera. Internist (Berl), 45(11), 1293-1298.
     
  1059. Briest W, Homagk L, Rassler B, Ziegelhoffer-Mihalovicova B, Meier H, Tannapfel A, Leiblein S, Saalbach A, Deten A, Zimmer HG (2004). Norepinephrine-induced changes in cardiac transforming growth factor-beta isoform expression pattern of female and male rats. Hypertension, 44(4), 410-418.
     
  1060. Aust G, Sittig D, Becherer L, Anderegg U, Schütz A, Lamesch P, Schmucking E (2004). The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases. Eur J Endocrinol, 150(2), 225-234.
     
  1061. Gerstner AO, Gutsche M, Bucheler M, Machlitt J, Emmrich F, Sommerer F, Tarnok A, Bootz F (2004). Eosinophilia in nasal polyposis: its objective quantification and clinical relevance. Clin Exp Allergy, 34(1), 65-70.
     
  1062. Morawietz L, Gehrke T, Classen RA, Barden B, Otto M, Hansen T, Aigner T, Stiehl P, Neidel J, Schroder JH, Frommelt L, Schubert T, Meyer-Scholten C, Konig A, Strobel P, Rader ChP, Kirschner S, Lintner (2004). Proposal for the classification of the periprosthetic membrane from loosened hip and knee endoprostheses Pathologe, 25(5), 375-384.
     
  1063. Gessner C, Woischwill C, Schumacher A, Liebers U, Kuhn H, Stiehl P, Jurchott K, Royer HD, Witt C, Wolff G (2004). Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer. Eur Respir J, 23(1), 14-19.
     
  1064. Reichenberger F, Heberlein JU, Muller A, Wirtz H, Schauer J (2004). [Pulmonary Infiltrate, Pleural Effusion and IgM Macroglobulinaemia] Pneumologie, 58(1), 33-35.
     
  1065. Braumann UD, Kuska JP, Einenkel J, Horn LC, Höckel M (2004). How to Quantify Cervical Carcinoma Invasion Fronts in 3D? Bulletin 1/2004 of the Swiss Society of Radiobiology and Medical Physics, 53, 9-11.
     
  1066. Pohlink C, Tannapfel A, Eichfeld U, Schmidt F, Fuhrer D, Paschke R, Koch CA (2004). Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors? J Endocrinol Invest, 27(6), 565-569.
     
  1067. Uhlig HH, Stephan S, Deutscher J, Kiess W, Richter T (2004). Angiodysplasia as a cause of gastrointestinal bleeding in childhood. Klin Padiatr, 216(1), 41-44.
     
  1068. Meier C, Müller P, Dalitz E, Tannapfel A, Lotz I, Schneider JP, Richter T (2004). Budd-Chiari-Syndrom Monatsschr Kinderheilkd, 152(9), 983-986.
     
  1069. Remmerbach TW, Mathes SN, Weidenbach H, Hemprich A, Bocking A (2004). [Noninvasive brush biopsy as an innovative tool for early detection of oral carcinomas] Mund Kiefer Gesichtschir, 8(4), 229-236.
     
  1070. Gundling F, Reitmeier F, Tannapfel A, Schutz A, Weber A, Ussmuller J, Keim V, Mossner J, Teich N (2004). Chronic parotitis: not another SPINKosis. Dig Dis, 22(3), 292-295.
     
  1071. Vogtmann M, Beer J, Tannapfel A, Rodloff AC, Hoheisel G (2004). Zur Differenzialdiagnostik und Therapie bei Husten, Fieber, Brustschmerz und einseitigem Pleuraerguss Ärzteblatt Sachsen, 15(5), 191-193.
     
  1072. Tannapfel A, Wittekind Ch (2004). Chirurgische Pathologie - Evidenzbasierte Prognosefaktoren aus der Pathologie. In: Grundmann RT, Holzgreve A, Jahrbuch der Chirurgie 2004 (S. 11-20), Köln: Biermann Verlag.
     
  1073. Wittekind Ch, Tannapfel A (2004). Pathologische Morphologie und Prognosefaktoren. In: Meyer HD, Burh HJ, Wilke H, Management des Ösophagus- und Magenkarzinoms. (S. 81-92), Berlin, Heidelberg, New York: Springer Verlag.
     
  1074. Tannapfel A (2004). Pathologische Morphologie der Magenlymphome und der gastrointestinalen Stromatumoren. In: Meyer HD, Buhr HJ, Wilke H, Management des Ösophagus- und Magenkarzinoms. (S. 103-112), Berlin, Heidelberg, New York: Springer Verlag.
     
  1075. Braumann UD, Kuska JP, Einenkel J, Horn LC, Höckel M (2004). Quantification of Tumour Invasion Fronts using 3D Reconstructed Histological Serial Sections. In: Tolxdorff T, Braun J, Handels H, Horsch A, Bildverarbeitung für die Medizin 2004 - Algorithmen, Systeme, Anwendungen. Proceedings des Workshops vom 29. - 30. März 2004 in Berlin (S. 70-74), Heidelberg: Springer-Verlag.
     
  1076. Braumann UD, Kuska JP, Einenkel J, Horn LC, Höckel M (2004). 3D-Rekonstruktion und - Quantifizierung der Tumorinvasion beim Zervixkarzinom anhand histologischer Serienschnitte. In: Wolf U, Wilke W, Medizinische Physik (S. 264-265), Köln: Deutsche Gesellschaft für Medizinische Physik.